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Abstract
While evidence-based medicine (EBM) is a widely accepted feature of contemporary
medicine, the applicability of evidence to clinical practice is often questioned. The
proprietary system UpToDate has emerged as one of the most heavily used point-of-care
evidence resources. While some existing research evaluates UpToDate’s utility and features,
no critical analysis of its content exists. This thesis is a multiple, mixed methods case study
examining how evidence, authors, and the patient-physician relationship are situated in
UpToDate. A descriptive analysis of the type and features of the cited evidence, as well as an
overarching textual analysis of the clinician and patient information entries was completed
for seven cases (conditions), chosen to represent different levels of certainty (with respect to
diagnosis and/or treatment), medicalization, and contestation (with respect to the ‘legitimacy’
of a condition). Cross-case analyses were also conducted. Data analysis was informed by the
field of Science and Technology Studies, which recognizes the study and development of
science and technology as social and interactive processes. Findings indicate that, in the
absence of explicit and transparent guidelines, authors who contribute to UpToDate adhere
loosely to the general principles of EBM. The content of entries suggests that UpToDate acts
not only as an evidence provider but as a ‘mentor’ and ‘curbside consultant’ to users,
functioning as a technological surrogate for in-person interactions. UpToDate is an attempt to
bridge a real gap between evidence and practice, however, this study brings to light signs of a
‘hidden curriculum’ embedded in this clinical tool. While on the surface UpToDate is
designed to support ‘scientific’ practice by incorporating clinical judgment, expertise, and
advice about tailoring care for patients with research evidence, it may also perpetuate
physician-centred, rather than patient-centred, care, and focus on the “art” rather than
“science” of medicine, seemingly contradicting EBM’s core purposes.
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Chapter 1: Introduction and Literature Review
Introduction
The breadth and depth of medical evidence has expanded greatly in the last halfcentury. To address the information overload reported by physicians and healthcare
practitioners (Bennett, Casebeer, Kristofco & Collins, 2005; Cook, Sorensen, Wilkinson &
Berger, 2013), information resources and tools that distill and summarize clinical evidence
have been developed. These tools are rapidly becoming the go-to information sources for
clinicians who are integrating evidence into their clinical decision-making. UpToDate is
reported to be the most popular summary resource currently used by doctors (Cooper &
Elnicki, 2011; Duran-Nelson, Gladding, Beattie & Nixon, 2013; Ensan, Faghankhani,
Javanbakht, Ahmadi & Baradaran, 2011; Hoogendam, Stalenhoef, Robbe & Overbeke, 2008;
Leff & Harper, 2006; Peterson, Rowat, Kreiter & Mandel, 2004; Schilling, Steiner, Lundahl
& Anderson, 2005). By using tools such as UpToDate, physicians who may previously have
struggled to find applicable and usable answers by consulting original research publications
(Chambliss & Conley, 1996; Gorman, Ash & Wykoff, 1994; Hoogendam et al., 2008; Thiele,
Poiro, Scalzo & Nemergut, 2010) are now able to find more concise and seemingly certain
answers to their clinical questions (Campbell & Ash, 2006; Ensan et al., 2011; Hoogendam et
al., 2008).
The content of UpToDate is developed by experts in the field of clinical medicine with
the goal of articulating their recommendations to fellow clinicians. While clinical science is
often presented as objective and precise, the actual practice of medicine relies heavily on
judgment and reasoning (Turpin & Higgs, 2009). Likewise, the creation of content for
UpToDate and the related decisions regarding the inclusion and exclusion of certain
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information resources into summary resources derive from thoroughly social and interactive
processes. Using a Science and Technologies Studies (STS) lens, in which technologies and
social practices are understood to be deeply connected, this study is an attempt to discover
what information is lost and what information is privileged during the distillation of
traditional health information sources, such as clinical studies and systematic reviews, into
point of care resources, specifically, UpToDate. While the evolution and distillation
processes which occur when the results and conclusions of original studies are summarized
into systematic reviews have been well explored, the process through which clinical research
is distilled into highly synthesized summary levels of evidence for clinical practice is not
well understood. The study reported here is an attempt to begin to address this gap (Figure 1
represents the area of research interest). Further, while summary resources, like UpToDate,
have been evaluated repeatedly in terms of their timeliness, breadth, depth of coverage and
the level(s) of evidence included; a critical analysis of the distillation and summarization
processes has yet to be undertaken. This study is one of the first systematic critical analyses
of the most popular resource used in clinical practice and represents an attempt to understand
the value and meaning of UpToDate within medical practice. As such, this study will be of
interest to medical librarians, clinicians, health educators and product developers, as well as
STS scholars.
Area of
Research
Interest:

Studies
Undistilled

Synthesis

Summaries
Distillation
into
Summary
Resources

Distilled

Figure 1: The Continuum of Evidence Summarization: Area of Research Interest
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Literature Review
Evidence-Based Medicine
Prior to the evidence-based medicine movement, clinicians relied heavily on “the art of
medicine” for medical decision-making. This comprised a knowledge base combining a
clinician’s experience and the collective experiences of the profession learned primarily
through apprenticeship and modeling (Daly, 2005). The art of medicine was the dominant
approach to medical care until the 1970s, when its validity began to be questioned. The art of
medicine was considered, in part, to blame for the field of medicine being fraught with
inconsistencies, overspending, and unproven and patriarchal health care practices. The
movement towards evidence-based medicine was, in part, an effort to downplay the ‘artistic’
practice of medicine to a model of consistent clinical care based in science.
The ways in which evidence-based medicine is enacted in practice have evolved from
its roots more than four decades ago. Archie Cochrane’s 1972 text, Effectiveness and
Efficiency: Random Reflections on Health Services, laid the foundation for evidence-based
medicine. In this text, Cochrane’s goals were connected to his commitment to social justice
and his belief that limited health resources should be used to provide equitable access to
those treatments shown to be most effective through high quality research studies
(specifically, the randomized controlled trial, or RCT). Cochrane’s early text provided the
seeds of what has now evolved into the Cochrane Collaboration and, more broadly, evidencebased medicine. Building on his early writings, in 1979 Cochrane called for the medical
profession to create an organized collection of summarized RCTs (Cochrane, 1979). A
decade later, Cochrane made the first reference to a systematic review of RCTs in obstetric
care, referring to the review as “a real milestone in the history of randomized trials and in the
evaluation of care” (Cochrane, 1989, p. 3). He urged health practitioners to continue this
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practice in support of what was later termed evidence-based medicine. Five years following
Cochrane’s death in 1993, the Cochrane Collaboration, a not-for-profit volunteer
organization committed to the systematic organization of medical research, was established
and over time many of his ideas came to fruition.
Following soon after the development of the Cochrane Collaboration, in 1995, Frank
Davidoff and his colleagues launched the journal Evidence-based Medicine and provided the
following description:
Evidence-based medicine is rooted in five linked ideas: firstly, clinical decisions
should be based on the best available scientific evidence; secondly, the clinical
problem, rather than habits or protocols, should determine the evidence to be
sought; thirdly, identifying the best evidence means using epidemiological and
biostatistical ways of thinking; fourthly, conclusions derived from identifying and
critically appraising evidence are useful only if put into action in managing
patients or making health care decisions; and, finally, performance should be
constantly evaluated. (Davidoff, Haynes, Sackett & Smith, 1995, pp. 1085-1086)
Davidoff et al. provided the first and most comprehensive definition of evidence-based
medicine (Cohen, Stavri & Hersch, 2004). One year later, Canadian physician David Sackett
and his colleagues (1996) formalized and defined the term Evidence-based Medicine (EBM)
as “the conscientious, explicit and judicious use of current best evidence in making decisions
about the care of individual patients” (p. 71). It is this definition that is commonly used and
operationalized. EBM is intended to bring a scientific foundation to clinical work and to
assist physicians to apply results from the vast amount of medical research to clinical
practice. As a result of the EBM movement, publishers, clinicians and authors have
developed new types of information tools and resources, including systematic reviews and
the very popular electronic point of care information tools, including UpToDate 1.

1

Other summary resources available include DynaMed and FIRSTConsult
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STS Perspective: EBM as a Technology of Medicine
Science and Technology Studies (STS) is a diverse and innovative field of
scholarship in which numerous fields of study, including sociology, history, philosophy,
anthropology, technology, medicine and information science, intersect. STS provides a
unique and much needed perspective on information technologies. Outside STS, technologies
are often conceived of as relatively straightforward and practical applications of science;
however, scholars of STS challenge this assumption and examine science and technology as
social activities. STS scholars assert that while scientists and engineers use the material
world in their work, their work is not merely translated into knowledge and objects by a
mechanical process, but rather through thoroughly social and interactive processes
(Sismondo, 2010). A necessity of scientific development is the sharing of research results
within and between scientific communities. Research can be challenged, defended,
supported, or built upon—but all scientific sharing and exchange is social and interactive.
Similarly, the process of distilling the body of clinical research into a usable and summarized
format is not a mechanical or neutral process but rather a process driven by social
interactions and personal judgment. Clinical experts make choices during the summarization
process about what information to include and what information to discard. These choices are
made not only at the resource level (what clinical studies to include or reject) but also at the
content level (what information that was reported in the clinical research to privilege enough
to include in these short summaries). The type of information that is included or excluded is
significant because summary resources are developed as a means to convince or at least
explain to physicians the best approach to clinical care.
STS provides an important and helpful lens to study the development, design and use
of information technologies. Information and STS scholars, Bowker and Star (2000),
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explored the ways in which information is formally and informally categorized and
classified. Their observations about the informal and invisible categorizations of information
that exist in communities of practice are helpful to understand the development and creation
of summarized resources. Systems that are used to organize knowledge and information
shape what we know and how we understand our environment. Bowker and Star suggest that
communities of practice (or groups of individuals who conduct activities together and share
items, processes and routines associated with these activities) often share ‘naturalized’
systems of categories of information. Naturalization occurs when individuals and
communities forget about how a system or object is created and lose sight of the situated
nature of such a system. Members of communities often forget that the meanings of such
systems or objects embedded in their activities are local in nature. The more entrenched
individuals become in a community, the more likely they are to forget that their own
categories may seem odd or out of place to those outside the community. Bowker and Star
use the example of the anachronistic “cut and paste” metaphor used for using a mouse,
selecting text, and digitally moving the text from one space to another. A basic medical
example is physicians’ routine use of the word negative to mean ‘normal.’ For example,
“your blood test came back negative for mono”. Conversely, ‘positive’ is used to imply an
abnormal result, which signifies bad news. Bowker and Star suggest that infrastructural
technologies “become a form of collective forgetting, or naturalization, of the contingent,
messy work that they replace” (p. 299). As these systems become increasingly embedded
into communities, they also become more invisible and more potent. The exploration of such
classifications is important because they may have significant political and ethical
dimensions and consequences. In this study, evidence selected by the community of
physicians who create and develop the summarized information for UpToDate was
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examined. The types of research and evidence selected as references for UpToDate content,
as well as what content is selected for inclusion in the UpToDate entries, were investigated.
In addition to gaining an understanding of the information included in the evidence
summaries, some of the features of the evidence not included in the entry were identified. As
Bowker and Star point out, there is value in understanding what and who are left out or
remain invisible within a community’s information categories.
When problems of knowledge and practice arise in healthcare, technological solutions
are often advocated (May, Rapley, Moreira, Finch & Heaven, 2006). Technologies such as
the electronic health record, patient blood pressure monitoring devices, diabetic insulin and
blood glucose meters are technological solutions for problems encountered in health care and
these technologies have been investigated by STS scholars. Similarly, the tools that deliver
health evidence to professionals, as well as the evidence itself, are technologies that also
warrant attention using an STS lens.
May (2007) has examined information innovations in clinical care. He suggests that
while autonomy and control over knowledge is a hallmark of professionalism, the current
information landscape in medical practice poses two challenges to physicians’ autonomy and
control over their knowledge. First, because medical knowledge is continually expanding, the
body of medical knowledge is impossible to master and within this massive corpus of
knowledge are variations and contradictions that bring about uncertainties and
inconsistencies in practice (Haynes, 2001). Second, physicians are faced with health policies
and practices, such as patient centered care 2, that increasingly rest on the assumption that
patients are active consumers of health information and capable of developing their own

2

The IOM (Institute of Medicine) defines patient-centered care as: "Providing care that is respectful
of and responsive to individual patient preferences, needs, and values, and ensuring that patient values
guide all clinical decisions".

8
expertise, assessing and choosing treatment options, and managing personal illness
trajectories (May, 2007). It is in the context of these two attributes of the health information
landscape that evidence-based medicine and its related tools are proliferating, including
summary sources such as UpToDate.
Circuit of Culture. Scholars of Science and Technology Studies have an interest in
how technologies acquire cultural meaning, shape our environments, and enact the cultures in
which they are created. One model which is helpful in understanding the cultural meaning
and value of an object is Hall’s Circuit of Culture. The Circuit of Culture framework is made
up of five coexisting processes: Representation; Production; Consumption; Identity; and
Regulation, which are all connected and interconnected (du Gay, Hall, Janes, Mackay &
Negus, 1997). The resulting Circuit provides a means to understand the cultural text or
artefact through examination of “how it is represented, what social identities are associated
with it, how it is produced and created, and what mechanisms regulate its distribution and
use” (du Gay et al., p. 3). Originally used to understand the cultural meaning of the
Walkman, the Circuit of Culture provides a framework to garner a greater understanding of
the shared meaning of textual objects and technologies, like UpToDate, within contemporary
medical and information environments (Hall, 1997).
Resistance to and Acceptance of EBM
Evidence-based medicine garners both significant support, and critique. The
professional and scholarly body of literature addressing evidence-based medicine is replete
with voices from both positions. Both sides are passionate, as evidenced by the zealous
language used: those who celebrate EBM often describe it using terms of religion and
salvation, while those who are critical sometimes rely on radical political and authoritative
language to support their claims.
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Resistance to EBM. Published literature highlighting the shortcomings and
limitations of EBM emerged quickly after Davidoff and colleagues first defined it in 1995
(Feinstein & Horowitz, 1997; Horowitz, 1996; Maynard, 1997; Naylor, 1995). The number
of scholars who express criticism and concern over the adoption of EBM has continued to
grow in the last two decades (Freshwater & Rolfe, 2004; Goldenberg 2006, 2010; Green,
2000; Holmes, Murray, Perron & Rail, 2006; Staller, 2006).
In a 2004 review, Cohen et al. identified five themes found in EBM critiques : 1)
EBM is based on empiricism, misunderstands or misrepresents the philosophy of science,
and is a poor philosophic basis for medicine; 2) the definition of evidence in EBM is too
narrow and excludes important information; 3) the usability and application of evidence to
individual patients is limited; 4) EBM threatens the autonomy of the patient and physicians’
relationship; and 5) there is no evidence that EBM is effective, and therefore, EBM itself is
not evidence-based (re-ordered from Cohen et al.). These themes, described by Cohen et al. a
decade ago, continue to be explored in current publications. Of particular interest in current
research are the first four themes:
EBM is based on empiricism, a poor philosophic basis for medicine. One of the
foundational concepts of EBM is that studies that ‘count’ as evidence should adhere to the
guidelines of positivistic quantitative research and provide an evidence base that minimizes
bias and attempts to generate an objective observer. However, EBM conflates the aim to
reduce bias and ensure objectivity with the notion that these qualities are actually achieved in
empirical research (Cohen, Stavri & Hersh, 2004). As a result of having the focus on
observation rather than understanding as the basis of medical knowledge, EBM is criticized
for disconnecting medicine from its scientific roots. Medical practitioners also condemn
EBM for drawing their focus away from understanding physiological processes and the
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mechanisms of disease towards evaluating the statistical purity of studies (Charlton & Miles,
1998). The objectivity, evaluation, and bias inherent in observation gives rise to the criticism
that the epistemological approach of empiricism on which EBM is based is inappropriate for
medicine and draws attention away from more scientific and holistic understandings.
The definition of evidence in EBM is too narrow and excludes important
information. The notion of ‘best’ evidence is a key concept in all definitions of evidencebased medicine. EBM ranks and grades evidence with the goal of excluding poor evidence
and including only the best evidence. EBM has identified and defined the best study design
for the array of clinical questions including diagnosis (cross sectional study), prognosis
(cohort study), aetiology (cohort study); however, the preeminent example of this
classification of research quality is the randomized controlled trial (RCT) as the best
evidence for the evaluation of interventions. The evidence defined as best is given
precedence – in a literal hierarchy - over all other types of evidence such as ethnographic
studies, qualitative research, or clinical experience/case study/anecdote.
The criticism of the RCT is longstanding. In 1991, Alvan Feinstein accused clinical
epidemiologists of being obsessed with RCTs, assuming that the methodology possesses a
superior form of truth, rather than recognizing it merely as an effective method for assessing
whether treatment A is better than treatment B (Daly, 2005, p.104). The restriction on the
types of results considered to be ‘evidence’ within specific types of research designs, namely
the RCT, has given rise to multiple critiques. First, the RCT can only answer a limited
number of types of questions. Research topics, such as quality of life and personal wellness
in relation to treatment protocols, require more subjective evaluation (qualitative methods or
natural observation) and cannot be effectively investigated by the methods that EBM deems
‘best’ (or even acceptable). Second, when epidemiological and statistical methods are applied
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to clinical trial results, the individual patient results are averaged out, which can lead to the
exclusion or disregard of important clinical details found within the data (Cohen et al., 2004).
Lastly, the narrow definition of evidence deemphasizes other types of clinically relevant
knowledge, including the patient and/or professionals’ qualitative understanding, knowledge
and experiences with respect to medical interventions and related psychosocial factors.
Critics of EBM suggest that the notion of best evidence, a fundamental element of all
definitions of evidence-based medicine, has the potential to eliminate, or at least discount,
other potentially important forms of knowledge. In other words, the selection of specific
evidence for EBM does not capture the ‘whole story’ of what occurs in clinical practice.
The usability and application of evidence to individual patients is limited. The
ability to effectively apply the results of the best evidence to specific patients has been called
into question. EBM requires clinicians to begin by utilizing “knowledge derived from large
trials, or from systematic reviews and meta-analysis—and translating this knowledge about
collectivities into an individual plan for a specific patient” (May et al., 2006, p. 1026).
However, the application of the results of clinical trials to clinical practice is not
straightforward because, unavoidably, the patients who comprise the subject base of a study
do not precisely reflect the population seen by physicians in their clinics (Daly, 2005). RCTs
enroll a restricted population: often those expected to be responsive to the treatment or
intervention being evaluated (Feinstein & Horowitz, 1997; Greenhalgh, Howick & Maskrey,
2014). Tonelli (1998) asserts: “to the extent that relevant differences between individuals
cannot be made explicit and quantified, an epistemologic gap between research and practice
must remain” (p. 1238). The heterogeneity of the population as well as the complexity of the
human body are substantial hurdles in the application of evidence to the individual patient.
Further, when applying research that evaluates treatment options, it is the average
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that is considered for each individual patient; however, “average” may not suffice in many
situations (Greenhalgh, Howick & Maskrey, 2014). Clinicians themselves do not consider the
application of a recommendation based on an average derived from the results in a select
population sample acceptable to answer the questions presented by the unique and complex
predicaments of their patient population (Greenhalgh, 2002). Greenhalgh and Weiringa
(2011) argue that “knowledge obstinately refuses to be driven unproblematically into
practice” (p. 501) because clinical practice is much more than a series of clinical questions
answerable by clinical trials. In spite of these concerns, The Users’ Guide to Medical
Literature: Essentials of Evidence-Based Clinical Practice encourages clinicians to consider
the question: “is there some compelling reasons why the results do not apply to the patient?”
(emphasis added, Guyatt, Rennie, Meade & Cook, 2008, p. 103) and continues its guidance
to physicians by suggesting that clinicians “usually will not find a compelling reason, and
most often you can generalize the results to your patient with confidence” (Guyatt et al.,
2008, p. 103). While questions of whether or not there is a compelling reason to not apply
the evidence, this approach turns a blind eye to what STS scholars Zuiderent-Jerak and
Jensen refer to as the “radical indeterminacy of the actor” (2007, p. 232). In their discussion
of ‘intervention’ in STS studies, they remind us that interventions, like medical treatments,
are themselves risky, complex and partly uncontrollable process(es), given that patients
themselves are largely unpredictable.
EBM threatens the autonomy of the doctor and the patient. Critics also suggest that
the autonomy of both the doctor and the patient is jeopardized by EBM in multiple ways
(Cohen et al., 2004; Holmes et al., 2006; May, 2007), and therefore the relationship between
the two can be compromised. Since its inception, EBM proponents have fought the notion
that it is merely ‘cookbook medicine’, and that it restricts patients’ and doctors’ choices in
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care (Tonelli, 1998). Those who conceived of EBM are adamant that it is not about
restrictions, however as Cohen et al. point out “the originators of EBM have no control over
how EBM is used or deployed” (p. 41). EBM’s focus on statistics has been condemned for
inflicting “the weight of numbers down on [clinical decisions],” perhaps restricting or
influencing the choices that are made (Cohen et al., 2004, p. 40). The weight of numbers is
not only a consequence of physicians’ review of evidence in the literature, but also as a result
of organization-imposed standards. EBM critics suggest that evidence-based medicine has
provided the groundwork for enforcing guidelines intended to control clinical practice and, in
some instances, to contain costs.
The development and creation of Clinical Practice Guidelines (CPGs) has been an
area of interest to STS scholars, in particular their role in monitoring, regulating, and
standardizing medical practice. May (2007) argues that, increasingly, medicine and the
clinical interaction are becoming an “intensively governed terrain” (p. 29). Guidelines,
protocols, standards and algorithms can be seen as a series of directives that prescribe what
should be done in each clinical instance (Sepers & ter Meulen, 2005). Some suggest that, by
prescribing the interventions that physicians are to use, there is an intrusion of the interests of
corporate entities, both public and private, into the clinical encounter. Increasingly, the
clinical encounter is undergoing surveillance, regulation and governance, with the goal of
standardizing medical care. This type of management and control also makes way for
performance-based medicine to be implemented whereby physicians can be rewarded for
observing guidelines set by the organization(s) for whom they work or by whom they are
paid (and, presumably, penalized when they do not) (Lewis and Orland, 2004). STS scholars
frame the regulation and standardization that are a result of information systems and
technologies as “technogovernance” (May, 2006, p. 1022).
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In the last decade, critiques of EBM have become increasingly political, with a focus
on the systemic effects of standardization. Canadian nursing scholar David Holmes and his
colleagues describe the power that EBM imposes on doctors and patients in the clinical
encounter as “a good example of microfascism at play in the contemporary scientific arena”
(Holmes et al., 2006, p. 180). In a later article, they argue that EBM adopts
corporate models of efficiency and accountability, right down to a corporate lexicon;
EBM relies reductively on quantitative evidence in which RCTs are fetishised; EBM
denigrates other forms of knowledge, including clinician experience and patient
testimony; finally, EBM evacuates the social and ethical responsibilities that ought to
distinguish health care professions, such as nursing (Murray et al., 2008, p. 27).
Although Holmes frames the limitations of evidence-based medicine in an extreme fashion,
even EBM’s more moderate critics cite similar concerns.
Acceptance of EBM. EBM’s proponents argue that it addresses overspending,
inconsistencies, and unproven and patriarchal health care practices. By enacting EBM’s
tenets, physicians no longer need to rely on intuition and experience to provide clinical care.
The resources (studies, reviews, summary resources) and tools (critical appraisal techniques)
that have evolved from the EBM movement represent attempts to give physicians new ways
of providing the best clinical care supported by the best possible evidence. Daly (2005)
explains:
Instead of having to face the dishearteningly subjective task of basing their decisions
on intuitions we could not explain (Sackett et al. 1999, p. ix), clinicians had available
to them a science that generated objective knowledge of effective interventions based,
where possible, on the results of unbiased experiments (p. 1).
By directly applying the knowledge gained from the best available evidence, such as
the “unbiased experiments” that Daly (2005) mentions, EBM is heralded for promoting
consistency in treatments, contributing to the establishment of national standards of patient
care, ensuring optimal patient outcomes, and measuring performance in medical practice
(Lewis & Orland, 2004). EBM supporters argue that positive outcomes for patients include
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the: “[prevention of] numerous avoidable deaths and injuries while improving the quality of
life for millions of individuals” (Roberts & Yeager, 2004, p. iv). Such was the enthusiasm
for EBM that Feinstein and Horwitz (1997) wrote that EBM had acquired the “sanctity often
accorded to motherhood, home, and the flag” (p. 529). Indeed, The New York Times hailed
the “revolution” of EBM as one of the most influential ideas of the year (Hitt, 2001) and, in
2006, Borry and Schotsmans descried EBM as a moral imperative.
EBM and Medical Education
The conversation regarding the applicability and appropriateness of evidence-based
medicine is clearly polarized; nevertheless, EBM has survived much of the criticism that has
been levelled at it and is now well integrated into undergraduate and graduate medical
curricula worldwide, as well as part of continuing medical education programs for practicing
physicians (Guyatt, Cook & Haynes, 2004; Green, 2000). In 1992, the Evidence-based
Medicine Working Group defined evidence-based practice in terms of four basic
competencies: (1) the recognition of a patient problem and construction of a structured
clinical question; (2) the ability to efficiently and effectively search the medical literature to
retrieve the best available evidence to answer the clinical question; (3) the ability to critically
appraise the evidence; and (4) the ability to integrate the evidence with all aspects of
individual patient decision making to determine the best clinical care for the patient. In order
to train effective evidence-based practitioners, EBM proponents advocate focused
educational interventions targeting each of these specific skills (Ghali et al., 2000). Currently,
research efforts in EBM education focus on building evidence to demonstrate the
effectiveness of teaching EBM in undergraduate and graduate medical curricula (Dorsch,
Aiyer, Meyer, 2004; Green, 2000; Hatalla & Guyatt, 2002; Vidyarthi, Kamei, Chan, Goh &
Ngee, 2015; West, Jaeger & McDonald, 2011). EBM teachings appear to have a positive
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impact on students’ knowledge and perceived value of evidence-based medicine. However,
systematic reviews suggest that EBM education does not result in a change in behaviours and
outcomes in clinical practice (Coomarasamy & Khan, 2004; Norman & Shannon, 1998;
Young, Rohwer, Volmink, Clarke, 2014).
Clinical relevance and biological focus. The direct connection of EBM to clinical
practice is appealing for many, especially medical students who are eager to embark on their
medical careers and identify themselves as physicians. Evidence-based practice places
student learning out of the classroom and into the clinic. As Rosenberg and Donald (1995)
explain, “[a]n immediate attraction of evidence-based medicine is that it integrates medical
education with clinical practice” (p. 1125). Through the lens of evidence-based medicine, the
socialization of new professionals into the practice of medicine focuses on the biological and
technological aspects of health and illness. EBM’s technological focus on clinical care allows
medicine to downplay other issues. For instance, Daly (2005) suggests that incorporating
EBM into the medical school allows the messy and complicated issues of community health
and the related social and political issues to be relegated “to the sidelines” (p. 126).
Uncertainty in medical knowledge. The relationship between evidence-based
medicine and uncertainty in medical knowledge-- whether it addresses or alleviates
uncertainty-- is another antecedent to the preoccupation with EBM in medical education. The
transformation of medicine into a practice based on concrete, scientific, evidence can be
attractive to stressed physicians and medical students (Armstrong, 2002; Daly, 2005). Not
only has the basic element of EBM, the clinical trial, been “institutionalized as the ultimate
arbiter for resolution of uncertainty about therapeutics” (Djulbegovic, 2001, p. 390), but the
packaging and summarization of evidence in clinical tools, such as UpToDate, has
contributed to a sense of attainable certainty in clinical practice. Timmerman and Angell’s

17
(2001) research on medical residents suggests that synthesized and summarized information
not only distills information into an easily accessible format but also guides “the budding
physician through the clinical encounter… [offering] a definitive answer to the problem of
clinical uncertainty” (pp. 343-344). According to Timmerman and Angell, even if these tools
do not provide the answer, they provide comfort to practitioners.
Six decades ago, medical sociologist Renee Fox (1957) argued that the practice of
medicine is inherently uncertain due to gaps and disparities in the knowledge base. While the
volume of medical information and research has exploded in the intervening years,
uncertainties in medical knowledge continue (Fox, 2012; Haynes, 2001; May, 2006).
Multiple ambiguities—unknowns, biases, errors, and differences in personal views—weaken
connections between a patient’s actual condition from the selection of a diagnostic test or
treatment. Medical information scientist Szolovits (1995) captures multiple points of
uncertainty in medicine through various levels of the process of clinical care:
Patients cannot describe exactly what has happened to them or how they feel,
doctors and nurses cannot tell exactly what they observe, laboratories report
results only with some degree of error, physiologists do not understand
precisely how the human body works, medical researchers cannot precisely
characterize how diseases alter normal functioning of the body,
pharmacologists do not fully understand the mechanisms accounting for the
effectiveness of drugs, and no one can precisely determine one’s prognosis
(p. 111).
Although uncertainty is woven throughout the medical encounter, doctors and
patients regularly make decisions about diagnosis, treatment and prognosis. Prior to the
EBM movement, to handle this uncertainty clinicians relied on a knowledge base made up of
their own experience, along with the collective experiences of the profession learned through
the apprenticeship and modeling of clinicians, teachers and mentors (Daly, 2005). The
movement towards EBM in the 1980s was, in part, an effort to move away from this ‘art’
towards clinical care that is based in ‘hard science’. However, while the goal of clinical

18
research and the evidence derived from it is to reduce uncertainty, uncertainty is inherent to
EBM. Uncertainty exists in EBM by way of unknowns, biases, errors, non-responders, and
even communication challenges. These attributes weaken the connections between an actual
patient’s reality and the EBM knowledge base. Szolovotis (1995) suggests that the
uncertainty in medicine is so “tacit and so obvious that it is beneath mention” (p. 113). The
application of research and evidence to clinical practice is a way to temper or mitigate
uncertainty in the clinical encounter and provides clinicians with a “secure foundation for
their clinical task” (Daly, 2005, p.1).
The desire for a ‘secure foundation’ and its potential to alleviate uncertainty may, in
some measure, account for the uptake and proliferation of EBM as a pillar of medical
education and practice (Good, 1998). The role of summarized evidence in clinical practice
appears to be clear: Physicians seek and use this type of information to confirm their
speculation or raise their level of certainty about their decisions (Gorman & Helfand, 1995).
Information Needs and Information Behaviour of Physicians
Reviews by Elayyan (1988), Verhoeven, Boerma, and Meyboom-de Jong (1995), and
Haug (1997) capture the research findings concerning the information needs and preferences
of physicians up to the 21st century. Numerous themes run through these three reviews. Print
textbooks and journals in printed format were important resources to meet physicians’
information needs, with academic and scholarly journals being the most important sources
for the latest developments in medical care (Elayyan, 1988; Haug, 1997; Verhoeven et al,
1995), and, in comparison with practicing physicians, medical students, residents and
inexperienced physicians were more likely to make use of medical textbooks and medical
libraries (Elayyan, 1988; Verhoeven et al., 1995). Physicians gained access to the medical
literature primarily by browsing journals, apparently because they had little knowledge about
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and experience with print indexes and abstracts (Elayyan, 1988).
At the time of these reviews, online databases were in their infancy. Interestingly, at
a time when physicians were largely limited to the medical research available through print
resources, they were already reporting information overload (Elayyan, 1988). Consultations
with colleagues were found to be equally, if not more important information sources than the
printed medical literature (Elayyan, 1988; Haug, 1997; Verhoeven et al, 1995). Accessibility
and time were found to be critical factors in the choice of information physicians used in
clinical practice (Verhoeven et al., 1995).
In an effort to build a model of information-seeking for professionals, Leckie,
Pettigrew, and Sylvain (1996) examined and synthesized what was known about information
seeking practices of three distinct professional groups: engineers, health care workers, and
lawyers. They found that several information-seeking and information-related practices
crossed professional divisions and that these practices are more similar across diverse
professions than had been previously thought. Leckie and her colleagues identified five
themes and patterns that traversed the different professions: (1) Despite training in a
particular area of expertise, professionals assume multiple, complex, and diverse work roles;
(2) these roles have a constellation of tasks associated with them; (3) these tasks are likely to
prompt information seeking; (4) intervening factors, including the awareness of information
and sources of information, may facilitate or inhibit information access and use; and (5) it
often takes more than one attempt to find appropriate information. These themes informed
Leckie’s General Model of the Information Seeking of Professionals. Six components
comprise the model, including work roles; associated tasks; characteristics of information
needs; factors affecting information seeking, such as awareness of sources; sources of
information; and outcomes. In summary, the roles and related tasks that are a part of the
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professionals’ daily work trigger information needs and initiate an information seeking
process. The information-seeking outcome is affected by multiple variables and throughout
the model feedback loops capture the iterative and non-linear nature of the process.
Of particular relevance to this research is the way in which the five themes are
manifest in information-seeking behaviours of health care professionals. Studies of the
information behaviours of physicians, nurses, and dentists were included in Leckie et al.’s
synthesis. Patient care is the most often cited trigger for information needs; however, health
care professionals’ information needs are also prompted by related tasks associated with
distinct work roles including practice management, administration, teaching, research,
current awareness, and continuing education. Health care professionals seek information
from multiple sources—formal and informal sources, interpersonal sources, and “print”
sources (much of the research reviewed was conducted before the Internet revolution). The
preference for and choice of certain resources is very much influenced by ease of access, past
experience, availability of time and the perceived quality.
Since Leckie et al.’s model was published in 1996, research and reviews examining
the information needs and behaviours of physicians have continued to support the model.
Patient care remains the primary role, which leads to an information need and to information
seeking (Bryant, 2004; Clarke et al., 2013; Gonzalez-Gonzalez et al., 2007), and
interpersonal sources of information and knowledge continue to play an important role in
answering the clinical questions of physicians (Andrews, Pearce, Ireson & Love, 2005;
Clarke et al., 2013; Gonzalez-Gonzalez et al., 2007). While these patterns continue to be
supported, one cannot turn a blind eye to the impact of digital technology on the information
landscape of physicians. Less than two decades ago, printed books and journals were critical
information sources for physicians (Dawes & Sampson, 2003; Elayyan, 1988; Haug, 1997).
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However, since the advent and proliferation of digital and Internet-based resources, print
resources have dropped dramatically in popularity (Bryant, 2004; Clarke et al., 2013).
Physicians not only have access to research studies and articles in digital format, but also
new types of evidence resources, that is, new and summarized evidence resources.
Evolving Medical Evidence for Clinical Practice
In order to address the reported shortcomings of more traditional forms of evidence,
such as the research article, in answering physicians’ clinical questions (Bennett, et al. 2005;
Gorman & Helfand, 1995; Rosenberg & Donald, 1995), producers and publishers of
evidence resources have attempted to build new tools to capture evidence in a way that meets
the needs of physicians. These new resources are described by EBM scholars, such as
Haynes (2001), as increasingly ‘evolved’. An exploration of what is currently understood
about this evolution of medical evidence to meet physicians’ needs is significant to the
research undertaken in this thesis.
The likelihood that physicians will search for information is greatly influenced by
their beliefs about whether an answer exists for their clinical problem. According to Gorman
and Helfand (1995), often doctors do not believe that they will successfully answer their
clinical questions through the published literature (Gorman & Helfand, 1995). Doctors’
conviction that they will be unsuccessful is attributed to their belief that studies are “invalid
and irrelevant” (Rosenberg & Donald, 1995, p. 1122). Twenty years ago, Gorman, Ash, and
Wykoff (1994) studied the effectiveness of the medical journal literature to answer primary
care physicians’ questions. The design of the study employed librarians to locate articles that
provided “answers” to clinical questions arising from physicians’ clinical practice. Clinicians
were then asked to provide feedback regarding the relevance and usefulness of the
information retrieved. Clinicians felt that the information provided a “clear answer” to their
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questions in less than half of the instances (44%). At the time of Rosenberg and Donald’s
study, the primary information resource was published journal articles. Since then,
synthesized and summarized information sources have proliferated. Moja and Banzi (2011)
posit that “publishers’ mission is changing: publishing trials and reviews in general or
specialist formats is perceived as too static and remote from practice” and suggest that
“[p]ublishers should find a balance between information consumed at the point of care—
necessarily distilled, unnecessarily simplistic—and fidelity to a cumulative and extended
approach to information” (p. 10). The physician-identified barriers of too much information,
too few searching skills, and too few answers in the medical research and primary literature
have led scholars and publishers to develop resources in which information is pre-packaged
in a synthesized and summarized format. The use of these resources has been strongly
supported by EBM advocates (see, for example, Guyatt et al., 2008).
The various levels of health information synthesis and summarization have been
described by numerous authors, many of whom conceptualize these classes of information as
a hierarchical evidence pyramid (for example: Grandage, Slawson, Shaughnessy, 2002;
Pandis, 2011; Haynes, 2001). Of these hierarchical schematics, the 6S Model—originally
created as a 4S model in 2005 (Haynes, 2001) and then later evolving into the 5S and 6S
models (Haynes, 2006; DiCenso, Bayley, Haynes, 2009)—is currently the most widely used
(Brown-Epstein, 2012) (see Figure 2). Initially, the four levels of organization of evidence in
the 4S model were studies (original research articles), syntheses (systematic reviews),
synopses (succinct summaries of articles), and systems. Here, ‘systems’ were defined as
computerized decision support systems that were integrated into electronic health records, as
well as advanced electronic decision support tools, such as UpToDate and Clinical Evidence.
One year later, products such as UpToDate, Clinical Evidence and DynaMed were classified
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in the fifth “S”–Summaries. The sixth and final “S” created a distinction between synopses of
studies and synopses of syntheses (DiCenso, Bayley & Haynes, 2009).

Figure 2: Levels of Organization of Evidence as suggested by Haynes and colleagues
From: National Collaborating Centre for Methods and Tools:
http://www.nccmt.ca/eiph/search-eng.html

Haynes (2001) suggests that “[p]roviders and consumers of evidence-based health
care can help themselves to the best current evidence by recognising the most evolved
information services in the topic areas of concern to them” (emphasis added). Practitioners
are directed to “begin the search for evidence to guide clinical decisions at the highest
possible level of the 5S pyramid of evidence” (Haynes, 2007, p. 7). If you do not find the
answer in one level then drop to the next level, but when one of the resources addresses the
query, “you don’t need to look any further” (Haynes, 2007, p. 7). According to Haynes
(2001), it is only when “every other S fails (ie, no system, [summaries,] synopses, or
syntheses)” that it is appropriate to look for original studies (p. 37). Embedded in such
guidance is the assumption that all the evidence physicians need for clinical decision-making
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can be found in a single summary resource; or, indeed, that this evidence even exists.
In the 6S model, the concepts of quality and synthesis appear to be conflated in a
problematic way. Haynes’ (2006) use of the term ‘evolved’ implies more advanced
knowledge, yet synthesis and summarization refers to a distillation process in which some
information has been removed. The National Collaborating Centre for Methods and Tool’s
(NCCMT) tutorial explicitly states, “starting a search at the top (or the highest possible layer
of the 6S pyramid model) yields the highest quality and most synthesized research evidence
first” (NCCMT, 2011, emphasis added). Even though the summarization and distillation
process is not well understood at the top of the evidence pyramid, the most summarized and
distilled information is clearly presented in this teaching tool to be of the highest quality and
the most “evolved” information available to clinicians.
Currently, the resources that occupy the top “S” of the pyramid, systems, are not well
developed nor are they readily available. Systems are sources of evidence that are integrated
into electronic health records, delivering to doctors and health care professionals relevant
evidence as called upon via the electronic health record. Although it is anticipated that these
resources will greatly improve the integration of evidence into the clinical encounter in the
future (Bates et al., 2003), summaries are the highest level of organization of evidence
currently in widespread use. Haynes (2006) argues that “a current summary trumps an
individual synopsis, synthesis, or study or a collection of these” (p. 6), suggesting that
summary sources provide all the information/evidence necessary for clinical understanding
and decision-making.
Research demonstrates that clinicians have readily adopted the recommended
guidance of integrating only the highest level of evidence into clinical practice. A study of
residents at the University of Minnesota Medical School revealed that the most popular
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resource accessed for information at point of care is the summary resource UpToDate, with
85% of residents using it daily (Duran-Nelson, Gladding, Beattie & Nixon, 2013). In
contrast, only 13.3% of residents accessed PubMed/MEDLINE (the main access point for
research studies) daily. Moreover, Wikipedia and the Google search engine were used with
greater frequency than PubMed/MEDLINE. While both speed and trust in information
quality were important factors in choosing a resource, speed appeared to be the users’ more
important consideration (Duran-Nelson et al., 2013); these results that align with Leckie’s
1996 model of professionals’ information seeking.
A more in-depth analysis of the 6S’s three main levels of organization - Studies,
Synthesis and Summaries - as well as the recommended structure for clinical questions that
provide the basis for these resources, is needed to understand the evolution of evidence for
clinical practice.
Clinical questions. The Centre for Evidence-based Medicine at the University of
Oxford declares that “one of the fundamental skills required for practising EBM is the asking
of well-built clinical questions” (Centre for Evidence Based Medicine, 2017). Evidencebased medicine recommends a standard framework for clinical questions, the PICO
framework, which includes four elements: Patient or Problems, Intervention, Comparison
and Outcome. This framework was first proposed in a journal editorial by Richardson,
Wilson, Nishikawa, and Hayward (1995) for therapy-type clinical questions, but later
expanded to questions of aetiology. Proponents of EBM suggest that the PICO framework
helps clinicians with the queries by clearly articulating the essential components of their
question and assisting the clinician to identify concepts. While PICO is widely advocated and
taught to medical students and clinicians, research indicates that the format may not reflect
real-world clinical questions. For example, Huang et al. found that actual primary care

26
questions rarely contain all four elements (Huang, Lin & Demner-Fushman, 2006).
Nevertheless, the PICO format is often used as a structure for research study and systematic
review design, and provides a helpful structure for examining UpToDate.
Studies. Clinically-focused primary biomedical research can be organized in two
main categories: clinical studies and preclinical research. Preclinical studies provide a strong
knowledge base in order to ensure safety and efficacy prior to human clinical studies, for
example via animal studies, model-testing, etc. Clinical studies comprise the observational
medical research on human subjects that generate safety and efficacy data for health
interventions (therapies, diagnostics, devices, prognostics). Practice is informed by these
clinical studies and clinicians are directed to them to answer the questions that arise in their
practice. While the most commonly discussed clinical questions relate to therapies and other
treatment-oriented interventions, other types of clinical questions include those relating to
diagnosis, prognosis, and aetiology (particularly risk factors). For clinical questions that
address therapy, the RCT is considered to be the best study design to reduce bias and
increase validity. Randomization, in this sense, is the allocation of patients into treatment
groups so as to increase the likelihood of creating groups that are comparable on preidentified baseline factors, both known or unknown, which may affect the study outcomes.
As noted earlier, clinicians question the application of research studies at the point of
care and claim that the usefulness of primary research is quite limited in practice (McKibbon,
Lokker, Keepanasseril, Wilczynski, Haynes, 2013). Specific limitations of clinical studies
cited in the literature include the speed at which single clinical trials are contradicted or
challenged; the inefficiency of clinician search skills (Bennett, Casebeer, Kristofco &
Collins, 2005) and subsequent time it takes for clinicians to find credible and applicable
research studies (Chambliss & Conley, 1996; González-González, et al., 2007; Gorman et al.,
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1994; Rudolph et al., 2002); and clinicians’ overall attitude that there is too much
information available and they are unlikely to find an answer regardless of their search
efforts (Bennett et al., 2005). In general, clinicians have not embraced clinical studies as an
efficient and effective source of evidence for their point of care needs.
Synthesis. Systematic reviews comprise the synthesis level of the 5/6S schema. The
Institute of Medicine (IOM) defined systematic review in 2011 as "a scientific investigation
that focuses on a specific question and uses explicit, prespecified scientific methods to
identify, select, assess, and summarize the findings of similar but separate studies.”
Systematic reviews are structured and rigorous reviews of literature pertaining to a focused
clinical question aimed to identify, select, appraise and synthesize all available high quality
evidence relevant to that question. Systematic reviews were a key element in Cochrane’s
vision of evidence-based medicine and are considered to be a foundation for the development
of evidence-based clinical practice guidelines (Cook & Greengold, 1997). The Cochrane
Collaboration, and its more than 5,000 reviews is considered a leader of evidence-based
medicine 3.
The development of systematic reviews, specifically the decision to include or
exclude studies in systematic reviews, has generated a great deal of attention and debate in
the literature. Developers of systematic reviews recognize that the conclusions of a
systematic review can only be trusted and implemented if the studies included are of the

3

In 2000, the Campbell Collaboration was formed to focus on the effect of social
interactions, encouraging the creation of systematic reviews on non-biomedical (and often
more complex) topics. The Campbell Collaboration contains just over 100 reviews in its
collection compared to the Cochrane Collaboration’s more than 5,000 reviews. Synthesis of
qualitative research differs from synthesis of quantitative research, as the end product is a
meta-synthesis, where findings from across the research are integrated to generate new
interpretations, formulate understandings, and produce new generalizations.
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highest quality, but how quality is defined and assessed is contentious (Juni, Altman &
Egger, 2001). One approach is to exclude trials that fail to meet a pre-defined standard of
quality, although this practice has the potential to exclude studies that might contribute valid
information. For clinical questions related to therapies, most systematic reviews exclude all
studies that are not RCTs or related comparative designs employing randomization.
The use and application of systematic reviews is not without critics. For instance,
Greenhalgh (2012) writes: “The problem is that the Cochrane machinery is built on the
assumption that by summarizing the findings around tightly focused questions we will build
a meaningful knowledge base” (p. 371). Systematic reviews best address ‘tightly focused
questions’ such as the efficacy of treatment A on condition X, however many health
challenges are complex and multifaceted. In addition to the narrowness and inapplicability of
the questions that are addressed through systematics reviews, the vast number of systematic
reviews (over 5000 in the Cochrane Library alone) has also been called into question. The
large and diverse body of systematic reviews may be overwhelming in much the same way
that the huge array of primary studies once overwhelmed (Hyde, Stanworth, Brunskill &
Murphy, 2005). As such, systematic reviews have been dismissed as a point of care
resource, and instead are suggested to “feed” point of care resources, including Summaries
(Banzi et al., 2010).
Summaries. Summary resources are intended to provide health care professionals an
outline of the evidence suitable for the point of care. Summary resources are suggested to be
appropriate when physicians need the “clinical bottom line” (Windish, 2013, p. 96).
Summaries are intended to incorporate the highest quality and most synthesized sources of
research evidence. Two categories of resources are included in the summary level of the 5/6
S schemes: evidence-based summary resources (like UpToDate and DynaMed) and clinical
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practice guidelines (CPGs). One of the defining qualities of summary resources is their goal
to “[convey] a clear and concise message about what to do within the context of a providerpatient dyad” (Moja & Banzi, 2011, p. 6). The summary resource explicitly lays out a
recommendation for clinical care.
CPGs provide clinicians with clear recommendation about how to provide care for
patients with specific conditions. Evidence-based CPGs are “statements that include
recommendations intended to optimize patient care that are informed by a systematic review
of evidence and an assessment of the benefits and harms of alternative care options”
(Institute of Medicine, 2011). Such guidelines “seek to bring recommendations that generally
prescribe where, when and how care professionals should act, aimed at reaching more
uniformity and transparency in health care delivery” (van Loon, Zuiderent-Jerak & Bal,
2013, p. 2). Empirical research on the use of guidelines in everyday clinical practice raises
questions about their applicability and usability (Kendall, Sunderland, Muenchberger, &
Armstrong, 2009; Rashidian, Eccles & Russel, 2008). Identified shortcomings of guidelines
include a narrow focus on one specific and static condition, restricted options for treatment,
and a lack of recognition of the diversity of roles that health care practitioners hold (Van
Loon, Zuiderent-Jerak & Bal, 2014; Kendall, Sunderland, Muechenberger & Armdytoh.
2009).
The most popular of the summary resource tools, related in many ways to CPGs, is
UpToDate. UpToDate is described as “an evidence-based, physician-authored clinical
decision support resource which clinicians trust to make the right point-of-care decisions”
(UpToDate, “About Us,” 2017). It is this resource that forms the base for the current research
study.
Summarised resources are now the ‘go-to’ resource for clinical questions (Alper,
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White & Ge, 2005; Edson et al., 2010). In a multi-institution study (Edson et al., 2010)
UpToDate was identified as the most effective resource for knowledge acquisition by 94.6%
of residents and cited as the first choice for answering clinical questions by 88.9% of
residents. In addition to noting the dramatic preference of clinicians for tools such as
UpToDate, their effect on clinical practice is noteworthy. Alper, White, and Ge (2005) found
that by making use of the summary resource DynaMed, primary care clinicians answered
more questions and changed clinical decisions more often without increasing overall search
time.
UpToDate: Overview and Previous Research
UpToDate is an online resource that provides physicians with evidence to support
their clinical decision-making. UpToDate is also the name of the parent company of the
resource, a brand of the Health Division of Wolters Kluwer Publishing. In 1992, UpToDate
was launched by nephrologist Dr. Burton Rose, with the aim of “creating the information that
doctors needed” (UpToDate, “The UpToDate Story,” 2012). After a potential publisher
claimed that no money was to be made by the Internet, Dr. Rose and his colleague Dr. Joseph
Rush developed UpToDate in Rose’s basement with the initial content being a print
nephrology textbook authored by Rose. UpToDate now provides articles related to more than
24 specialties, authored by over 6,500 physicians, editors and peer reviewers (UpToDate,
“About Us,” 2017). More than 10,500 topics are included in UpToDate, covering a wide
variety of medical conditions, therapies, and issues. All entries include Summary and
Recommendations, and References as consistent subtopics. Beyond these core subtopics,
there is a varied level of specificity relating to individual topics that, ultimately, does not
facilitate a consistent structure across all entries/articles. Possible subtopics included in
UpToDate entries are: Physiology and Anatomy; Treatment; Evaluation; Management; and
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Prognosis. An additional feature of UpToDate available for some topics is the classification
of the level of recommendation based on the Grading of Recommendations, Assessment,
Development, and Evaluation (GRADE) system. GRADE is a system of rating the quality of
evidence and strength of recommendations in synthesis and summary resources (Guyatt, et
al., 2011). GRADE uses an explicit and transparent process and criteria to evaluate the
evidence including study design, risk of bias, inconsistency, indirectness, and magnitude of
effect. The inclusion of this classification of recommendation is not included in all UpToDate
articles (Farrell, 2008).
The translation of current evidence into clear recommendations for clinicians is a
unique feature of UpToDate, which relies upon physician expertise to determine what
evidence should be applied to individual patients and provide clear recommendations to their
colleagues (UpToDate, “Creating Content,” 2017). The necessity for the expertise offered by
UpToDate’s physician-authors is captured in UpToDate’s philosophy that “(e)vidence alone
is never sufficient to make a clinical decision — expertise is required to move from evidence
to recommendations”. UpToDate describes the work of the physician-authors as “a
systematic process for identifying, reviewing and synthesizing the medical literature as it
applies to a clinical question” (UpToDate, “Creating Content”, emphasis added). The details
of the ‘systematic process’ referred to by UpToDate are not readily available. However, a
short description on the UpToDate website reads:
UpToDate follows a hierarchy of evidence consistent with most evidence-based
resources. At the top of the hierarchy are meta-analyses of randomized trials of high
methodological quality, followed by randomized trials with methodological
limitations, observational studies and unsystematic clinical observations. Inferences
are stronger when the evidence is summarized in systematic reviews of the literature
that present all relevant data.
Each topic has an author who is an expert in the area discussed, and at least two
separate physician reviewers. This group works together to perform a comprehensive
review of the literature and carefully select studies for presentation based on the
quality of the study, the hierarchy of evidence discussed above, and clinical
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relevance. When current, high-quality systematic reviews are available, UpToDate
topics and recommendations rely heavily on these reviews. When such reviews are
unavailable, UpToDate summarizes the key studies bearing on the clinical issues at
hand. (UpToDate, “Editorial Policy,” 2017)

The UpToDate site states that the authors select the evidence for the topic based on the
widely accepted hierarchy of evidence, with no additional details. This brief description can
be contrasted against the processes followed and made public by the Cochrane Collaboration.
The details of the meticulous Cochrane process are described in a 670-page handbook,
Cochrane Handbook for Systematic Reviews, and is made publicly available through the
Cochrane website (Cochrane Collaboration, Cochrane Handbook, 2015). While the
systematic process claimed by UpToDate is not clear, UpToDate positions itself as a leader
in using the best available evidence: “While other clinical information resources may use —
or claim to use — the best available evidence, UpToDate excels in determining how that
evidence is applied to the individual patient.”
UpToDate provides a list of 466 journals that are hand-searched by a community of
physician-authors that is responsible for selecting the evidence to be included, and using this
evidence to inform the creation of each UpToDate entry. In the study described in this thesis,
these journals are referred to as UpToDate’s core journals. In addition to the hand-searched
journals, UpToDate provides a list of resources from which evidence is derived including
electronic searching of key databases, practice guidelines, published reports of clinical trials
by governmental agencies, conference and meeting proceedings, and “the clinical experience
and observations of our authors, editors, and peer reviewers” (UpToDate. “Editorial Policy”,
2017). These resources are the base of evidence from which the content of UpToDate is
derived.
Over 1,300,000 physicians in more than 187 countries use UpToDate to find medical
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information for clinical decision-making; access is online, and more recently on mobile
devices, primarily through personal and institutional subscriptions (UpToDate, “About Us”,
2017). As well as being one of the most popular medical resources, UpToDate is also one of
the most well-researched point-of-care summary resources. More than 25 empirical studies
have been undertaken by information scientists, clinicians, and librarians to examine the
structure and use of UpToDate. These studies reveal that UpToDate is consistently one of, if
not the most consulted evidence-based resource for clinical practice (Chisolm & Finnel,
2012; Cook, Enders, Linderbaum, Zwart & Lloyd, 2014; Marshall et al., 2013, Nasir,
Nicholson, Vandermeer, Kumar& Robinson, 2014; Shariff et al., 2011) and is rated very
positively by physicians for ease of use, layout, and quality of content (Campbell & Ash,
2006; Duran-Nelson, Gladding, Beattie & Nixon, 2013; Ensan et al., 2011; Marshall et al.,
2013; Phua & Lim, 2008). Doctors consult UpToDate to obtain information about treatments,
to find drug information, to identify appropriate diagnostic tests, to reduce delay in treatment,
and to seek reassurance about clinical decisions (Addison, Witcombe & Glover, 2012;
Chisholm & Finnell, 2012).
More than one-third of the identified studies of UpToDate focus on how medical
students, clerks and residents adopt, use and learn from UpToDate (Duran-Nelson, Gladding,
Beattie & Nixon, 2013; Egle, Smeenge, Kassem & Mittal, 2015; Hoogendam, Stalenhoef,
Robbe, Overbeke, 2008; Kim, Willett, Murphy, O’Rourke, Sharma & Shea, 2008; Leff &
Harper, 2006; O’Carroll, Westby, Dooley & Gordon, 2015; Phua & Lim, 2008). Medical
students have been found to be more likely to adopt UpToDate than practicing clinicians
(Peterson, Rowat, Krieter, and Mandel, 2004; Marshall et al., 2013) and students identified
UpToDate as the most effective and most popular resource for knowledge acquisition (Edson
et al., 2010; Lai et al., 2006; Leff & Harper, 2006). Students tend to use UpToDate primarily
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for patient care and preparation for physician rounds, and much less for exam preparation
(Cooper & Elnicki; Edson et al.; Peterson et al.). However in two studies it is reported that
UpToDate was an effective learning tool for exam preparation (McDonald et al, 2007; Reed
et al., 2012).
Many studies have compared the efficacy and efficiency of UpToDate with other
evidence resources. Table 1 outlines evidence resources across the 6S pyramid and the
studies that compare these resources to UpToDate.
Organization of

Study reporting
Resources

Evidence (6S)

comparison to UpToDate.

Systems

Currently in development

Summaries

UpToDate, DynaMed, ACP PIER

Ahmadi et al. (2011);

(now ACP Smart Medicine),

Campbell & Ash (2006);

Essential Evidence Plus, BMJ

Chan & Stieda (2011); Egle

Point-of-Care, Cline-Guide,

et al. (2015); Farrell (2008);

Nursing Reference Centre,

Fenton & Badgett (2007);

Micromedex, PEPID Best

Hayes (2012); Hoogendam

Practice, BMJ Clinical Evidence,

et al. (2008); Jeffrey et al.

Bandolier, MedScape Reference,

(2012); Ketchum et al.

Diseasedex, InfoRetriever,

(2011); Kronenfield et al.

FirstConsult, ClinicalKey

(2013); Nasir et al., (2014);

Clinical Practice Guidelines

O’Carroll et al., 2015;

(accessed via National Guidelines

Prorok et al. (2012); Shurtz

Clearinghouse),

& Foster (2011); Turvey et

35
al., 2013
Synopsis of

Cochrane Summaries, Evidence

Synthesis

Based Abstract Journals (e.g.,:
ACP Journal Club, EvidenceBased Medicine, Cancer Care
Reviews)

Synthesis

Cochrane Collaboration / Library

Synopsis of

Evidence Based Abstract Journals

Studies

(e.g.,: ACP Journal Club,
Evidence-Based Medicine, Cancer
Treatment Reviews)

Studies

Journal articles indexed in

Ensan et al. (2011);

PubMed, OVID Medline,

Hoogendam et al. (2008);

PsychInfo, AMED

Schulling et al. (2005);
Thiele et al. (2010)

Other

Google, Google Scholar,

Duran-Nelson et al. (2013);

Wikipedia

Hasty, et al. (2014); Thiele
et al. (2010)

Table 1: Resources across the 6S Levels of Organization of Evidence and related studies
Because UpToDate is not the only summary resource designed for clinicians, several
studies have set out to compare it with other competing products (Ahmadi et al., 2011;
Campbell & Ash, 2006; Chan & Stieda, 2011; Farrell, 2008; Thiele, Poiro, Scalzo &
Nemergut, 2010; Hoogendam et al., 2008; Ketchum, Saleh & Jeong, 2011; Shurtz & Foster,
2011; Turvey, Hussain, Banfield & Bhandari, 2013). Multiple studies in which student and
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physician ability to answer clinical questions using UpToDate (a summary resource) is
compared with use of PubMed (a database providing access to studies and synthesis, and to a
lesser extent clinical practice guidelines, synopsis of studies, and synopsis of synthesis)
(Ensan et al., 2011; Hoogendam et al., 2008; Schilling et al., 2005; Thiele et al., 2010)
suggest that, by using UpToDate, study participants were able to locate more relevant
answers to clinical questions, and to find answers to clinical questions in a shorter time. In
addition to PubMed, UpToDate has also been evaluated against a variety of combinations of
products including: ACP's PIER, DISEASEDEX, FIRSTConsult, InfoRetriever, BMJ
Clinical Evidence, Bandolier, Google, OVID, Essential Evidence Plus, BMJ Point-of-Care,
Clin-eguide, AskMayoExpert, ClinicalKey, Nursing Reference, and the National Guidelines
Clearinghouse (Ahmadi et al., 2011; Campbell & Ash, 2006; Chan & Stieda, 2011; Farrell,
2008; Fenton & Badgett, 2007; Kronenfeld, Bay & Coombs, 2013; Theile et al., 2010;
Turvey et al., 2013). In studies evaluating a resource’s usefulness for answering physicians’
clinical questions, UpToDate consistently rated at the top (Ahmadi et al., 2011; Campbell &
Ash, 2006; Thiele et al., 2010). Physicians were also able to answer clinical questions more
quickly using UpToDate in comparison with other products (Ahmadi et al., 2011; Thiele et
al., 2010). Only Google was reported to be as quick as UpToDate, however physicians did
not report a high level of trust and confidence in Google. In only one study, in which
UpToDate and related products were evaluated by non-physicians (nurses, administrators,
librarians) as well as physicians, was no difference between product preferences reported
(Chan & Stieda, 2010).
The breadth and depth of UpToDate’s content for two specialties, primary care and
orthopaedic surgery, has been compared against similar products. While UpToDate had
greater breadth of content related to primary care than National Guidelines Clearinghouse

37
(Fenton & Badgett, 2007), UpToDate had the most limited orthopaedic content compared
with ACP Pier, DynaMed, FirstConsult, and Clinical Evidence (Turvey et al., 2013). While
UpToDate claims to address twenty-one specialties, the depth of coverage across specialties
appears to be inconsistent.
The influence of UpToDate on clinical decisions and clinical practices has also been
explored (see, for example, Addison et al., 2013; Bonis, Pickens, Rind & Foster, 2008; Isaac,
Zheng & Jha, 2012; Phua & Lim, 2008; Phua, See, Khalisah, Low & Kim, 2012; Schilling et
al., 2005). Physicians have repeatedly reported that consulting UpToDate affects their
clinical decision-making: Phua and Lim found that 57.9% of physicians using UpToDate
reported that the use of UpToDate led to a change in the way that they managed patients.
UpToDate it touted as the “ONLY decision support resource associated with improved
outcomes” (UpToDate, “About Us,” 2017), and, indeed, two studies by Bonis et al. (2008)
and Isaac et al. (2012) provide particularly startling results about the effects of using
UpToDate on outcomes. It should be noted that UpToDate funded both of these studies and
two of the authors of Bonis et al.’s study were employees of UpToDate. The authors
compared the practices and outcomes of hospitals with and without access to UpToDate and
report that hospitals using UpToDate consistently demonstrated reduced length of stay, lower
risk-adjusted mortality rates, and higher quality performance 4. From this comparison, the
authors extrapolate that UpToDate can save lives, going so far as to announce that UpToDate
prevented 11,500 deaths in 424 US hospitals in a three-year period (Isaac, Zheng & Jha,
2012).

4

To assess the quality of hospital performance the researchers used the US Hospital Quality
Alliance process measures for four conditions (acute myocardial infarction, congestive heart
failures, pneumonia, surgical infection prevention). The quality of performance is judged
according to how well an entity provides care to its patients based on the evidence that
particular processes are followed. In other words, ‘quality’ here reflects process adherence.
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While UpToDate has been the subject of numerous studies, its structure,
development, and content have not been extensively or systematically studied. Three small
studies examined its structure and content. Jeffrey et al. (2012) compared the currency of
DynaMed, UpToDate, ACP Pier, and Best Practice and found that, across 200 topics, the
time elapsed since the last update varied substantially for the four platforms. The average
time since the last update for each topic ranged from 170 days for DynaMed to 488 days for
PIER and the topics in UpToDate averaged 427 days since the last update. When assessing
the need for topics to be potentially updated, UpToDate lagged significantly behind
DynaMed, with 104 topics in UpToDate needing potential updates in comparison with 47
topics in DynaMed. Health sciences librarian Andrea Ketchum and her colleagues compared
the number, levels, and currency of evidence used in five resources, including UpToDate
(Ketchum et al., 2011). Again, UpToDate was found to be not as current as DynaMed.
DynaMed also had significantly more references per topic and relative to the other 4
resources, UpToDate had the lowest percentage of evidence from two of the top levels of
evidence, systematic reviews and randomized controlled trials. Amber, Dhiman, and
Goodman (2014) examined UpToDate’s treatment of six topics that have controversial or
uncertain treatment. They examined the topics for evidence of potential conflict of interest
(including financial) and report that authors and editors of UpToDate were allowed to
maintain financial relationships with drug companies whose products are evaluated within
these articles. Each of these three studies provides indications of the structure and content of
UpToDate, as well as suggesting some of its potential shortcomings.
Medicalization
As noted earlier, more than 10,500 topics are covered in UpToDate, and more topics
are continuously being added. Interestingly, not all the topics covered by UpToDate would
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be found in medical textbooks from 100 or 50 years ago. Included in the vast number of
UpToDate entries are ailments and illnesses that have been ‘medicalized’ over time.
Medicalization is the process by which medical definitions and practices are applied to
behaviours, psychological phenomena, and somatic experiences not previously within the
conceptual or therapeutic scope of medicine. In the simplest terms, medicalization arises
when previously non-medical problems are defined and treated as medical problems, usually
in terms of illnesses or disorders. Medicalization has been a topic of interest to researchers in
sociology, anthropology, medicine, history, and science and technology studies for more than
four decades (Davis, 2010). In 1972, Zola’s definition of medicalization as “the involvement
of medicine in the management of society” focused on medicalization as a means of medical
control and regulation (p. 488). Originally, researchers interested in this field focused on the
medicalization of deviant behaviours (for example, children’s misbehaviours and child
abuse) and natural life processes (for example, childbirth and menopause). However, the
concept of medicalization has evolved and expanded. Medicalization is not only about
medical control but also results from individuals’ eagerness to seek diagnosis, affecting not
only the utilization of medical interventions but also the expansion of medical categories
themselves (Conrad, 2005, 2007).
Changing patterns of medicalization have been attributed to the “rise of corporate
managed care and the corresponding decline of physicians’ professional power” (Barker,
2008), p. 21). Researchers and critics note that the practice of medicalization can: increase
unnecessary medical labelling, promote poor treatment decisions, and increase the marketing
of unnecessary pharmaceutical treatments (Moynihan, Heath, & Henry, 2002; Conrad &
Leiter, 2004). Moynihan et al. (2002) examine medicalization in relation to “widening the
boundaries of treatable illness in order to expand markets for those who sell and deliver
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treatments” (p. 886), characterizing it as a form of ‘disease mongering’. They describe five
(non-discrete) categories of medicalization: ordinary processes or ailments of life classified
as medical problems; mild symptoms portrayed as portents of a serious disease; personal or
social problems seen as medical ones; risks conceptualised as diseases; and disease
prevalence estimates framed to maximise the size of a medical problem. Medicalized
conditions often are unique in the ways in which the patient is positioned, the certainty of the
“evidence” available, and the roles in which experts and expertise enact; this makes them a
useful site of investigation for the present study.
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Chapter 2: Research Questions and Methods
As evidenced in the published literature, UpToDate dominates as the resource tool of
choice for physicians who are looking for answers to their clinical questions. A physician’s
choice to use the information found in summary sources of information, such as UpToDate,
is supported by the principles of evidence-based practice (Guyatt et al., 2008) and aligns with
Haynes’s suggestion that “[providers and consumers of evidence-based health care can help
themselves to the best current evidence by recognizing the most evolved information services
in the topic area of concern to them” (2001, p. 37). The drive towards the use of summary
resources is directly tied to the notion that these resources provide information that is more
evolved and as such, of a higher quality. However, the discursive practice of referring to
these resources as ‘evolved’ may be problematic as evolution infers a transformation from a
simpler form to a more complex form. This is actually contrary to the process that evidence
goes through during the summarization process. As the basis of evidence moves from the
bottom of the 6S pyramid (studies) to the top (summaries and systems) information does not
become more complex; in fact, it becomes less complex, and seemingly more certain. A key
question posed in the present study is how a more simple (and certain) product ‘evolves’
from the complex (uncertain) inputs and how evolution corresponds with a process that
actually distills and strips away detail.
While summarized resources have been examined in several studies in terms of their
editorial quality, uptake and application, breadth of coverage of medical conditions, and
timeliness, the ‘evolution’ of primary evidence into summary resources has not yet been
systematically investigated. Important questions to be explored about the ‘evolutionary’
process include what evidence is selected for inclusion and how such evidence is positioned
vis-a-vis clinical practice.
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Summary resources, such as UpToDate, present the body of clinical research on a
topic in a usable and understandable format suitable for clinical practice. Greenhalgh (2012)
describes the evolution of clinical research to systematic reviews as the “technical process of
stripping away all but the bare bones of a focused experimental question” and further
contends that this stripping away “removes what practitioners and policymakers most need to
engage with: the messy context in which people get ill, seek health care (or not), receive and
take treatment (or not), and change their behaviour (or not)” (p. 371). Greenhalgh describes
a distillation—rather than evolution—process, i.e., a process that purifies and condenses in
order to collect a refined product. This process, by definition, requires the loss or removal of
some of the initial substance. This research delves into the distillation process that moves
(some) clinical research into the summary resource, UpToDate. The main research question
addressed in this study is: What information is sacrificed and what information is privileged
during the summarization process? Additional research sub-questions include how the
complexities inherent in clinical practice are presented in summarized information sources
and how the patient and patient-centered care is or is not presented in UpToDate.
In the summarization process, potentially thousands of pages of information that
make up the corpus of evidence on a topic must be distilled into a few paragraphs. Unlike
chemical distillation, however, the selection, filtering, and condensing of information is not
mechanical, consistent or pure, rather these are conscious human and social acts. The
UpToDate website describes this summarization work undertaken by its authors:
Drawing on their extensive experience, our physician authors and editors begin
with a structured clinical question, placing the latest evidence about the topic in
context with the larger body of available evidence. Next, they synthesize that
evidence into recommendations clinicians can use to diagnose and treat their
patients, even when the evidence is thin or no consensus exists. (UpToDate,
“Physician Authors and Editors,” 2017)
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A multiple case study analysis explored these processes. By examining seven cases 5 and
following up with a cross-case analysis, what information is privileged and excluded in
UpToDate at various points in the distillation process was identified. The investigation
included what types of evidence as well as what content from the evidence base was
included.
Content Analysis and Multiple Case Study Design
Content analysis is a useful method for identifying both the conscious and
unconscious messages within a text (i.e., what is stated explicitly and what is implied by the
manner in which content is expressed) (Krippendorff, 2013). It is a flexible methodology that
lends itself to both qualitative and quantitative analysis (Cavanagh, 1997). Its roots are found
in the 1950s as a quantitative method used in the study of mass communications. Since then,
researchers across many fields have adapted content analysis as a quantitative and qualitative
approach to address a wide range of research questions and research strategies. It is used
extensively in library science, information studies, and medical fields (Hseih & Shannon,
2005; Krippendorff, 2010; Neuendorf, 2002; Weber, 1990; White & Marsh, 2006).
Descriptive information was collected to understand the evidence base utilized by UpToDate
and a qualitative content analytic approach was used to gain a more holistic understanding of
the context and process of summarizing evidence for clinical practice.
Qualitative content analysis "is the intellectual process of categorizing qualitative
textual data into clusters of similar entities, or conceptual categories, to identify consistent
patterns and relationships between variables or themes" (Julien, 2008, p. 121). Analytic

5

The multiple case study analysis is made up of seven cases. Because the grief and
bereavement case is made up of two entries: one addressing normal grief and bereavement
and one addressing complicated grief and bereavement, eight UpToDate topic entries are
analysed to make up the seven cases.
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constructs, or rules of inference, are used to find prominent patterns within the data and yield
inferences from textual data. While there is quite an extensive body of literature evaluating
and describing selected resources supporting evidence based medicine, an analysis of the
context, process, and underlying meaning of how lower order “S”s (e.g., studies and
syntheses) become higher order summaries has not been evaluated. The flexibility afforded
by the content analysis methodology was important to this research because there was some
uncertainty about what would emerge from the data. An inductive approach was used in that,
rather than looking for preconceived categories in the analysis, the categories were allowed
to emerge from the data. Content analysis allows researchers to identify what is stated
explicitly and what is implied by the manner in which content is expressed and, while it may
not provide definitive answers to critical concerns, content analysis can provide ‘signposts”
for further inquiry (Beach et al., 2009, p. 136).
In this study, the units of text that were subjected to analysis were the main clinician
entries of UpToDate for eight conditions (making up the seven cases), the associated patient
information where available, and the abstracts of the referenced evidence (evidence cited
within the UpToDate entry). The data from these texts were analysed individually by topic
and then analysed across the topics to understand the points of divergence and convergence
across the topics (Figure 3). Descriptive information from these three data sources was also
extracted, collected, and analysed.
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Figure 3: Comparing Similar Phenomena Inferred From Different Texts
(Adapted from Krippendorff, 2013, p. 94)
In order to ensure that this research captured a holistic and comprehensive
understanding of how UpToDate functions within health information practices and culture,
following the descriptive and qualitative analysis, the results were considered in relation to
Stuart Hall’s ‘Circuit of Culture’ framework (DuGay, Hall, Janes, Mackay & Negus, 1997).
The Circuit of Culture framework presents five coexisting processes: Representation;
Production; Consumption; Identity; and Regulation, which “taken together complete a sort of
circuit...through which any analysis of a cultural text or artefact must pass if it is to be
adequately studied" (DuGay, et al., p.3). Examining UpToDate using the framework of the
Circuit of Culture provides insight into the position and meaning of UpToDate in medical
and information environments, Figure 4 provides an overview of the model, including short
definitions for the five elements.
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Figure 4: Circuit of Culture Framework (Adapted from Du Gay et al., 1997)
The framework poses several questions in this study: How and why is UpToDate
created? (Production); How does the language of evidence based medicine and the language
used in UpToDate create meaning? (Representation); How is UpToDate consumed and
deployed by user groups (librarians and physicians)? (Consumption); What identities are
created and reinforced by UpToDate? How is UpToDate used to create and reinforce the
identity of its creators and users? (Identity); and What regulations, norms, and values
influence how UpToDate is created and used? (Regulation).
Data Sources for Content Analysis
The number of topics that comprise the corpus of evidence for clinical practice is
vast. More than 10,500 entries across 24 specialties are included in the UpToDate database.
For this multiple case study analysis, eight UpToDate entries, representing seven case
studies, were selected for evaluation. Each entry, along with the corresponding patient
information (where available) was analysed as a separate case, with the exception of the
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Grief case which comprises two UpToDate entries: the 2015 entry on treating complicated
grief and the 2015 entry on non-complicated grief. As outlined in the Diagnostic and
Statistical Manual of Mental Disorders by the American Psychiatric Association, the
diagnostic criteria and subsequent treatment of grief underwent a substantial shift in 2013
(American Psychiatric Association, 2013; Zachar, First, Kendler, 2017). A comprehensive
explanation of the changes and the decision to include two UpToDate entries for the Grief
case are included in the results section for Grief and Bereavement. An UpToDate entry is
defined in this study as a single UpToDate webpage addressing a discrete subject related to a
single condition/illness for either professionals or patients. The main clinician entry is
defined as the webpage content written for professionals accessible only by subscription to
the resource.
A multiple case study structure allows researchers to examine how the phenomenon
of interest presents in different environments (Stake, 2006). Whereas in a single case study
researchers seek to identify the common themes within the case, in a multiple case study
researchers are also interested in the atypical (i.e., unique concepts that do not transcend
across the cases, and/or distinctive concepts that are not common across all cases) (Stake,
2006). Toward this end, entries selected for analysis represent varying levels of complexity
and certainty. Per Stake (2005), each topic represents its own case study and the cross-case
analysis forms the multiple case study.
A unique feature of this research is that, unlike interviews where the text is analysed
as it is presented, and taken to be the entirety of the story or perspective, there is additional
information that is critically important to understanding the meaning and material embedded
in the text, i.e., the referenced evidence. The referenced evidence for this study includes the
studies, systematic reviews or other sources of evidence cited within the UpToDate entries
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examined. As such, in addition to the content of the entry, the referenced evidence is a unit of
analysis for which descriptive data is collected.
Entries for Analysis
The selection of cases is a critical and often challenging step in designing case study
research (Yin, 2009). In an attempt to reflect the realities of clinical practice, the topics
chosen as the cases address varying levels of complexity and medicalization of
conditions/illnesses, as well as of clarity, i.e., the level of certainty regarding interventions
and outcomes. For example, the treatment for the topic, Treatment of Children with Otitis
Media, would be expected to convey information about an illness with a clearly defined
organic medical cause, in which drug and non-drug interventions are evaluated in an attempt
to relieve the symptoms and cure the inflammation of the inner ear in children. In contrast, at
the other end of the spectrum, Complicated Grief and Bereavement in Adults is a more
complex and multifaceted topic. Unlike a physical ailment, grief and bereavement is an
emotional, but also highly medicalized, response to the loss of a loved one, which does not
have clear treatment. Seven cases were chosen for analysis. Each case contained one main
entry, with the exception of Grief and Bereavement, which contained two interrelated entries
(described below). The seven cases (eight entries) selected for this study were 6:
1. Acute otitis media in children (AOM): Acute Otitis Media (AOM) is the medical
term for inflammation of the inner ear. Otitis Media is a common childhood illness
with a known organic cause and pathophysiology. While 80% of occurrences of
AOM dissipate without treatment, AOM is the most common diagnosis for which
children receive antibiotics (Grijalva, Nuorti & Griffin, 2009). While complications
of acute otitis media are rare, complications include perforation of the eardrum,

6

Copies of the UpToDate entries analysed are available upon request
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infection of the mastoid space behind the ear, and, in very rare cases, bacterial
meningitis. For this case, the title of the entry analysed is Acute Otitis Media in
Children: Treatment.
2. Androgenetic alopecia (AGA): Androgenetic Alopecia is the medical term for male
pattern balding. While research demonstrates that hair loss can affect self-esteem in
men (Cash, 2001), Moynihan highlights that ordinary processes or ailments, like
balding, are often framed as medical problems. Androgenetic alopecia is commonly
diagnosed and treated by physicians, and the treatment for baldness is a multi-billion
dollar industry with many products in development (Ellis, Sinclair & Harrap, 2002).
Treatment of Androgenetic Alopecia in Men is the entry analysed.
3. Irritable bowel syndrome in adults (IBS): Irritable bowel syndrome (IBS) is a
chronic functional gastrointestinal disorder and has no known organic cause. As such,
IBS is a symptom-based diagnosis characterized by chronic abdominal pain and
altered bowel habits. While there are individuals with IBS who are incapacitated by
their symptoms, for many, IBS is “a mild functional disorder- requiring little more
than reassurance about is benign natural course” (Moynihan et al., 2002, p. 887). IBS
has been identified as a condition that has been medicalized, i.e., the relatively mild
symptoms of this common disorder may be portrayed as a sign of a serious disease
(Moynihan et al., 2002). The title of the entry in UpToDate analysed in this case is
Treatment of Irritable Bowel Syndrome in Adults.
4. Fibromyalgia in adults (FIB): This topic represents an illness or condition with a
high level of uncertainty with respect to its cause and treatment. Because
fibromyalgia involves unpredictable pain, has no known organic cause and the
treatment options are not consistently effective, there is a high level of uncertainty
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about it among both patients and professionals. Although, currently, there is a general
acceptance of fibromyalgia as a legitimate medical condition, questions have been
raised about its physiological authenticity, whether it is a single condition, and even
whether it represents a “medicalization of misery” (Hadler, 2003, p. 1668). The entry
analysed in for the FIB case is Initial Treatment of Fibromyalgia in Adults.
5. Chronic fatigue syndrome (CFS): Chronic Fatigue Syndrome (CFS) is an illness
characterized by persistent fatigue for at least 6 months, and is often accompanied by
several other symptoms including headaches, muscle pain, insomnia, and
concentration issues. There is no clear cause identified and no effective diagnostic
test developed for CFS. As such, CFS is diagnosed through symptom identification.
The lack of cause and diagnostic test has led to questions and challenges about the
legitimacy of CFS by some health care professionals who argue that a diagnosis of
CFS may be self-validating, self-reinforcing and potentially a self-fulfilling prophecy
(Huibers & Wessely, 1996). In February 2015, the United States Institute of Medicine
(IOM) published a report renaming Chronic Fatigue Syndrome as Systemic Exertion
Intolerance Disease (SEID), as well as proposing a redefinition of the diagnostic
criteria for CFS. While the content of the entry primarily uses the term Chronic
Fatigue Syndrome, the title does reflect the redefinition. The entry analysed for the
CFS case is Treatment of Chronic Fatigue Syndrome (Systemic Exertion Intolerance
Disease).
6. Grief and bereavement (NGB and CGB): Increased attention was recently drawn to
the potential for the medicalization of personal and social problems as a result of
changes to the psychiatric manual, the DSM-V (Diagnostic Statistical Manual of
Mental Disorders, Version 5), regarding guidelines and criteria for depression. Prior
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versions of the DSM advised physicians not to diagnose major depressive order after
the death of a loved one, even if all other criteria were met. The removal of the
“bereavement” exclusion was met with harsh criticism as it suggested that the
depressive syndromes that result from bereavement do not differ from “ordinary”
occurrences of depression. The treatment of personal or social problems as medical
problems has been questioned extensively. The case for Grief and Bereavement
included two UpToDate entries: Grief and Bereavement in Adults: Management and
Complicated Grief in Adults: Treatment.
7. Intimate partner violence: (IPV): Intimate partner violence (IPV) is a complex social
and health issue. The physician’s role in supporting a patient experiencing abuse are
often initiated when IPV is detected or disclosed. Physicians and health care workers
are increasingly encouraged to talk about, screen for, and provide options for
intervention when intimate partner violence is disclosed (American College of
Obstetricians and Gynecologists, 2012; Cronholm, Fogarty, Ambuel & Harrison,
2011; Society for Obstetricians and Gynecologists of Canada, 2009). While
preventing IPV and ensuring supports and resources are in place for IPV victims is
recognized as a priority and a potential outcome of the medicalization of IPV, the
issues underlying these actions and potential consequences of these actions are
numerous and complex. As such, the role of health care workers in identifying and
providing intervention options for IPV has been debated extensively (Cole, 2000;
Wathen & MacMillan, 2012). The entry analysed for the IPV case is titled Intimate
Partner Violence: Intervention and Patient Management.
Because the most common types of questions encountered in the clinical setting
address the treatment of illnesses and conditions (Crowley et al., 2003), all entries chosen for
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the multiple case study address treatment options. Individual analysis was followed by crosscase analysis. The triangulation between the seven cases, comprised of eight topics, highlight
themes that transcend the cases, as well as themes that are unique to specific cases, were of
interest.
It is important to note here that UpToDate is an internet-based evidence resource and
researchers face a number of challenges in conducting a content analysis of internet-based
resources (Weare & Lin, 2000). First, internet-based content consistently includes multiple
hyperlinks to additional material. These hyperlinks may be considered similar to “see also”
references in a print source; however, the immediacy of the hyperlinked content encourages
the reader to shift from the initial content to the supplementary reading. Moreover, the
dynamic nature of Internet resources adds additional challenges to analysis. Any content
captured may be edited or completely rewritten in minutes. This makes any particular
snapshot of the content somewhat arbitrary (Weare & Lin, 2000). While UpToDate updates
are not continual, and in fact can be quite slow (Prorok et al., 2012; Jeffrey et al., 2012), in
this study the web content was captured as a PDF to address the dynamic nature of the webbased data and ensure that the content analysed could be consistent throughout the study (as a
PDF, see Appendices A to G). Although UpToDate entries were updated over the course of
the study, the PDF of the captured entry was used for analysis.
Research Questions
Multiple case study research begins with core questions, but sub-questions are likely
to evolve over the course of data collection and analysis and, eventually, will help to inform
the themes that evolve from the data. It should be noted that the core research questions in
case study research: (a) are open-ended, evolving, and non-directional, (b) reinforce the
purpose of the research, (c) and are often ‘what’ or ‘how’ questions, rather than ‘why’
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(Cresswell, 201; Agee, 2009).
The following six research questions initially made up the base of the analysis and
met the criteria for research questions that are appropriate when using the case study method:
a.) What types of information sources do clinical experts include/privilege when developing
content for the summary source, UpToDate? b.) What information is overlooked or excluded
by clinical experts when developing content for the summary source UpToDate? c.) How is
evidence situated in the entries for UpToDate? d.) How is expertise situated in the entries for
UpToDate? e.) How is the patient situated in the entries for UpToDate? f.) How are these
processes understood in the five concepts of the Circuit of Culture?
Throughout the course of the analysis minor alterations were made to the research
questions. For example, it was not anticipated that expertise would be tied so directly to the
authors. Specifically, the entries heavily used phrases such as ‘In our experience’ and ‘we
suggest.’ The authors prominently presented and described expertise as their own so in turn,
the fourth question evolved from ‘How is expertise situated in the entries for UpToDate?’ to
‘How is author situated in the entries for UpToDate?’ In addition, the final question changed
from ‘How is the patient situated in the entries for UpToDate?’ to ‘How is the patientphysician relationship situated in the entries for UpToDate?’ This change largely evolved
from the inability to disentangle the two entities from the relationship as described in the text.
The final six research questions informing the analysis were:
1. What types of information sources do clinical experts include/privilege when
developing content for the summary source, UpToDate?
2. What information is overlooked or excluded by clinical experts when developing
content for the summary source UpToDate?
3. How is evidence situated in the entries for UpToDate?
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4. How is expertise situated in the entries for UpToDate?
5. How is the patient-physician relationship situated in the entries for UpToDate?
6. How are these processes understood in the context of the five concepts of the Circuit
of Culture?

Figure 5: Data Collection and Analysis Schematic
Four levels of analysis, as presented in Figure 5, addressed the five research questions
described above. The Level 1 and Level 3 analysis focused on the availability and inclusion
of evidence in UpToDate while the Level 2 analysis focused what content is included in each
UpToDate entry. Then, an overarching qualitative content analysis of the eight entries
making up the seven cases was performed as a means to better understand how evidence,
expertise and the patient is situated within the UpToDate entries. Finally, the process(es) was
examined in the context of the five key elements of the Circuit of Culture.
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Descriptive Data Extraction
Level 1 analysis relies heavily on the extraction of descriptive data from the
referenced evidence. A core objective in this study is to understand what types of evidence
sources are selected for inclusion as referenced evidence and what information is selected for
inclusion in the entry. As such, along with the overall text of the UpToDate entry, key data
sources for analysis were the referenced evidence of the eight entries. Referenced evidence
refers to those articles or sources that have been listed in the topic citation list as evidence
and appear in the reference list in the UpToDate entry. Descriptive information about the
referenced evidence was gathered from the bibliographic record and the abstract. The full
article was consulted when necessary. Information about when each case was downloaded,
last update, and number of sources included as referenced evidence is presented in Table 2.
Entry Title

Download

Review

Last

Date

current

Updated

# of
References

Acute otitis media in children

Sept 2015

Aug 2015

Jan 31, 2014

82

Androgenetic alopecia in men

Nov 2015

Oct 2015

July 21, 2015

41

Irritable bowel syndrome in adults

Jan 2015

Dec 2014

Oct 2, 2014

84

Fibromyalgia in adults

Oct 2015

Oct 2015

Aug 28, 2015

91

Chronic fatigue syndrome

Nov 2015

Nov 2015

Jul 30, 2015

46

Grief and bereavement

Dec 2015

Nov 2015

Aug 6, 2015

20

Complicated grief

Oct 2015

Nov 2015

Aug 6 2015

30

Intimate partner violence

Nov 2015

Oct 2015

Apr 28, 2015

24

Table 2: Number of Sources Cited as Referenced Evidence
Descriptive data were mined from the evidence sources. The data extraction form
was created for this study and web-based, making data entry more portable and easier using
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form tools including: checklists, radio buttons and open text. Further the web-based form
allowed the data to be easily exported to multiple formats (PDF, Word, Excel, SPSS) (see
Appendix H). Descriptive data were collected not only to describe the content and the
referenced evidence that make up the UpToDate topic information, but also to identify
relationships between the evidence and the entries in relation to five primary elements:
1. Publication Source: The titles of publication sources for each article cited
within the eight entries were recorded. The publication title for each
referenced evidence was also compared to the list of 466 core journals
identified by UpToDate for hand-searching. Hand-searching refers to
manually searching through select journal titles from cover to cover for
articles and citations relevant to a topic. Hand-searching aims to identify
articles that may be missed due to limitations in indexing practices. Since the
proliferation of digital publishing, hand-searching is now mostly done online
but still requires the careful review of online tables of content and online
article-by-article browsing.
2. Date of publication: The month (if available) and year of publication of the
references were recorded for each source cited across the eight entries.
3. Location of Study, if applicable: For research studies, the country where the
study took place was recorded. The country location(s) of data collection was
recorded, not the home institution of the author. If data were collected in more
than one country, it was recorded as multinational, also capturing the
individual countries.
4. Authorship, professional/academic background: To understand the relative
proportions of professional backgrounds that contribute to the UpToDate
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evidence base, the authors’ professional backgrounds were noted. Each cited
reference was given a weighting of one, and the background of each author of
the reference was assigned proportional weighting based on the number of
authors contributing to the cited reference. For example, a paper with a single
physician author would be assigned a value of 1.0 for physician background
and a paper co-written by a basic scientist, a nurse and two physicians, would
be assigned a value of .25 for the background for nurses and basic scientists
and .5 in the physician background. No difference of weighting was given for
order of authors.
5. Type of Evidence: In order to gain a better understanding of the type of
evidence included in UpToDate, each cited reference was analysed for the
level of evidence from Haynes’ 6S model,’ (e.g. Study; Synthesis); Type of
Resource (e.g. Quantitative Research; Systematic Review); and Research
Design, if applicable (e.g., RCT, Longitudinal). If the evidence/source cited
was not recognized under the 6S Model, this was recorded with details about
the type of resource (e.g. public health website).
6. PICO Elements of Clinical Question: The PICO framework identifies the
Patient/Problem, Intervention, Comparison, and Outcome of the clinical
question answered by the study. All identifiable elements of the referenced
evidence were recorded. It was anticipated that certain PICO elements of the
clinical question will have more or less importance in the entry depending on
the topic and the question addressed. Using the PICO framework helped to
separate and identify the features of the clinical question, as well as assist in
identifying relevant evidence not included in the entries.
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The conclusions of the study were also recorded. In incidences where all relevant
information could not be captured by the abstract, the full-text of the referenced evidence
was used.
Evidence Not Selected. A survey of the literature was conducted to better understand
the corpus from which the referenced evidence was selected. In addition to understanding
what is included as evidence, as Bowker and Star (2000) note, there is value in understanding
what has not been selected or has been omitted from the entry. The content of UpToDate is
claimed to follow “a hierarchy of evidence consistent with most evidence-based resources”
(UpToDate, “Editorial Policy,” 2017). Specifically,
[w]hen current, high-quality systematic reviews are available,
UpToDate topics and recommendations rely heavily on these reviews.
When such reviews are unavailable, UpToDate summarizes the key
studies bearing on the clinical issues at hand. (UpToDate, “Editorial
Policy,” 2016)
To gain an understanding of the body of available evidence from which authors select
systematic reviews and clinical trials, a purposeful search was conducted in PubMed.
Specifically, the PubMed portlet, which links clinical trials to the systematic reviews, which
subsequently cite them, was used (see Figure 6).

Figure 6: PubMed Portlet to Identify Citing Systematic Reviews

59
By using the portlet, systematic reviews that address clinical questions with similar elements
of PICO (i.e.: Patient, Intervention, Comparison, Outcome) to referenced clinical trials in the
entry could be identified.
Additionally, the size and nature of the body of qualitative research available across
the eight topics was of interest. While clinical trials, especially randomized controlled trials,
are privileged in the EBM hierarchy, qualitative research studies are rarely included in these,
and rarely recognized as components of evidence for practice. While qualitative research is
often overlooked in evidence hierarchies, this type of research provides empirical accounts of
the lived experience of health conditions from the patient perspective (Al-Busaidi, 2008). In
health-care, qualitative research provides insight about how patients experience, navigate,
and respond to health challenges through empirical accounts of such events (Dancet, et al,
2011; Given, 2008). Because the current study was interested in the ways that the patient and
patient-centred care is situated within evidence-based medicine and in turn, the ways that
patients and their experiences are situated within UpToDate, an understanding of the
availability of qualitative research was sought. Targeted literature searches were performed
to identify qualitative research on the eight topics. Qualitative findings are presented in single
qualitative studies and meta-analyses. Table 3 provides an overview of the search strategies
used in PubMed to identify qualitative evidence. The searches were limited to those articles
where the topic or condition is assigned as a major subject heading (denoted in PubMed as
[Majr]) by PubMed in order to identify focused and highly relevant articles.
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Case

Medical Subject

Date

Strategy for

Strategy for

Heading assigned to

Limiter Qualitative Studies

Meta-Analysis

condition
AOM

"Otitis Media"[Majr]

08/2015 AND "Qualitative

AND (("meta

AGA

"Alopecia"[Majr]

10/2015 Research"[Mesh] AND

synthesis" OR

IBS

AND "male"[MeSH

("therapy"[Subheading]

"metasynthesis")

Terms]

OR "therapy"[All

OR ("Meta-

"Irritable Bowel

10/2015 Fields] OR
"treatment"[All Fields]

Syndrome"[Majr]

Analysis"
[Publication Type]

FIB

"Fibromyalgia"[Majr]

11/2015 OR

or "meta-analysis"

CFS

"fatigue syndrome,

11/2015 "therapeutics"[MeSH

and qualitative))

Terms] OR

chronic"[Majr]
N/CGB

(("Grief"[Majr]) OR

11/2015 "therapeutics"[All
Fields])

"Bereavement"[Majr])
IPV

(("Domestic

10/2015

Violence"[Majr])
Table 3: Search Strategies to Identify Availability of Qualitative Evidence
The targeted searches for systematic reviews and qualitative research are not intended
to be comprehensive, but rather to gain a general sense of the body of literature from which
authors select evidence for inclusion in UpToDate. This is particularly of interest because
UpToDate “follows a hierarchy of evidence consistent with most evidence-based resources”
but lacks clear guidelines for the selection of evidence for UpToDate entries. Searches for
systematic reviews help to gain an understanding of whether the searches for evidence in
UpToDate follow the guidance of evidence based medicine that it is only when “every other
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S fails (ie, no system, [summaries,] synopses, or syntheses)” that it is appropriate to look for
original studies (Haynes, 2001, p. 37). Identifying the availability of qualitative research
helps to gain an understanding of the prominence of the patients’ accounts of illness
experiences in comparison to physician experiences in treating such conditions.
Overarching Qualitative Analysis
As noted earlier, the goal of this research was not only to identify and analyze what is
explicitly cited and stated in UpToDate entries but also to understand what is implied by the
manner in which content is expressed, and how, if at all, this relates to the core constructs in
the Circuit of Culture. As such, a key component of the study is the overarching analysis of
the texts that make up the seven cases. The qualitative content analysis was undertaken to
identify themes and patterns in the ways in which the authors of the entries present the
content they have selected for inclusion (Berg, 1995, 2007). Because this type of analysis
has not been previously done, inductive analysis was critical to allow data analysis and
concept development to occur simultaneously. The inductive approach allowed themes to
emerge from the data iteratively, rather than relying on pre-determined themes. Qualitative
content analysis was used for each entries making up the seven cases in an attempt to make
inferences about three particular phenomena of interest: certainty, expertise, and the position
of the patient, then relate these to the Circuit of Culture.
In order to facilitate valid and reliable inferences, a systematic and transparent
procedure was followed and documented. To develop the codes and categories inductively,
the constant comparative method outlined by Strauss and Corbin (1990) was used as a guide
for analysis. Initially, the texts of the entries were read and coded with general descriptions
of the content. This process focused on “breaking down, examining, comparing,
conceptualizing and categorizing the data” (Strauss & Corbin, 1990, p. 61) At this open
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coding stage, many descriptors, categories and a wide range of codes were recorded to
describe the various elements of the data (Berg, 1995). Axial coding, where connections
between the initial codes and categories are made and recorded, followed, where new higher
order concepts emerged, evolved and were ultimately labelled (Strauss & Corbin, 1990, p.
96). Core themes emerged from axial coding and extensive documentation of what falls
beneath the broader themes was recorded. Finally, once the core themes were identified, the
data were analysed as a whole with the core themes and the Circuit of Culture constructs in
mind. Key content or phrases that support and confirm the core themes were selected from
the text and noted. Outlying divergent statements were also selected and recorded. Multiple
readings of the entries with the core themes and subheadings were needed in order to ensure
reliable coding. This overarching qualitative analysis was assisted by the use of the
qualitative analysis software NVivo (v. 10).
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Chapter 3: Results
This multiple case study analysis included seven topics, where two of the cases, i.e.,
those related to bereavement, were combined in the cross-case analysis. These cases
represented varying levels of contestation, complexity, and certainty. This section first
analyses the cases individually, followed by the cross-case analysis. Data sources analysed
for each case included: the related main professional entries for each topic, the referenced
evidence of the main entries (descriptive analysis only), and the patient information in Basic
and/or Beyond the Basics format, when available. Each case contained one main entry, with
the exception of Grief and Bereavement, which contained two interrelated entries. A brief
introduction to each topic leads each case, including an overview of issues that are discussed
and debated about the topic. A descriptive analysis of the references cited in each of the cases
is then presented, followed by the textual analysis. Across the seven cases, three broad
higher-order categories emerged from the textual analysis that address the initial research
questions about certainty, expertise, and the role of patient: Situating the Authors, Situating
the Evidence, and Situating the Patient-Physician Relationship.
The analysis of the patient information entries was conducted to evaluate how
these align with the main UpToDate entry for professionals, specifically in relation to
the representation of certainty and uncertainty of evidence and the framing of the
patient-physician relationship, including decision-making responsibilities. The analysis
of the patient information focused on the section addressing treatment in order to best
align the patient and professional content for comparison.
Table 4 provides an overview of the topics and data sources analysed, including the
review date (re: currency) and word counts of the analyzed data.
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Topic

Main

Basics

Beyond

Case

Word Count

Word Count

Word Count

#

Review

Review

Review

Current

Current

Current

6176 words

732 words

1539 words

08/2015

10/2015

10/2015

1

Acute Otitis Media

AOM
2

Androgenetic Alopecia

3693 words

1430 words
N/A*

AGA
3

10/2015
Fibromyalgia

FIB
4

Chronic Fatigue Syndrome

CFS
5

Irritable Bowel Syndrome

IBS
6

Normal Grief and Bereavement

GRF

12/2015

7489 words

534 words

3371 words

10/2015

12/2015

12/2015

3847 word

736 words

1369 words

11/2015

12/2015

12/2015

5374 words

460 words

3202 words

11/2015

12/2015

01/2016

N/A

N/A

N/A

N/A

N/A

N/A

2182 words
11/2015

Complicated Grief

2669 words
11/2015

7
IPV

Intimate Partner Violence

3679words
10/2015

*N/A: UpToDate does not provide patient information at this level (Basics or Beyond the
Basics)
Table 4: Overview of Topics and Entries Analysed
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Case Study Analysis: Acute Otitis Media
Acute Otitis Media (AOM) is a painful ear infection that causes the middle ear to
become inflamed. AOM is a common illness in children. More than two-thirds of children
will experience AOM before the age of three (Vergison, Dagan & Arguedas, 2010). AOM
has a clear organic cause, and the cause and validity of the illness is not contested. However,
while AOM is the diagnosis for which children are most frequently prescribed antibiotics, the
necessity for and role of antibiotics in treating AOM is heavily debated. Because children can
recover spontaneously without treatment, one option for care is observation with comfort
measures, i.e., watchful waiting with analgesics. The other primary strategy for care is to
treat AOM with antibiotics although there is “strong evidence that antibiotics provide
minimal benefit” (Hansen, Howlett, Del Mar & Hoffmann, 2015). The caregiver’s
understanding of and desire for treatment with antibiotics has been shown to be a key
influence in the likelihood of antibiotics being prescribed (Cockburn & Pit, 1997; Hansen et
al.; McNulty, Nichols, French, Joshi & Butler, 2013). The debate is further magnified when
considering the current focus on reducing the use of antibiotics in order to prevent
development of antibiotic resistant bacteria. In a 2015 editorial on antibiotics and AOM, Del
Mar, Venekamp, and Sanders explain: “any recommendation that may increase the use of
antibiotics in primary care will contribute to antibiotic resistance, which is now a serious
threat to global public health” (p. 1574).
To guide physicians in providing care for children with AOM, the American
Academy of Pediatrics (AAP) and American Academy of Family Physicians (AAFP)
developed a clinical practice guideline in 2004. The organizations updated the guideline in
2013. The document provides recommendations to primary care clinicians for the
management of children from six months through 12 years of age with uncomplicated AOM.
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The guidelines present both observation and antibiotics as options for care of children with
AOM over six months of age. The presentation of both options and the perceived lack of
decisiveness and clear position by guidelines has been criticized (Nikolopoulos, 2014). The
debate about the best approach to antibiotics in AOM pervades and is addressed in the
UpToDate entry, Acute Otitis Media in Children: Treatment.
Descriptive Analysis
The AOM case contained 82 cited references ranging in date of publication from
1980-2015. Fewer than one quarter (n=18, 22%) of the references were published between
2010 and 2015. The vast majority (74%) of cited references were from UpToDate’s list of
core journals. The journal most commonly cited in the AOM main entry was Pediatric
Infectious Disease Journal, a key journal identified by UpToDate.
This UpToDate entry contained evidence situated in three levels of the 6S hierarchy:
Summary, Synthesis, and Study (Figure 7). Of the 82 references, there are also 15 (18%)
cited that are not recognized as evidence in the 6S hierarchy: non-systematic/narrative
reviews (n=8); public websites (n=2); editorials/commentaries (n=3), textbooks (n=1) and
case reports (n=1). The majority of referenced evidence (59%) were studies; all 48 studies
were quantitative, 21 of which were RCTs.
Cited
References
82
Not in 6S
15 (18%)

Summary
5 (6%)

Synthesis
14 (17%)

Study
48 (59%)

Quantitative
48 (59%)
RCT
21 (26%)

Qualitative
0 (0%)

Other Quant
27 (33%)

Figure 7: Types of Evidence in the AOM Entry
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More than half of the cited studies were conducted in the United States (n=27,
56.3%). Three studies were multinational, all with partnerships with locations in the United
States (two studies collaborating with sites in Canada and one with a site in Chile). Fourteen
studies took place in European countries: (United Kingdom (n=4); France (n=3); Israel
(n=3); Finland (n=2); and Italy (n=1); Denmark (n=1)); and one study each took place in
Canada, Australia, Costa Rica and Japan.
The 82 cited references were written by a total of 376 authors. Based on the number
of authors contributing to the paper, a proportional weighting was assigned for the
background of each author. Across the 82 papers, the highest known proportional
representation (.56) of the authors had a Medical Doctor (MD) background (see Figure 8).
Background of Authors - AOM References
0.6

0.56

0.5
0.4
0.3

0.25

0.2
0.08

0.1

0.04

0.06

0
MD

PhD

Non-MD

Prof Org

Unknown

Figure 8: Relative Contributions by Author Background
Textual Analysis
Situating the Authors. The content of the AOM case is connected closely with the
expertise of the authors. Most prominently, the authors share their expertise through their
recommendations. The authors explicitly communicate their recommendations to the reader
as their own position: “We recommend treatment to reduce ear pain in children with AOM
whether or not they are treated with antibiotics” (AOM). Using the phrase ‘we recommend’
or ‘we suggest’ extensively, the authors make it overt that their guidance is developing out of
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their own expertise and understanding. For example, they provide the following
recommendation:
For children with AOM and tympanic membrane perforation, we suggest oral
rather than topical antibiotic therapy. We suggest amoxicillin 90 mg/kg per
day orally divided in two doses (we suggest a maximum of 3 g/day) as the
preferred firstline oral therapy. (AOM)
The authors commonly provide specific details about the ways in which treatment options are
enacted (e.g., the timing and allocation of medication dosages) by way of their own
recommendations/suggestions. In addition to details about the execution of treatment
regimens, the authors frequently connect their recommendations to specific patient features
and circumstances. For example:
We suggest that children <2 years, children with AOM and tympanic
membrane perforation, and children with a history of recurrent AOM be
treated for 10 days. We suggest that children ≥2 years without tympanic
membrane perforation or a history of recurrent AOM be treated for five to
seven days. (AOM)
Follow-up for children whose symptoms have resolved depends upon the
child's age and underlying medical problems, particularly language delay
or learning problems. We suggest that:
Children <2 years be seen 8 to 12 weeks after diagnosis (by which
time middle ear effusion will have resolved in 80 to 90 percent);
many such children will already have a routine healthcare visit
scheduled within this time frame
Children ≥2 years who have language or learning problems be seen 8
to 12 weeks after diagnosis
Children ≥2 years who are without language or learning
problems be followed up at their next health maintenance visit,
or sooner if there are concerns regarding persistent hearing loss
(AOM)
The specific details about treatment, which vary depending on the individual patient’s
circumstances (e.g., age, medical history, presence of language and learning issues), are often
provided by way of a recommendation by the authors.
There are 22 incidences where the authors utilize the phrase ‘we suggest’ or ‘we
recommend’ to promote their approach to AOM through their own expertise. On selected
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occasions, the authors followed up their recommendation with published evidence, which
supports their recommended approach:
We suggest oral ibuprofen or acetaminophen for pain control in children with
AOM […] In a multicenter trial, 219 children (one to six years of age) with
AOM were treated with antibiotics and randomly assigned to receive
ibuprofen 10 mg/kg three times per day, acetaminophen 10 mg/kg three times
per day, or placebo. (AOM)
We do not suggest preflight treatment with antihistamines or decongestants.
In a randomized trial, predeparture administration of pseudoephedrine did not
decrease ear pain, but was associated with increased drowsiness. (AOM)
The authors’ endorsements of particular treatment options are presented first and then
reinforced by clinical trials.
In addition to providing explicit recommendations, the authors also provide accounts
of their own practices. The authors describe the approach to treatment that they take when
treating children with AOM:
We generally treat children <2 years, children with tympanic membrane
perforation, and children with recurrent AOM for 10 days. We generally treat
children ≥2 years without a history of recurrent AOM for five to seven days.
(AOM)
Through the accounts of their own routine practices (e.g., length of treatment based of patient
characteristics), authors make implicit recommendations when treating patients and like the
explicit recommendations, also often address the tailoring of treatment to individual patients.
In this case there is a noteworthy instance where the authors’ steady presentation of
their own recommendations by the phrase ‘we recommend’ or ‘we suggest’ was relinquished
when the approach shifted from the prescription of antibiotics to observation. The authors
provide guidance for four subgroups of children with AOM:
We recommend that children <6 months with AOM be treated immediately
with an appropriate antibiotic.
We suggest that children six months to two years with AOM be treated
immediately with an appropriate antibiotic;
We suggest that children ≥2 years who appear toxic; have persistent otalgia
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for more than 48 hours; have temperature ≥102.2°F (39°C) in the past 48
hours; have bilateral AOM or otorrhea; or have uncertain access to followup
be immediately treated with an appropriate antibiotic.
For children ≥2 years who are normal hosts (eg, immune competent, without
craniofacial abnormalities) and have unilateral AOM with mild symptoms and
signs and no otorrhea, initial observation may be appropriate [emphasis
added] if the caretakers understand the risks and benefits of such an approach.
(AOM)
In this quotation, the authors provide a clear recommendation for antibiotics for three
subgroups of children with otitis media. However, in the fourth and final bullet, the authors
shift from the pattern of providing a clear recommendation—using ‘we recommend’ or ‘we
suggest’—to stating that the approach of delaying or forgoing antibiotic treatment “may be
appropriate” (AOM). Following three clear recommendations which the authors appear to
‘own’, the authors appear not to endorse or support their final suggestion.
Later in the case the authors provide additional details with respect to observation
as a possible approach to treatment:
We suggest initial observation as an alternative to antimicrobial therapy for
children ≥2 years who are normal hosts (eg, immune competent, without
craniofacial abnormalities), without otorrhea, and who have mild
symptoms and signs of unilateral acute otitis media (AOM) (ie, nonsevere
ear pain for <48 hours and temperature <39°C [102.2°F]). Clinicians who
recommend initial observation should exercise rigor in diagnosing AOM
similar to that in the research protocols that support the safety of this
practice. (AOM)
In this quotation, the authors do not endorse the treatment, but rather frame observation as an
alternative treatment for this subgroup of children. The authors further separate themselves
from the approach by referring to “clinicians who recommend initial observation” (AOM).
The authors’ lack of full endorsement for observation as a treatment option for AOM is
significant because of its alignment, or misalignment, with key clinical practice guidelines
discussed in the Situating the Evidence section.
Situating the Evidence. The summary level of evidence is described by Haynes

71
(2007) as an integration of “best available evidence from the lower layers (drawing on
syntheses [i.e., systematic reviews] as much as possible) to provide a full range of evidence
concerning management options for a given health problem” (Haynes, p. 6). Both UpToDate
and clinical practice guidelines are located in the Summary level of evidence. As established
in the Situating the Authors section, the authors of this entry do not appear to fully endorse
observation as a treatment option for children over 6 months of age. In contrast, the 2013
iteration of the AOM Clinical Practice Guideline of the American Academy of Pediatrics
(AAP) and American Academy of Family Physicians (AAFP) recommends that for children
as young as six months with unilateral AOM, “physicians should either prescribe antibiotic
therapy or offer observation with close follow-up based on joint decision-making with the
parent(s)/caregiver” (Lieberthal et al., 2013). The authors of the case acknowledge that their
perspective counters this Clinical Practice Guideline:
The 2013 American Academy of Pediatrics (AAP) and American
Academy of Family Physicians (AAFP) guideline recommends immediate
treatment for children <6 months, children with severe signs or symptoms
(defined by moderate or severe ear pain, ear pain for ≥48 hours, or
temperature ≥39°C [102.2°F]) and bilateral AOM in children <24 months
of age. The 2013 AAP/AAFP guideline recommends either immediate
treatment or observation (with pain control) for children between 6 and 24
months with unilateral nonsevere AOM and for children ≥24 months with
unilateral or bilateral nonsevere AOM. However, given the additional
analysis now available showing a high rate of treatment failure among
children <24 months with unilateral nonsevere AOM, we suggest that such
children be treated with antimicrobial therapy. (AOM, emphasis added)
The authors, here, describe the recommendations that are provided by the AAP and AAFP,
which include options for both immediate treatment and observation, then highlight evidence
that contradicts observation as a treatment option. In turn, they propose the alternative
suggestion, the prescription of antimicrobial therapy for children less than 2 years of age. The
preference for antimicrobial therapy aligns with their recommendation stated earlier: “We
suggest that children six months to two years with AOM be treated immediately with an
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appropriate antibiotic” (AOM). The authors also draw attention to other clinical practice
guidelines that counter their recommendation: “Guidelines from other countries (e.g., the
Dutch College of General Practitioners) recommend a no or delayed antibiotic strategy for
most children with AOM” (AOM). Although the authors appear not to endorse initial
observation as a treatment strategy, the authors repeatedly make clear that the guidelines
affirm the option for observation. There is a willingness by the authors to position themselves
counter to the published clinical practice guidelines.
In addition to highlighting the conclusions of clinical practice guidelines from the
Summary level of evidence, the authors summon evidence from the Study and Synthesis
level of the 6S hierarchy to exemplify certainty within the AOM case:
A 2001 metaanalysis concluded there is no evidence to support any particular
antibiotic regimen versus another for treatment of AOM. (AOM)
Individual randomized trials that used stringent diagnostic criteria and
experienced otoscopists to make the diagnosis of AOM and appropriate
antibiotic regimens to treat AOM indicate that children younger than two
years benefit from antibiotic therapy. (AOM)
The presence or absence of evidence is highlighted as a source of certainty in these examples.
Throughout the case, there is wide variance in the amount of information that is provided
about the referenced evidence from these levels, ranging from no details about the study to
scant descriptions to extensive reports. In the quotations below, the variance in the extent of
descriptions is demonstrated:
In a randomized trial, predeparture administration of pseudoephedrine did not
decrease ear pain, but was associated with increased drowsiness. (AOM)
In a multicenter trial, 219 children (one to six years of age) with AOM were
treated with antibiotics and randomly assigned to receive ibuprofen 10 mg/kg
three times per day, acetaminophen 10 mg/kg three times per day, or placebo.
On the second day of illness, fewer children who received ibuprofen or
acetaminophen had pain (7 and 10 percent, respectively, versus 25 percent
among placebo recipients); the reduction in pain was only statistically
significant for ibuprofen. (AOM)
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While the type of study design is included in both descriptions, it is only in the second
quotation that details about the study’s patient population (i.e., age and number), intervention
(i.e., ibuprofen with dosage), comparators (i.e., placebo) and outcome (i.e., pain relief) were
provided. Details about all elements of the PICO clinical question were included in the
second quotation, while the first quotation only highlighted the basic outcomes of the study.
Descriptions of meta-analysis and systematic reviews also included varying levels of
detail. Examination of the reporting of synthesis level of evidence provides a good example
of the ways that the results and conclusions of a study or review influenced the level of
description and detail by the authors. More detail about meta-analyses and systematic
reviews that supported the prescription of antibiotics were provided than those that did not
support antibiotic prescription. The single meta-analysis that demonstrated benefit of
antibiotic care was described in a paragraph:
In a 2006 meta-analysis of individual data from six randomized trials (1643
children age six months to 12 years), children who were younger than two
years who had bilateral AOM and children with otorrhea benefited most from
antibiotic therapy. Among children younger than two years with bilateral
AOM, 25 percent (95% CI 14-36 percent) fewer children treated with
antibiotics than with symptomatic care continued to have pain and/or fever on
days three to seven of illness. Among children with otorrhea, 36 percent (95%
CI 19-53 percent) fewer children treated with antibiotics than with
symptomatic care continued to have pain and/or fever on days three to seven
of illness. (AOM)
The description of the meta-analysis includes details about the four PICO elements (i.e.,
patient, intervention, comparators, and outcome) of the investigated clinical question, as well
as statistical results. In contrast, the description of five systematic reviews that do not
support the use antibiotics is considerably shorter:
Systematic reviews and meta-analyses suggest that many children with AOM
do well, even without antibiotic therapy, and that the benefits of antibiotics are
modest. (AOM)
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The authors cite five systematic reviews in the sentence quoted above. While the authors note
that the intervention assessed was antibiotics in children, extensive details about the PICO
elements are not provided, with the exception of a brief indication that the outcomes of the
study found that “the benefits of antibiotics are modest” (AOM). The authors also follow-up
the statement with critique of the conclusions:
However, many of the studies included in the meta-analyses had increased
risk of bias (related to nonstringent diagnostic criteria, inclusion of children
with mild disease, exclusion of patients <2 years of age, use of an
inappropriate antibiotic or inappropriate dose, etc), making the results difficult
to interpret. (AOM)
The authors highlight in this excerpt some of the shortcomings of the research, including bias
within the study selection. The authors favour details about the systematic review supporting
the use of antibiotics. The way in which these two systematic reviews containing conflicting
findings are handled accentuate the authors’ ability to select what details about the evidence
are brought to the fore.
The inclusion of commentary on the available evidence is common throughout the
AOM case. The authors repeatedly provide critiques of the body of evidence available for
AOM:
Randomized trials comparing immediate versus delayed antibiotics have
used different outcome measures (eg, parental satisfaction, rate of filled
prescriptions, etc) and types of followup (eg, telephone versus office
examination). (AOM)
In this example, the authors highlight that the research studies evaluating AOM treatments
often do not measure the same outcomes. In addition to the inconsistent outcomes across
research studies, the authors’ commentaries also highlight methodological shortcomings of
specific research studies including a lack of placebo, atypical dosing regimes, and unreliable
diagnostic criteria. The authors also comment on insufficiencies in the research base as a
whole. In particular, they draw attention to multiple areas where evidence is lacking or is

75
inconsistent:
Most clinical trials and standard pediatric practice provide a 10day
course of an oral antimicrobial agent for the treatment of AOM.
However, some data suggest that a shorter course (ie, seven days) may be
adequate. Unfortunately, many of the studies comparing short and
longterm antibiotic therapy have significant limitations that preclude
definitive conclusions. (AOM)
These therapies have been proposed, but there are no placebocontrolled trials
that directly address their effectiveness. (AOM)
The authors are transparent about gaps or inconsistencies in the current literature on AOM,
giving rise to some uncertainty. In two instances within this entry, the authors fill in the lack
of evidence in the research literature with their own recommendation:
Interventions to equalize middle ear and atmospheric pressure have not
been well studied in controlled trials. We suggest that children be awake
during descent and chewing gum or food (or sucking on a pacifier or
bottle if they are too young to chew gum or food) to open the Eustachian
tube and facilitate equalization of middle ear pressure. (AOM)
There are no randomized trials to guide treatment of recurrent AOM in
children. […]
When recurrence occurs within 30 days of completion of antimicrobial
treatment for the previous episode, we suggest [list of antibiotics]. (AOM)
The authors provide suggestions for care in the absence of evidence. This practice of
authors ‘filling in’ where there is a lack of evidence aligns with the description of the
work of authors and editors from UpToDate (UpToDate, “Physician Authors and
Editors,” 2016).
Situating the Patient-Physician Relationship. The clinical practice guideline from
the AAP/AAFP, which is referenced in the entry, states that the decision on which of the two
approaches, observation or antibiotics, is adopted for a patient occurs “after joint decisionmaking with the parent(s)/caregiver” (Lieberthal et al., 2013, p. e965). In contrast, in the
main UpToDate entry the clinician, rather than the patient, is positioned at the center of that
choice:
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When treating such children, practitioners should weigh the potential
symptomatic benefit against the reported adverse events and potential for
prolongation of middle ear effusion. (AOM)
In the quotation above, the practitioners are the decision-makers who assess multiple factors
in order to make a choice. Physicians’ need to consider specific patient characteristics is
highlighted by the authors: “The choice of strategy depends upon the age of the child and the
laterality and severity of illness” (AOM). Here, it is clear that the decision should take into
consideration traits and characteristics of the patient; however, the responsibility for
decision-making appears to rest with the physician. The focus on the physician in the
decision-making process, and the subsequent absence of the patient/caregiver, runs counter to
the AAP/AAFP guidelines that emphasize joint-decision making between the clinician and
parent/caregiver (Lieberthal et al., 2013). Even when the factors are largely related to patient
preference or patient context, overt acknowledgement and identification of the patient is
absent in the text:
When the decision is made to treat acute otitis media (AOM) with
antimicrobial agents, the selection among available drugs is based upon:
Clinical and microbiologic efficacy; Acceptability (taste, texture) of the oral
preparation; Absence of side effects and toxicity; Convenience of the dosing
schedule; Cost. (AOM)
The decision-making for treatment is presented as the responsibility of physicians in
consideration of the patient circumstances and preferences. The patient experience was
treated much like patient preferences in that it was disconnected from the patient. The focus
is not on patient experience, but rather the resolution of symptoms.
There are three instances in the AOM case where the caretakers of children with
AOM are specifically mentioned. All three are in relation to the caretakers’ need to
understand the risks and benefits of observation:
When the initial observation strategy is chosen, caretakers must understand
the risks and benefits, and appropriate follow-up must be ensured so that
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antibiotic therapy can be initiated if symptoms worsen or persist after 48 to 72
hours. (AOM)
As demonstrated in the excerpt above, the authors only refer to caretakers when emphasizing
the need for caretakers to comprehend the risks and benefits of not initiating antibiotics
immediately. The caretaker’s need for awareness of risks and benefits was only discussed in
relation to observation therapy but not the alternative, antibiotic therapy. The effect of
antibiotic resistance on the patient or the public is minimaly addressed in the entry:
“Although the child is at higher risk for a nonsusceptible pathogen, we suggest high dose
amoxicillinclavulanate as initial therapy, even if the child received amoxicillinclavulanate
for the previous episode” (AOM). Antibiotic resistance is primarily discussed in relation to
the resistance and domination of certain bacteria to particular antibiotics, but not in relation
to the impact or responsibility of the patient:
Macrolide or lincosamide antibiotics can be used to treat AOM in children
who have had an immediate type 1 hypersensitivity reaction (anaphylaxis,
angioedema, bronchospasm, or urticaria) to amoxicillin or other betalactam
antimicrobial agents. However, macrolide or lincosamide resistance is
common (approximately 25 to 35 percent) among isolates of S. pneumoniae,
and macrolides and lincosamides generally are not effective for eradication of
H. influenza. (AOM)
Trimethoprimsulfamethoxazole, macrolides (eg, erythromycinsulfisoxazole,
azithromycin, clarithromycin), and lincosamides (eg, clindamycin) are not
recommended for AOM that fails to respond to treatment with highdose
amoxicillin. Pneumococcal surveillance studies indicate that resistance to
these agents is substantial). (AOM)
Antibiotics resistance is addressed through underscoring the antimicrobial activities of
different antibiotics: physicians’ and patients’ responsibility to prevent antibiotics resistance
is not addressed. The authors advise physicians to caution patients about the risks of
observation; however, the side effects or risks of antibiotics are not included as key
components of the physicians’ education for AOM caregivers.
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Patient Information. UpToDate provides patient information in two forms, The
Basics and Beyond the Basics. The two patient entries were analysed to evaluate how the
patient information entries align with the main professional UpToDate entry in relation to the
representation of certainty and uncertainty of evidence and the framing of patient-physician
relationship, including decision-making responsibilities. The analysis of the patient
information is focused on the sections addressing treatment of acute otitis media in order to
best align the patient and professional content for comparison.
As discussed, two strategies for care are available when treating AOM in children.
Both treatment approaches are presented in patient information entries. In The Basics, the
two treatments options for AOM are outlined as such:
Doctors can treat ear infections with antibiotics. These medicines kill the
bacteria that cause some ear infections. But doctors do not always prescribe
these medicines right away. That’s because many ear infections are caused by
viruses — not bacteria — and antibiotics do not kill viruses. Plus, many
children get over ear infections without antibiotics. (AOM Basics)
In this excerpt from The Basics patient information, the rationale behind each choice is
described. The cause of AOM and the effects of antibiotics primarily dictate this choice. This
explanation of choice is followed by an explanation of what children commonly are and are
not prescribed antibiotics.
Doctors usually prescribe antibiotics to treat ear infections in infants younger
than 2 years old. For children older than 2, doctors sometimes hold off on
antibiotics. Your child’s doctor might suggest watching your child’s
symptoms for 1 or 2 days before trying antibiotics if: Your child is healthy in
general; The pain and fever are not severe. (AOM Basics)
The recommendations outlined here align with author recommendations to prescribe
antibiotics for children under the age of two. In contrast, the 2013 clinical practice guideline
of the AAP/AAFP “recommends either immediate treatment or observation (with pain
control) for children between 6 and 24 months with unilateral nonsevere AOM” (AOM). The
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patient information, while presenting both options for care, the specifics of the two treatment
options align closer with the authors’ recommendations than with the AAP/AAFP guidelines.
The Basics version of the patient information does align closely with the AAP/AAFP
in terms of a shared decision-making process between health care professional and caretaker:
You and your doctor should discuss whether or not to give your child
antibiotics. This will depend on your child’s age, health problems, and how
many ear infections he or she has had in the past. (AOM Basics)
The physician and the caregiver are presented as shared decision-makers. This emphasis on
joint decision-making is only present in the basic information. In contrast, decision-making
in the Beyond the Basics patient information is not presented as a shared process. The choice
is based on choosing the best treatment for the patient: “The ‘best’ treatment depends on the
child's age, history of previous infections, degree of illness, and any underlying medical
problems” (AOM Beyond). These four factors that dictate the best treatment are followed by
short explanations about who is most likely to receive observation or antibiotics based on
these four factors. For example, the following explanation about how age influences the
likelihood of antibiotic prescription:
Antibiotics are usually given to infants who are younger than 24 months or
who have high fever or infection in both ears. Children who are older than 24
months and have mild symptoms may be treated with an antibiotic or
observed to see if they improve without antibiotics. (AOM Beyond)
The appropriateness of antibiotics for children who are younger and or who have more
significant symptoms is highlighted (aligning with the authors’ recommendations, not the
AAP/AAFP guidelines). A similar description of who is best suited for observation (i.e.,
those who are older, healthy and have less severe symptoms) is also included in the entry. In
the Beyond the Basics entry, the notion that there is a “best” treatment based on medical
status and history places a great deal of decision-making responsibility with the physician
because of the implied need for the physician’s expertise to identify the most suitable
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treatment.
Additional roles of the caregiver highlighted in both entries include ensuring
symptom identification, pain control, and proper follow-up. The importance of monitoring
and follow-up is emphasized when observation is adopted as the treatment approach.
In substantial contrast to the UpToDate entry, the risks of antibiotics are put forth in
the Beyond the Basics patient information:
Antibiotics can have side effects such as diarrhea and rash, and overusing
antibiotics can lead to more difficult to treat (resistant) bacteria. Resistance
means that a particular antibiotic no longer works or that higher doses are
needed next time. (AOM Beyond)
These side effects are not emphasized in the main entry for professionals.
The patient information does not reflect the same preference for antibiotics that the
authors of the main entry inferred. The patient information resources present both
observation and antimicrobial therapy as options for treatment. However, antibiotics for
children between 6 months and 2 years of age are favoured over the AAP/AAFP guidelines
for the choice between antibiotics or observation. Further, the patient information provides
insight into some of the potential side effects and outcomes of antibiotic prescribing. There is
also variance within the two patient information sources concerning with whom the
responsibility for decision-making sits. Specifically, The Basics accentuate the need for
shared decision-making between patient and physician. In contrast, the presentation of a
“best” treatment in Beyond the Basics implies that physician expertise is needed to identify
the best option. There are substantial inconsistencies across the main professional entry, The
Basics patient information, and the Beyond the Basics patient information.
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Case Analysis: Androgenetic Alopecia
Androgenetic alopecia (AGA) is a common form of hair loss and is often referred to
as male pattern balding. In AGA, hair is lost in a well-defined pattern beginning above both
temples and over time, the hairline recedes to form a characteristic ‘M’ shape. While
androgenetic alopecia can affect both men and women, the analyzed UpToDate main entry,
Treatment of Androgenetic Alopecia in Men, only addresses the condition in men. A separate
entry for AGA in women is included in UpToDate. AGA affects 30% of Caucasian men by
the age of 30 and the incidence of AGA increases with age with up to 80% of men affected
by the age of 70 (Ellis, Sinclair & Harrap, 2002; Yip, Rufaut & Sinclair, 2011). While
alopecia in men is a common process that accompanies aging, the societal imperatives
regarding maintenance of the appearance of vigour and vitality has led to a demand for
intervention to treat this common process. Although balding is a normal process of aging,
androgenetic alopecia is a condition often diagnosed and treated by physicians (Ellis, Sinclair
& Harrap, 2002; Moynihan, 2002).
Descriptive Analysis
The AGA case contained 41 cited references ranging in publication date from 1987 to
2015. Twelve of the 41 references (29%) were published between 2010 and 2015. The
majority (63%, n=26) of cited references were from UpToDate’s list of core journals. The
most commonly cited journal in the AGA main entry was the Journal of the American
Academy of Dermatology, a core UpToDate journal.
The UpToDate entry for AGA contained three types of evidence from the 6S
hierarchy: Summary, Synthesis, and Study (see Figure 9). Twenty-two per cent (n=9) of the
cited references were not recognized as evidence in the 6S hierarchy. These nine references
were made up of seven non-systematic reviews, a case report/brief, and a drug information
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brief. Only one summary and one synthesis (systematic review) were cited in the entry.
Cited
References
41
Not in 6S
9 (22%)

Synthesis
1 (2%)

Summary
1 (2%)

Study
30 (73%)

Quantitative
30 (73%)
RCT
24 (59%)

Qualitative
0 (0%)

Other Quant
6 (14%)

Figure 9: Types of Evidence in AGA Main Entry
Approximately three quarters of the cited references (n=30) were studies, all of which
were quantitative, with 24 RCTs and most conducted in the US (n=20, 67%). Two
multinational studies were cited, both in partnerships with locations in United States. Three
studies took place in European countries (Germany (n=2), Turkey (n=1)), and one each in
Canada, Japan, Iran, and India. It is unknown where one study of the 30 studies was
conducted.
The 41 cited references were written by a total of 203 authors. Across the 82 papers,
the highest known proportional representation (.51) of the authors had a Medical Doctor
(MD) background.
Background of Authors - AGA Entry
0.6

0.51

0.5
0.4
0.28

0.3
0.2

0.13
0.05

0.1

0.02

0
MD

PhD

Non-MD

Prof Org

Unknown

Figure 10: Relative Contribution by Authors’ Background in the AGA main entry
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Textual Analysis
Situating the Authors. While the use of ‘we’ is supported by the Editorial Policy of
UpToDate and is common throughout the previous case (AOM), in the AGA case, the
authors did not overtly acknowledge themselves in the content. Instead, the authors presented
the information without explicit recognition of themselves as a source of expertise.
The authors only make one reference to themselves as authors and experts:
For male patients with androgenetic alopecia who desire treatment, we
suggest treatment with oral finasteride (1 mg/day) over topical minoxidil
Treatment with minoxidil 5% solution or foam is an alternative firstline
therapy that may be preferred by patients who prefer to avoid systemic
therapy. The response to treatment with both agents is variable. No high
quality randomized trials have directly compared their efficacies. (AGA)
In this quotation, which appears in the Summary and Recommendation section, the authors
provide guidance to the reader to use one treatment over another. By making use of the ‘we
suggest’ statement, the authors make explicit that this recommendation comes from their own
endorsement, aligning with UpToDate policy (UpToDate, “Editorial Policy,” 2016).
Concurrently in the statement, the authors acknowledge that the evidence base to support
their recommendation is not strong.
There is content in the main entry for which the source of the knowledge is
ambiguous; it may be emerging from the authors’ expertise, but there is no explicit
acknowledgment as such. For example, the authors note that: “[m]en utilizing minoxidil for
androgenetic alopecia should be advised of the following: [List of patient information
needs]” (AGA). There is no reference to where this information originates and the use of the
word ‘should’ frames this as guidance. The source of the expertise, experience, or evidence is
not made explicit.
Situating the Evidence. In the absence of situating themselves in the content, the
authors present the evidence as the primary source of certainty for the effectiveness of
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treatments for AGA. The body of evidence available to the authors is the basis for justifying
treatment selections:
In addition to improved hair counts, other factors, such as increases in hair
thickness, pigmentation, and length may contribute to the perception of
improved scalp coverage during therapy. This concept is supported by a
randomized trial that followed men treated with finasteride for up to 192
weeks and found that net improvements in hair weight were greater than
improvements in hair count. (AGA)
Here, the authors draw from a randomized trial for support. The authors also highlight the
existence of a seemingly broad research base as a means to support the two first-line
treatments:
Topical minoxidil and oral finasteride are the therapeutic agents that have
been most extensively studied for the treatment of androgenetic alopecia in
men. Both drugs have demonstrated efficacy and high tolerability in
placebocontrolled randomized trials, supporting their status as firstline
agents. (AGA)
The authors evaluate treatments based upon type and breadth of research available, often
underscoring the volume of research available: “In comparison to finasteride, fewer studies
have evaluated the efficacy and safety of dutasteride in male androgenetic alopecia” (AGA).
They note the lack of a broad research base and bring attention to areas where the evidence is
insufficient. In turn, they highlight the need for more research evaluating novel therapies,
comparing between treatment options, appraising the effectives of combination therapies, and
assessing treatment side effects.
The highlighted lack of significant research and understanding about the risk for
sexual dysfunction and male breast cancer as a result of a first-line AGA treatment is
noteworthy. The authors state that little is known about sexual dysfunction as a side effect of
finasteride and the need for more research:
Additional studies are needed to validate these findings and evaluate the
frequency with which persistent sexual dysfunction might occur. (AGA)
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Nevertheless, finasteride is identified as a first-line therapy.
The majority (73%) of the references cited in the AGA entry were quantitative
studies, and more than half were RCTs. The details provided about the studies varied greatly.
Few or no details were provided for some (e.g., “A randomized trial of 326 men found that
the drug was efficacious for frontal scalp hair thinning” (AGA)) while others were detailed
extensively:
Data from an evaluatorblinded randomized trial of 99 men with midfrontal
and/or vertex androgenetic alopecia that compared finasteride 1 mg/day with
the 2% formulation of minoxidil are less straightforward. Although patients
and evaluating clinicians were more likely to perceive increased hair growth
at three months with minoxidil, at 12 months, finasteride was associated with
significantly greater increases in hair counts, and the differences in patient and
evaluator global assessments of clinical response were not statistically
significant (62 versus 56 percent improved on blinded evaluator assessment)
(AGA).
In the largest randomized trial that compared the 5% and 2% solutions,
393 men with androgenetic alopecia were randomly assigned to treatment
with 5% or 2% topical minoxidil solution or placebo. After 48 weeks of
therapy, 5% minoxidil was significantly better than the 2% solution or
placebo in terms of change from baseline in nonvellus hair count (increase
in count of 18.6, 12.7, and 3.9 per cm2, respectively), patient ratings of
scalp coverage and treatment benefit, and investigator rating of scalp
coverage. Treatment with 5% minoxidil was also associated with an
earlier therapeutic response and an improvement in the patients'
psychological perceptions of hair loss. However, patients treated with 5%
compared with 2% minoxidil reported more pruritus and local irritation.
(AGA)
The sole systematic review was cited twice in the AGA main entry with a focus
on study outcomes:
A metaanalysis of placebocontrolled randomized trials identified
moderate quality evidence in support of the use of finasteride for
treatment of androgenetic alopecia in men. After 6 or 12 months of
treatment, the mean percentage change in hair count was 9 percent higher
among patients treated with finasteride compared with patients who were
given placebo (95% CI 811 percent). This difference increased over
time. After 48 months of therapy, the mean percentage change in hair
count was 24 percent (95% CI 1831 percent) higher in patients treated
with finasteride. (AGA)
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This systematic review is later cited when the side effects of sexual dysfunction are
addressed in the AGA main case, stating: “A systematic review of nine trials with a total
of 3570 patients found an overall absolute increase in sexual dysfunction of 1.5 percent”
(AGA). Here, new information is provided about the review, including the number of
studies and the number patients included. Both times the systematic review is cited, the
authors highlight the type of evidence (i.e., systematic review) from which the
knowledge emerges. In contrast, only one summary level resource was cited in the main
entry of the AGA case and the authors made no indication of its level of evidence (i.e.,
summary) or type of resource (i.e., clinical practice guideline) when citing. The
‘Evidencebased (S3) guideline for the treatment of androgenetic alopecia in women and
in men’ was published in the Journal der Deutschen Dermatologischen Geselischaft.
The main entry stated: “Hair shedding may occur at the initiation of treatment and is
thought to occur as a result of the stimulation of telogen follicles to reenter the anagen
phase” (AGA). While there is a parenthetical reference, there is no indication of the type
of evidence from where the information emerges. There was also no acknowledgement
of the type of resource that the information emerged from when information was cited
from resources not recognized as evidence by the 6S hierarchy.
Situating the Patient-Physician Relationship. The patient’s experience of hair loss
is the key driver for people to seek treatment for the condition. The authors acknowledge in
the beginning and at the end of the main entry that hair loss is a normal process that has
evolved into a medical issue due to non-medical concerns:
Although androgenetic alopecia is a benign and asymptomatic disorder,
cosmetic concerns lead some patients to seek treatment. (AGA, repeated
in summary)
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AGA is a cosmetic, not medical, concern. While not explicitly denoted as an example of
medicalization, the authors highlight that AGA poses no harm or risk to the patient.
Beyond the recognition that it is “cosmetic concerns that lead some patients to seek
treatment” (AGA), there is no explanation of how these cosmetic concerns affect the
individual.
References to the AGA patient focus on the potential for and experience of side
effects when receiving treatment. Specifically, the side effects of the two first-line
treatments are discussed. The side effects of and precautions for minoxidil are described
in single paragraph highlighting that few patients experience side effects and the most
common are skin reactions and irritations. In contrast, the side effects of and precautions
for finasteride are covered more extensively. The authors advise that physicians be aware
of rare side effects including gynecomastia, testicular pain, and depression that “are more
likely to occur with the typical 5 mg dose used to treat benign prostatic hypertrophy”
(AGA). The authors also highlight uncertainty around the effect of treatment on the
levels of prostate specific antigen, the risk of prostate lesions, and the risk for male breast
cancer. While these and other precautions of finasteride are briefly acknowledged, more
significant attention is paid to the effect of finasteride on sexual function. The
information provided by the authors focus on the prevalence and persistence of the
sexual side effects based on the published evidence:
A systematic review of nine trials with a total of 3570 patients found an
overall absolute increase in sexual dysfunction of 1.5 percent. The risk for
sexual side effects increases with age. Sexual side effects related to
finasteride usually resolve after discontinuation of the medication.
However, persistent sexual dysfunction after the discontinuation of
finasteride was reported in a surveybased study of 71 men who
associated their symptoms of sexual dysfunction with the use of
finasteride for hair loss. The mean age of the study participants was 26
years and the mean duration of finasteride use was 28 months. Twenty
percent of these men reported continued symptoms for greater than six
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years after cessation of the medication. Moreover, a followup study of 54
of the interviewed men found that 9 to 16 months after the initial survey,
96 percent continued to report sexual side effects. Additional studies are
needed to validate these findings and evaluate the frequency with which
persistent sexual dysfunction might occur. Reductions in sperm count also
may occur during treatment with finasteride. This effect reverses after
drug discontinuation. (AGA)
This excerpt cites one systematic review and eight studies that identify and evaluate side
effects related to sexual function. The authors do not address the impact of these side
effects on patient experience, the likelihood of patient discontinuation of treatment due to
these side effects, or ways that physicians might address these side effects, based on
published evidence or clinical observation. Unlike other entries included in the multiple
case study, the authors do not include their personal experiences, or their tacit
knowledge, with patients as a source of knowledge.
In the AGA case, there is little acknowledgement of the interaction between physician
and patient during treatment. The role of the physician in patient education when treating is
referred to once within the entry: “Men utilizing minoxidil for androgenetic alopecia should
be advised of the following: [list].” Patient education for minoxidol in AGA treatment
includes the need for: proper application, continuous treatment to maintain effect, and
recognition of the possibility of side effects. This one instance of patient education is the only
indication of interaction between the patient and physician.
As stated in Situating the Evidence, the authors refer heavily to the results of
studies as a key element for selecting treatments for patients; however, the authors do
acknowledge the variability in patient preference that will influence the choice of
treatments:
Treatment with minoxidil 5% solution or foam is an alternative firstline
therapy that may be preferred by patients who prefer to avoid systemic
therapy. (AGA)
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The subsequent development of minoxidil 5% foam offered an alternative
vehicle for drug delivery that is preferred by some patients. (AGA)
Preferences of patients are acknowledged as factors for consideration when deciding on a
treatment plan; however, decision-making responsibility is not addressed explicitly
within the entry.
Patient Education. In stark contrast to the main entry written for professionals, the
difficulties of experiencing hair loss are overtly and extensively addressed. The entry states
early in the entry that for “many people, losing their hair is a frustrating experience” (AGA
Beyond). The challenging nature of the condition is described in the patient information as:
The psychosocial impact of hair loss can be severe for some people, especially
women, since there is little understanding or acceptance of the condition.
Women may have difficulty with issues of low self-esteem or feeling
unattractive. (AGA Beyond)
In this quotation, women are also suggested to have a more difficult time with hair loss and
in turn may suffer from low self-esteem and feelings of being unattractive. While the main
entry for AGA addressed only treatment in men, there was acknowledgement that men are
pushed towards treatment because of cosmetic, not medical, concerns. The expansion of the
patient information to include women provided interesting contrast to the ways the
psychosocial effects of hair loss factors are framed. The cosmetic concerns are not outlined
in any detail in the main entry, but “low self esteem and feeling unattractive” may also
describe the cosmetic concerns of men.
The entry contains additional guidance to help the patient navigate the psychological
and social issues related to AGA:
If you are having difficulty with the psychosocial impact of losing your hair,
speak to a healthcare provider about your feelings. Providers can offer support
and may recommend that a patient work with a therapist, clinical
psychologist, or support group; individual and group therapy can help patients
adjust and cope with hair loss, and may also provide tips on cosmetic
coverings. (AGA Beyond).

90

While the need for psychosocial support is recognized in the patient information, there is no
acknowledgement of the need for additional support in the professional entry.
The two first-line treatments for men, minoxidil and finasteride, are discussed
alongside a unique drug appropriate and safe only for women. Information about minoxidil
includes how the treatment works, how to apply, what to expect (e. g. time to see effects;
transience of effects after discontinuation). The lack of consistent results for the treatment is
also acknowledged in the patient information.
Not all people benefit from minoxidil. The best results are seen when baldness
has been present for less than five years, when it affects the crown (top) of the
head, and when the area of hair loss is less than 10 centimeters in diameter.
Studies have shown that 30 to 40 percent of men and women with crown hair
loss experience cosmetically significant results with minoxidil. (AGA
Beyond)
The inconsistent results across patients are acknowledged and in turn the attributes that
increase the likelihood of success are highlighted. The side effects and precautions of the
treatment area also made clear:
Minoxidil causes few side effects. Occasionally, the skin may become
irritated. Body-wide side effects are possible if minoxidil is absorbed through
cracks or cuts in the scalp. People with a history of heart disease, in particular,
should watch for systemic side effects, such as an increased heart rate,
swelling in the hands or feet, or weight gain. (AGA Beyond)
The information provided about finasteride is much briefer. Finasteride is described as “a pill
that decreases the production of one of the hormones associated with androgenetic alopecia,
resulting in an increased amount of hair covering more of the scalp” (AGA Beyond). The
possible effect of sexual dysfunction covered at length in the main professional entry is
briefly acknowledged:
Men can take finasteride by mouth at a dose of 1 milligram (mg) per day.
Higher doses of finasteride (such as those used to treat some prostate
conditions) can cause side effects including erectile dysfunction and decreased
sex drive. However, such side effects are rarely seen with the 1 mg dose used
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to treat hair loss. (AGA Beyond)
Few details about the sexual side effects for finasteride are presented in the patient
information. The patient information communicates that the side effects are rarely seen in
patients treated with finasteride for hair loss. In comparison, the authors of the main
professional entry call upon a systematic review, which included 3570 patients to provide a
rate of prevalence for sexual side effects of 1.5%. When comparing the main professional
and patient entries subtle differences in the presentation of the psychological effects of AGA
and the potential side effects emerged.
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Case Analysis: Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) affects the large intestine (colon) and is
characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel
habits. Diarrhea or constipation may predominate, or they may alternate. This variability has
given rise to subtypes of irritable bowel syndrome: IBS-C (irritable bowel syndrome with
constipation), IBS-D (irritable bowel syndrome with diarrhea), and IBS-M (mixed IBS with
constipation and diarrhea). The cause of IBS is unknown and the diagnosis is symptombased. Because of the multiple factors that are considered to be elements of the root cause of
IBS, including psychological influences, Wessely and Hotopf (1999) described IBS
alongside Fibromyalgia and Chronic Fatigue Syndrome as occupying “that grey area between
medicine and psychiatry” (p. 430). Moynihan et al. present the diagnosis of IBS as an
example of medicalization because of its portrayal of mild problems as serious illnesses that
need to be treated aggressively with medications. However treatment of IBS is complicated
by the variability in symptoms, the uncertainty in the cause, and its psychological elements.
Descriptive Analysis
The IBS case cited 89 references ranging in date of publication from 1984-2015.
Fewer than half (n=35, 39%) of the references were published between 2010 and 2015.
Fewer than one quarter of the cited references (22%) were from UpToDate’s list of core
journals. American Journal of Gastroenterology, a core journal, was the most commonly
cited, at 14 times.
The UpToDate entry contained three types of evidence from the 6S hierarchy:
Summary, Synthesis, and Study (see Figure 11). Eleven of the 89 references (12%) cited are
not sources recognized as evidence within the 6S hierarchy. Of these, seven are nonsystematic/narrative reviews, two are drug profiles, one is a textbook and the other is the U.S.
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Food and Drug Administration website. Three clinical practice guidelines (Summary level of
evidence) were cited in the entry. Seventeen per cent of references cited (n=15) were
systematic reviews, which are situated in the Synthesis level of the 6S hierarchy. Sixty of the
89 references (67%) of the references were quantitative studies (n=60), of which 50 were
RCTs.
Cited
References
89

Not in 6S
11 (12%)

Synthesis
15 (17%)

Summary
3 (3%)

Study
60 (67%)

Quantitative
60 (67%)

RCT
50 (56%)

Qualitative
0 (0%)

Other Quant
10 (11%)

Figure 11: Type of Resources Cited in the IBS Main Entry
The United States (n=26, 43%) is the most frequent location of the cited individual
studies. The remaining 34 studies took place across the globe: United Kingdom (n=7),
Australia (n=5), China (n=4), Netherlands (n=3), Norway (n=2), Iran (n=2), France (n=1),
India (n=1), Canada (n=1), Belgium (n=1), Italy (n=1), Lebanon (n=1), Spain (n=1), Sweden
(n=1), Taiwan (n=1). There were two multinational studies spanning the United States and
Canada, and multiple European countries.
The 89 references making up the IBS case were written by 534 authors. The relative
contribution from the array of professional backgrounds of the authors was determined.
Across the 89 papers, the highest known proportional representation (.33) of the authors had
a Medical Doctor (MD) background followed by Basic Scientists (.08). The backgrounds of
the authors of the articles cited in the IBS entry included professional organizations (.02) and
non-physician (MD) health professionals (.03) (i.e., nurses, pharmacists, public health
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professionals). Proportionally across all 46 papers, .54 of the backgrounds of authors were
unknown.

Background of Authors - IBS Entry
0.6

0.54

0.5
0.4

0.33

0.3
0.2
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0.1
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0.02

0
MD

PhD

Non-MD

Prof Org

Unknown

Figure 12: Relative Contribution by Authors’ Background in the IBS main entry
Textual Analysis
Situating the Authors. The authors share their expertise and experience
throughout the main entry of IBS, mainly through the provision of recommendations. The
authors of the case share their expertise by way of clear recommendations for the care of
patients. For example, the authors advise: “In patients with persistent abdominal pain
despite antispasmodics, we recommend a trial of antidepressants” (IBS). In alignment
with the guidance of the UpToDate Editorial Policy, author recommendations are clearly
delineated by the phrases ‘we recommend’ or ‘we suggest.’
The authors focus many of their recommendations on providing specific details
about treatment regimens. For example, they suggest specific details about the treatment
regime for the pharmacotherapy, loperamide: “In patients with IBSdiarrhea (IBSD), we
suggest loperamide 2 mg 45 minutes before a meal on regularly scheduled doses” (IBS).
The authors provide details about the exact dosage and timing of the drugs as a
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suggestion. The recommendations often provide guidance to the reader about how to
implement potential treatments.
Overwhelmingly, the authors of the IBS case provide recommendations for
treatments aimed at patients who have not responded to other initial therapies. The
following examples demonstrate the recommendations for care following an unsuccessful
treatment trial:
In patients with IBS with constipation (IBSC) who have failed a trial of
soluble fiber (eg, psyllium/ispaghula), we suggest polyethylene glycol
(PEG). We treat patients with persistent constipation despite treatment
with PEG with lubiprostone or linaclotide. (IBS)
We also suggest an empiric trial of a lactosefree diet in patients who
complain of persistent abdominal bloating despite exclusion of
gasproducing foods. (IBS)
While antibiotics should not be routinely recommended in all patients with
IBS, in patients with moderate to severe IBS without constipation,
particularly those with bloating, who have failed to respond to other
therapies (eg, a diet low in fermentable oligo, di, and monosaccharides
and polyols [FODMAPs], antispasmodics, and TCAs), we suggest a
twoweek trial of rifaximin. (IBS)
Because of the variability in IBS symptoms, the variability in treatment response, and the
overall lack of clarity around IBS, multiple treatments aimed at alleviating symptoms often
are attempted for a single patient. The authors provide their recommendations as to how
physicians may progress and navigate through the treatment options, almost by trial and
error. The possibility of repeated failed treatments led the authors to suggest treatments that
lack strong evidence:
We suggest a twoweek trial of a glutenfree diet in patients with
diarrheapredominant IBS (IBSD) with significant abdominal bloating
and flatulence whose symptoms have failed to improve with a low
FODMAP diet and avoidance of gasproducing foods. However, there is
limited evidence to support gluten avoidance in patients with IBS. (IBS)
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The authors acknowledge that there is little evidence to support the suggestion to avoid
gluten in patients with IBS however UpToDate supports the provision of
recommendations when strong evidence is not available.
In addition to providing recommendations about treatments by way of phrases such as
‘we recommend’ or ‘we suggest’, the authors also provide details about what they do in their
own practice. For example,
We initially start with 17 g of powder dissolved in 8 ounces of water once
daily and titrate up or down (to a maximum of 34 g daily) to effect.
However, side effects of bloating and abdominal discomfort limit the use
of PEG. (IBS)
In patients with abdominal pain due to IBS, we use antispasmodics on an
as needed basis. (IBS)
The authors’ choice to present accounts of what occurs within their own practices
gives rise to an implied endorsement, comparable to the explicit recommendations
and suggestions for the treatment regime. Moreover, statements of the authors’ own
practices are similar to the recommendations because they also address treatment
options in light of failed treatment:
We treat patients with persistent constipation despite treatment with
PEG with lubiprostone or linaclotide. (IBS)
In patients with persistent diarrhea despite antidiarrheals, we use bile
acid sequestrants (eg, cholestyramine, colestipol, colesevelam).
However, their use is limited by associated gastrointestinal side
effects including bloating, flatulence, abdominal discomfort, and
constipation. (IBS)
The authors provide accounts of specific follow-up treatments they have applied based on
patients’ individual responses, more specifically lack of responses, to treatments.
Situating the Evidence. At the beginning of the entry, the alignment of the
authors’ approach and CPG-based recommendations for treatment is made explicit: “Our
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recommendations are largely consistent with the American College of Gastroenterology
guidelines” (IBS).
As noted above, multiple treatments have been studied in an attempt to alleviate
symptoms, but none has been found to address the symptoms in all patients. Throughout
the case, the authors present evidence to support the array of treatment options evaluated:
The efficacy of linaclotide in the treatment of IBSC has been
demonstrated in two randomized controlled phase III trials. (IBS)
A 2009 metaanalysis concluded that the overall treatment effects of
SSRIs were similar to TCAs. (IBS)
As demonstrated here, the type of study that has been called upon as evidence is used as
an indicator of the strength of certainty. When the authors use recognized evidence
resources, specifically systematic reviews or RCTs, the type of resource is often
highlighted.
In addition, the authors provide varying levels of detail about the 60 studies and
15 systematic reviews cited in the case. Some research was cited with no description of
the study details. For example, the following statement was followed by a parenthetical
reference to a systematic review assessing the efficacy of probiotics in IBS: “Although
[probiotics] have been associated with an improvement in symptoms, the magnitude of
benefit and the most effective species and strain are uncertain” (IBS). This statement
does not indicate that this information was derived from a systematic review or that 19
RCTs were included. In contrast, the following is the most comprehensive description of
a systematic review in the IBS main entry:
A 2011 metaanalysis that included eight placebocontrolled trials of
antidepressants in adults with IBS concluded that antidepressants were
significantly more effective as compared with placebo in improving pain
(54 versus 37 percent) and global symptoms (59 versus 39 percent). The
number need to treat to benefit one patient was four. (IBS)
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In this description, the study type (i.e., systematic review/meta-analysis) and number of
studies included in the review were included, along with descriptions of the patients (i.e.,
adults with IBS), interventions (i.e., antidepressants), comparison (i.e., placebo), and
outcomes (i.e., pain, global symptoms and number needed to treat). The descriptions of
the synthesis level of evidence were much briefer than study descriptions in the IBS
main entry. The most extensive description of a study was related to a trial for the
pharmaceutical linaclotide. The long paragraph provides multiple details about the
patient (number of subjects), intervention (dosage), and comparison (placebo) alongside
extensive details about the outcome of the study. Outcomes included both the positive
effects of the drug, as well as the adverse side effects. Thus, the authors are selective
when calling upon evidence.
In addition to describing the research that provides evidence for treatment
options, the authors also provide their own appraisal of the quality of research that is
available:
However, the randomized trials included in the metaanalysis had a
relatively short term followup and the improvement in abdominal
bloating in patients with IBS without constipation was modest. (IBS)
At times the authors suggest that readers should exercise prudence when considering the
results of studies because of weaknesses in the research design:
However, the results of this study should be interpreted with caution due
to methodological limitations and small sample size. (IBS)
The commentary on the research available goes beyond critiques of specific studies but
also highlights the limitations of the wider research base:
Randomized trials evaluating specific pharmacologic agents have
demonstrated their superiority as compared with placebo. However, there
have been few controlled trials evaluating specific strategies for how these
drugs should be used in conjunction with other types of treatment (eg,
fiber therapy), how long they should be used, or whether they should be
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given continuously or as needed. (IBS)
In this example, the authors’ commentary highlights a lack of high-quality controlled
trials evaluating how non-pharmacological and pharmacological treatments can be used
together.
The authors often establish the relationship between their expertise and the
chosen evidence in a consistent arrangement. They commonly present treatments by
leading with their own recommendation or suggestion for treatment (as either an explicit
recommendation or as a description of their own treatment practices), and then follow up
the recommendation with evidence that supports their recommendation. For instance,
We suggest a diet low in fermentable oligo, di, and monosaccharides
and polyols (FODMAPs) in patients with IBS with abdominal bloating or
pain despite exclusion of gasproducing foods… Studies have
demonstrated an improvement in IBS symptoms with FODMAP
restriction. In one randomized trial, 25 patients with IBS were randomly
challenged by graded dose introduction of fructose and fructans alone or
in combination, or glucose for a maximum test period of two weeks.
Patients receiving fructose and/or fructans were more likely to report
inadequate symptom control as compared with patients receiving glucose
(70 to 79 versus 14 percent). Symptoms were dosedependent and
mimicked the patients' baseline IBS symptoms. In another randomized,
singleblind, crossover trial, 30 patients with IBS and 8 healthy controls
were assigned to 21 days of a diet low in FODMAPs or a moderate
FODMAP Australian diet followed by a 21day washout period before
crossing over to an alternate diet. Subjects with IBS, but not controls, had
significantly lower overall gastrointestinal symptoms scores with an
improvement in scores for abdominal pain, bloating, flatulence, and
dissatisfaction with stool consistency while on a low FODMAP diet as
compared with the moderate FODMAP diet and their diet at baseline.
(IBS)
This same format is used when there is uncertainty within the evidence in spite of the
authors’ recommendation. A qualified recommendation to trial fibre in patients with IBS
is followed by conflicting evidence:
The role of fiber in patients with IBS is controversial, but given the
absence of serious side effects and potential benefit, psyllium/ispaghula
should be considered in patients with IBS whose predominant symptom
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is constipation. As some patients may experience increased bloating and
gas, we suggest a starting dose of psyllium of onehalf to one tablespoon
daily. The dose should then be slowly titrated up based on response to
treatment.
A 2011 systematic review that included 12 studies found no beneficial
effect
for bulking agents over placebo in improving abdominal pain, global
assessment or symptom scores. On subgroup analyses, there was no
significant benefit with either soluble (eg, psyllium) or insoluble fiber
(eg, methylcellulose. However, another meta analysis that pooled data
from the same trials and used a combined endpoint for abdominal pain
and global IBS symptoms demonstrated that in six trials, psyllium was
associated with a small improvement in symptoms as compared with
placebo with a number needed to treat to prevent one patient with IBS
remaining symptomatic of six (RR of persistent symptoms 0.76, 95% CI
0.630.96). (IBS)
While suggesting that fibre should be considered as treatment for IBS patients, the
authors frame its use for the treatment of the constipation variant as controversial
because of conflicting outcomes from two systematic reviews.
Situating the Physician-Patient Relationship. The clinician-patient relationship is
explicitly mentioned three times in the IBS case. For example:
Establishment of a clinician-patient relationship and continuity of care are
critical to the management of all patients with irritable bowel syndrome
(IBS).
In all three instances, the authors call for the “establishment of a clinician-patient
relationship” (IBS) with little explanation of what that relationship entails. In one
instance, it is clarified that there is need for a therapeutic clinician-patient relationship
It is important to establish a therapeutic clinician-patient relationship to
validate the patient's symptoms. Patients should also be counseled that
although IBS does not increase their risk of malignancy, it is a chronic
disease. (IBS)
Few details about what constitutes therapeutic clinician-patient relationship are included,
beyond ensuring that the clinician validates the syndrome as real. The quotation also
implies that patient education and counseling are key components; the section continues,
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“The clinician should establish realistic expectations with consistent limits and involve
the patient in treatment decisions” (IBS). This is the only instance in the entry where the
patient’s role in decision-making is specified. While the clinician-patient relationship is
mentioned in the IBS case, descriptions and guidance provided by the authors about what
it entails are scant.
As seen in the above excerpts, the authors choose to use the term ‘clinician’,
rather than ‘physician’. In one instance, they do acknowledge the need for care from
someone other than a physician: “Low FODMAP dietary education should be provided
by a trained dietician to avoid unnecessary dietary overrestriction and a nutritionally
replete diet” (IBS). While the authors choose to use the broad term clinician, the majority
of the care and treatment (e.g., pharmaceuticals) described in the case are delivered by
physicians.
As discussed in the preceding two sections, there is very wide variation in IBS
symptoms and experiences, and in patient responses to treatment. As such, the need to tailor
treatment for the individual patient is featured prominently throughout the case: “Since IBS
generally presents as a complex of symptoms, treatment should be based on the predominant
symptom and subtype” (IBS), as is the emphasis on the need to adjust or change treatment
approaches:
For the treatment of abdominal pain in IBS, antidepressants should be started
at low doses. The initial dose should be adjusted based upon tolerance and
response. Due to the delayed onset of action of antidepressants, three to four
weeks of therapy should be attempted before increasing the dose. (IBS)
In patients with abdominal pain due to IBS, we use antispasmodics on an as
needed basis. In patients with IBS with constipation, we initiate
antispasmodics only if the abdominal pain persists despite treatment of
constipation. In patients with persistent abdominal pain despite
antispasmodics, we recommend a trial of antidepressants. (IBS)
While there are recognized psychological factors associated with IBS, the
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acknowledgement of these factors throughout the UpToDate entry is minimal. The authors
only acknowledge these factors in relation to the need for transitory or supplementary
treatments:
The use of anxiolytic agents in patients with IBS should be limited to
shortterm (less than two weeks) reduction of acute situational anxiety that
may be contributing to symptoms. (IBS)
For patients with IBS in whom depression is a cofactor, serotonin
reuptake inhibitors (SSRIs) can also be used. (IBS)
Patients with unrelenting symptoms that are associated with psychiatric
impairment may benefit from behavioral modification in conjunction with
antidepressants (IBS)
The psychological factors are not treated individually in relation to the patient experience
but rather as a circumstance or conditions requiring additional treatment.
Patient Information. Both levels of patient information acknowledge that
treatments “help alleviate symptoms but do not cure the condition” (IBS Beyond), which
closely reflects the content of the main entry. The lack of cure is repeatedly highlighted
in the patient information:
Although many drugs are available to treat the symptoms of irritable
bowel syndrome, these drugs do not cure the condition. They are primarily
used to relieve symptoms. (IBS Beyond)
Most people with IBS have the condition for the rest of their life. Even so,
most people find ways to improve their symptoms. (IBS Basics)
In these quotations, the lack of cure is indicated, first, by the recognition that pharmaceuticals
are used only as a means to alleviate symptoms, and second, by the assertion that IBS is a
life-long condition. This absence of a known cure largely arises out of the fact that a clear
cause of IBS has not yet been identified. As noted in the Beyond the Basics information,
“there are a number of theories about how and why irritable bowel syndrome (IBS)
develops” (IBS Beyond). The Beyond the Basics also presents an overview of six potential
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causes for IBS.
Because of the many unknowns associated with IBS, the treatment plan for IBS is not
clearly outlined for physicians. The subsequent need for patients to trial multiple therapies
throughout their treatment is conveyed to patients in the two patient information sources. The
trial and error approach is described in the Beyond the Basics entry as:
Treatments are often given to reduce the pain and other symptoms of
irritable bowel syndrome, and it may be necessary to try more than one
combination of treatments to find the one that is most helpful for you.
Treatment is usually a long-term process; during this process, it is
important to communicate with your healthcare provider about symptoms,
concerns, and any stressors or home/work/family problems that develop.
(IBS Beyond)
The same message of perseverance through multiple treatments is articulated in Basics: “The
key is to keep working with your doctor or nurse until the 2 of you find an approach that
works” (IBS Basics). The need to try multiple treatments in sequence is also reflected in the
main professional entry where the authors attempt to map out a strategy for physicians to
navigate the treatment options based on treatment responsiveness. When discussing the trial
and error approach the relationship between patient and physician is also accentuated. The
Beyond the Basics entry also emphasizes that patients should communicate with the clinician
about symptoms, concerns and life stressors affecting health. This presentation of treatment
planning and decision-making as a joint process between patient and clinician is not as
evident in the main professional entry.
The effects and overlap between stress and IBS is more upfront in the patient
information. In The Basics, counselling is suggested “because stress and worry can make the
condition worse” (IBS Basics). The Beyond the Basics entry presents the management of
stressors as a collaborative process between clinician and patient.
The best approach for reducing stress and anxiety depends upon your situation
and the severity of your symptoms. Have an open discussion with your
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clinician about the possible role that stress and anxiety could be having on
your symptoms, and together decide upon the best course of action. (IBS
Beyond)
Once again, open communication and joint decision-making is emphasized in the Beyond the
Basics information when addressing the stress and anxiety. This co-management of stress
that is underscored in the Beyond the Basics is not reflected clearly in the main professional
entry.
The strain that can develop in the relationship between physicians and IBS patients
due to the chronicity and uncertainty of the illness is underscored in the patient information:
“The chronic nature of irritable bowel syndrome and the challenge of controlling its
symptoms can be frustrating for both patients and healthcare providers” (IBS Beyond).
Because of the changing and chronic nature of IBS and the need to try many treatments in
order to alleviate rather than cure the disease, frustration can develop in both patients and
physicians.
Both The Basics and Beyond the Basics information provides an overview of habits
and practices which patients can adopt to help with their symptoms, prior to pharmacological
interventions or concurrently with pharmacological interventions. These lifestyle changes
include dietary monitoring, dietary modifications, and incorporation of an exercise program.
The Beyond the Basics patient information reflects the main professional entry in its
advocacy for treating patients first with non-pharmacological lifestyle changes prior to
introducing medications. The Beyond the Basics patient information communicates,
“medications are reserved for people whose symptoms have not adequately responded to
more conservative measures such as changes in diet and fiber supplements” (IBS Beyond). In
contrast, The Basics entry does not indicate that there is an attempt to treat IBS with dietary
and lifestyle changes prior to introducing medications; it introduces a list of possible
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medications that may be used to treat IBS with:
How is IBS treated? — Medicines can ease the symptoms of IBS. But no
treatment can cure the condition. Counseling might also help with IBS,
because stress and worry can make the condition worse.
The medicines that can help with IBS symptoms include: [followed by the
types of medications used in to treat IBS (eg. “Medicines called
‘antispasmodics’”]. (IBS Basics).
While the Basics entry of the patient information does provide a list of lifestyle changes that
may alleviate symptoms, there is no indication that these should be trialled prior to the
introduction of medications. Only in the Beyond the Basics format of the patient information
is the preference to try non-pharmacological approaches prior to medications underlined.
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Case Analysis: Fibromyalgia
Introduction
Patients diagnosed with fibromyalgia have severe and often-debilitating symptoms,
including distinctive tenderness on palpitation as well as widespread pain, fatigue, sleep
disturbances, cognitive challenges, and depressive symptoms—all of which are medically
unexplained. There is considerable controversy about the legitimacy of diagnosis (Wolfe,
2009). The scepticism by physicians, sociologists, medical historians, even family members
is grounded in the perception that the diagnosis of fibromyalgia has arisen from the
medicalization of discomfort in modern society, the need for labelling and diagnosis in order
to access health and wellness supports, and the substantial power of the pharmaceutical
industry (Wolfe). In response to the scepticism about the diagnosis of Fibromyalgia, patient
advocacy groups, pharmaceutical companies, physician-specialists, professional
organizations have fought hard to have fibromyalgia recognized as a “real disease,” and have
been able to advocate for the development of criteria for diagnosis by the American College
of Rheumatology (ACR) and an International Classification of Disease (ICD) code by the
World Health Organization. These changes enable patients to provide proof of condition to
employers, colleagues and family, as well as a diagnosis that is recognized and compensated
by insurance companies and government agencies.
While organizations and associations increasingly recognize fibromyalgia as a real
illness, researchers and clinicians continue to search for the cause of the symptoms of
fibromyalgia. Proposed contributing factors include psychological, genetic, neurobiological,
and environmental origins. Because of the unknown cause and the possibility of a
psychological component to the condition, there are challenges in clearly defining the
medical profession’s approach to patients diagnosed with fibromyalgia. As a result, the
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controversy extends beyond the diagnosis to treatment. Critics suggest that treatment of
fibromyalgia prolongs and preserves the diagnosis rather than ameliorates it. According to
Hayden (2003),
The treatment acts, dripping with empty promises of elucidation and unproved
promises of palliation, are iatrogenic. I would further suggest that these
circular treatment acts will exacerbate whatever mood or thought disorder is
complicating the plight of these patients. (p. 1669)
The treatment is viewed as a self-perpetuating cycle in which more (not fewer) complications
develop.
Descriptive Analysis
The main entry for fibromyalgia written for professionals contained 91 cited
references ranging in date of publication from 1986-2015. Fewer than half (n=37, 41%) of
the references were published between 2010 and 2015. The majority (73%) of cited
references were from UpToDate’s list of core journals. The most commonly cited journal
was Arthritis and Rheumatology, cited 17 times. UpToDate identifies Arthritis and
Rheumatology as a core journal.
UpToDate’s main entry addressing the treatment of fibromyalgia contained four types
of evidence within the 6S hierarchy: Summary, Synopsis of Synthesis, Synthesis, and Study
(see Figure 13). Only seven references (8%) cited in the entry were sources that are not
recognized as evidence in the 6S hierarchy: All seven of these references were nonsystematic/narrative reviews. The largest proportion of references was from the study level of
evidence (n=60), all of which were quantitative. Thirty-two of the 60 studies cited in the FIB
case were randomized controlled trials.
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Cited
References
91
Not in 6S
7 (8%)

Synopsis of
Synthesis
2 (2%)

Summary
3 (3%)

Synthesis
14 (17%)

Study
60 (66%)

Quantitative
60 (66%)
RCT
32 (35%)

Qualitative
0 (0%)

Other Quant
28 (31%)

Figure 13: Types of Evidence in FIB Main Entry
The greatest proportion of empirical studies in the FIB case were conducted in North
America with 32 studies conducted in the United States (53.3%) and 11 (18.3%) in Canada.
Seven studies (12%) were conducted in Spain. Other European locations for these studies the
United Kingdom (n=2), Turkey (n=2), and Denmark (n=1). One study was conducted in
South Korea and four were multinational.
The 91 references included in the fibromyalgia entry were written by a total of 531
authors. Across the 91 papers, the highest known proportional representation (.41) of the
authors had a Medical Doctor (MD) background (see Figure 14).
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Figure 14: Contributions by Authors’ Backgrounds for FIB main entry

Textual Analysis

109
Situating the Authors. Within the context of the many unanswered
questions about fibromyalgia, physicians and specialists persevere in their attempts
to treat the symptoms of fibromyalgia. It is also within this context of uncertainty
that the authors of UpToDate share their personal expertise about the treatment of
fibromyalgia. The authors’ knowledge and experiences are consistently positioned as
central to the content presented in the fibromyalgia main entry.
Aligning with UpToDate’s policy, the authors of the FIB entry share their
expertise by way of explicit recommendations for treatment. The authors’
recommendations often provide specific details about how to deliver treatment
regimens. For example, the authors provide recommendations about dosage and
timing for tricyclic medications:
We suggest initiating therapy with a low dose of a tricyclic
medication (eg, amitriptyline 10 mg) at night time, especially since
these drugs are effective, widely available, and far less costly for
most patients than some of the newer agents. (FIB)
In addition to the specific information about dosage and timing, the authors also highlight the
accessibility of the drug treatment, information that is not often provided in the published
research. In their recommendations, the authors provide extra information about the exact
patient for whom the treatment is best. The authors provide information that facilitates a
tailoring of the treatment based on the preferences, needs, and context of the patient:
In patients who do not respond to trials of lowdose tricyclics or who have
intolerable side effects, we advise a trial of pregabalin, duloxetine, or
milnacipran, depending upon the patient’s symptoms. (FIB)
In patients unresponsive to or intolerant of amitriptyline and in
patients with more severe sleep disturbance in addition to pain, we
suggest the use of pregabalin. (FIB)
The authors here provide suggestions of ways to tailor care for individuals based on the
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patient’s symptoms and responsiveness.
In addition to explicit recommendations, the authors further integrate their personal
expertise into the UpToDate entry by providing accounts of what occurs in their own
practice. For example, the authors share their approach to patient counselling to encourage
exercise in fibromyalgia patients:
We counsel patients regarding the importance of exercise for
reconditioning and for functional capacity, and caution that a temporary
increase in myalgias may occur upon initiating an exercise program.
(FIB)
As demonstrated in this quotation, these descriptions of treatment practices from their own
experience serve as an endorsement for the approach, albeit not explicitly. The authors also
provide accounts of what occurs in their own practices when there is a lack of evidence:
We use gabapentin, for which evidence is more limited, as an alternative
to pregabalin in patients for whom cost of the medication or regulatory
requirements limit the use of pregabalin. We begin with a dose of 100 mg
at bedtime before titrating the dose upwards as tolerated and as required.
The recommended dose is 1200 to 2400 mg/day, based upon the study
described below. As with pregabalin, some patients may respond to lower
doses. (FIB)
In this quotation, there is no explicit recommendation for the drug gabapentin; however, the
authors’ communication of their own practices to prescribe the drug is an implicit
recommendation of this approach in light of the limited evidence available.
The details about the authors’ approaches to care are often directly tied to tailoring
treatment for individuals. For example, they provide guidance on how to administer two
pharmacological treatments in order to meet the needs of specific patients:
Milnacipran is an alternative to duloxetine in patients with severe fatigue
in addition to pain. We initiate therapy with 12.5 mg each morning,
gradually titrating as tolerated to 50 mg twice daily. Some patients will
require a higher dose; up to 100 mg twice daily may be needed … In those
patients with more severe problems with sleep, we use pregabalin taken at
bedtime. (FIB)
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In patients unresponsive to or intolerant of amitriptyline and in patients
with more severe sleep disturbance in addition to pain, we suggest the use
of pregabalin. We begin with a dose of 25 to 50 mg at bedtime before
adjusting the dose upwards as tolerated to the recommended dose of 300
to 450 mg/day. Some patients may respond to lower doses, such as 100 to
300 mg/day, and do not require further dose escalation. (FIB)
Treatments are adjusted to address patients’ individual preferences, socioeconomic
status, symptom presentation, drug reactions and tolerability, or treatment
responsiveness.
The authors broaden the experiences and expertise they bring into the
fibromyalgia entry by sharing with the reader some of the acquired knowledge from
their experiences in treating patients:
In our experience, patients generally have a better response to treatment
when they understand that they are not harboring some infectious agent
over which they have no control. (FIB)
In our experience, sustained responses are seen in most patients receiving
duloxetine who initially benefit from treatment, when such patients are
followed for more than one year on continued therapy. (FIB)
The authors set apart information derived from their clinical experience by explicitly using
the phrase ‘in our experience’.
The authors of this entry take such acquired knowledge and experience one step
further to compare their practice-acquired knowledge to the results and conclusions of
the published research. Specifically, the authors reveal to the reader where the
approaches and conclusions of research and their own practice diverge:
Various doses of cyclobenzaprine have been used in placebocontrolled trials,
including 10 mg in the morning and 20 mg at night, 10 mg three times daily,
10 mg in the morning and 30 mg in the evening, and 10 to 40 mg daily as
needed. We usually start with doses of 10 mg near bedtime and increase as
tolerated to the larger doses. In patients who find an initial dose of 10 mg too
sedating, we reduce the dose to 5 mg before bedtime. (FIB)
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In this example, the authors provide an overview of dosages used in research and contrast
them with the unique approach that they have developed within their own practice. In
other incidences, the realities of applying the conclusions of clinical research to practice
are highlighted. The following quotation succeeds a statement extolling the benefits of
exercise in fibromyalgia patients citing six published articles:
In practice, it has been difficult to start and maintain fibromyalgia patients
in a structured cardiovascular exercise program, because patients
generally perceive that their pain and fatigue worsen as they begin to
exercise. (FIB)
Here, the authors contrast the research showing the benefits of exercise against their own
experience in practice where patients are hesitant to start and sustain an exercise program
because they perceive that exercise worsens their condition. This experience, however,
does not preclude the authors from recommending “an exercise program, including
aerobic conditioning, stretching, and strengthening” (FIB) as one of three key
components of the initial treatment for fibromyalgia. While many drugs administered on
their own appear to benefit patients in clinical trials, in the authors’ clinical experience
no great benefit arises from a single medication.
Despite the clinical trial efficacy, in “realworld experience” the majority
of fibromyalgia patients do not achieve great benefit from any single
medication. (FIB)

Here, the authors explicitly contrast the results of clinical trials and the realities of
everyday life outside of the structured inquiry.
Situating the Evidence. The authors’ recommendations and experiences are
central to the content in the fibromyalgia main entry. In turn, evidence is used to support
the authors’ recommendations and approaches. The authors often share their
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recommendations and practices at the outset of each section and then follow-up with an
acknowledgement of the research that supports their approach:
In patients unresponsive to or intolerant of amitriptyline and in patients
with more severe sleep disturbance in addition to pain, we suggest the use
of pregabalin. We begin with a dose of 25 to 50 mg at bedtime before
adjusting the dose upwards as tolerated to the recommended dose of 300
to 450 mg/day. Some patients may respond to lower doses, such as 100 to
300 mg/day, and do not require further dose escalation.
The efficacy and safety of pregabalin has been evaluated in randomized
trials and in systematic reviews and metaanalyses. In a 2010
metaanalysis involving three randomized trials and a total of 1890
patients, those allocated to receive pregabalin in any one of three doses
(600, 450, and 300 mg daily) were significantly more likely to respond to
treatment, defined as a ≥30 percent reduction in pain score, compared
with patients receiving placebo (odds ratios 1.7, 95% CI 1.272.29, 1.92,
95% CI 1.492.12, and 1.53, 95% CI 1.181.98, respectively). (FIB)
Here, the authors offer their expertise as recommendations for the drug preglabin and
accounts of their practices with dosages and tolerability, then follow up their expertise
with studies that support the efficacy and safety of their approach.
The authors select studies and systematic reviews which provides evidence for
their approach:
In patients unresponsive to or intolerant of amitriptyline and in patients
who have severe fatigue or who require concomitant drug therapy for
depression in addition to pain, we suggest treatment with duloxetine in
place of amitriptyline. It is also available in many countries for the
treatment of depression and of diabetic neuropathy. Duloxetine should be
used in the morning at breakfast. The usual starting dose in patients with
fibromyalgia is 20 to 30 mg/day, which is gradually increased to the
recommended dose of 60 mg/day… The benefits of duloxetine in
fibromyalgia have been shown in a 2014 systematic review that identified
six randomized trials involving 2249 patients in which duloxetine was
compared with placebo. On metaanalysis of the data, duloxetine (60 mg
daily) was significantly more likely than placebo to reduce pain by at least
50 percent at 12 weeks (RR 1.57, 95% CI 1.202.06) and at 28 weeks (RR
1.58, 95% CI 1.102.27). The number needed to benefit at 12 weeks was 8
(95% CI 421). The efficacy of duloxetine in patients with fibromyalgia
was initially demonstrated in two multicenter trials of 12 weeks’ duration.
As an example, in one trial, pain was reduced by at least 30 percent in a
significantly greater proportion of patients receiving duloxetine (60 mg
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once or twice daily) compared with those taking placebo (55 and 54
versus 33 percent, respectively). (FIB)
In this example the authors select a systematic review and two randomized controlled
trials to demonstrate the effectiveness of duloxetine in treating fibromyalgia patients.
They bring attention to two trials that initially demonstrated the drug’s effectiveness, and
select one systematic review for which to provide details. The authors are transparent at
times that they have selected the evidence based on what they have deemed the best
approach to treatment.
The level of detail about the evidence that the authors call upon for support varies
greatly. There are evidence sources for which few or no details about the studies are
provided. In other instances, extensive details are included:
In randomized trials, [milnacipran] improved pain and global wellbeing
more than placebo. As an example, in one trial, 1196 patients were
randomly assigned to treatment with one of two doses of milnacipran or to
placebo [50]. Primary outcomes were improvement in a composite of
pain, patientreported global status, and selfreported physical function
after 15 weeks of treatment. A greater than 30 percent improvement in the
composite measure was significantly more likely among those receiving
milnacipran at either dose (100 mg/day or 200 mg/day) than among the
placebo group (OR 1.79, 95% CI 1.142.8, and 1.75, 95% CI 1.112.75,
respectively). Greater improvements in individual component scores (ie,
pain, global status, and physical function) were also noted in the
milnaciprantreated patients compared with the placebo group. As an
example, patientreported pain (on a 100 point scale) improved from
baseline levels by a statistically greater degree in the patients receiving
milnacipran than those receiving placebo (15.7 and 17.4 versus 13).
Adverse effects leading to discontinuation of study drug were more
common in the milnaciprantreated subjects than in the placebo group (19
to 24 percent versus 9.5 percent, respectively). Commonly reported
adverse effects were nausea, headache, and constipation. (FIB)
In this description of a single study, extensive details are included about the intervention
(i.e., dosage), comparison (i.e., placebo) and the outcome (i.e., improvements, side
effects), as well as the number of patients involved.

115
The effectiveness of treatments, especially drug treatments, is a focus in the
presentation in evidence; however, the limitations of particular treatments are also
highlighted within the FIB case:
Although all of these agents, including amitriptyline, duloxetine, and
milnacipran, are considered as firstline medications by experts on
fibromyalgia, a 2012 metaanalysis of antidepressants used for
fibromyalgia found that only a minority of patients experienced
substantial improvement with these drugs and that adverse side effects
were common. Moderate degrees of benefit were seen in pain and sleep,
but effects on fatigue and quality of life were small. (FIB)
Here, the authors acknowledge that there are limitations to the efficacy of drug
treatments for fibromyalgia.
Occasionally in the fibromyalgia case, the authors extend the description of the
evidence beyond describing features of the study to include a commentary on the
evidence, whether studies or synthesis. For example, they highlight that conclusions may
be weak due to methodological shortcomings: “The strength of the conclusions was
limited, to some degree, by the lower methodological quality of the amitriptyline trials”
(FIB). In addition to calling attention to the limitations of particular evidence sources, the
authors also point out where the corpus of literature on the treatment of fibromyalgia is
lacking:
Strength training and flexibility exercises have not been extensively
studied; However, there is some evidence of benefit from strength
training in some small trials that used several different types of resistance
training programs. (FIB)
The efficacy of these drugs compared with placebo has been demonstrated
in randomized trials and metaanalyses, but there have been few direct
comparisons of one with another, particularly with the older drugs. (FIB)
At the end of the main professional entry, the authors’ overall approach is
compared to Clinical Practice Guidelines created by panels of experts:
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Our approach is generally consistent with the recommendations of
various expert panels and with the guidelines from professional
organizations that have been proposed for treatment of adults with
fibromyalgia. Most of these guidelines preceded the regulatory approval
of pregabalin, duloxetine, and milnacipran for fibromyalgia treatment.
(FIB)
In this quotation, the clinical practice guidelines to which the authors refer are sponsored by
the European League Against Rheumatism and the Canadian Pain Society with the Canadian
Rheumatology Association, and two guidelines that were not sponsored by an organization
but authored by experts in the field. Both the Clinical Practice Guidelines and UpToDate
entry are considered to be evidence within the Summary level of evidence within the 6S
hierarchy.
Situating the Patient-Physician Relationship. The main professional entry for
fibromyalgia starts with the following description: “Fibromyalgia is a chronic pain disorder
that is challenging to treat.” From the outset of the entry, the challenging nature of the
fibromyalgia is acknowledged. The authors of the case are explicit that the goal of treatment
is not cure but rather, symptom reduction:
Treatment of fibromyalgia is directed at reducing the major symptoms of this
disorder, including chronic widespread pain, fatigue, insomnia, and cognitive
dysfunction.
They underscore that patients are going to continue to experience the symptoms of
fibromyalgia when they are receiving treatment:
Most patients with fibromyalgia continue to have chronic pain and
fatigue, although most longitudinal longterm studies of outcome in
fibromyalgia have been from tertiary referral centers. One study of 538
patients followed at six referral centers found that pain, fatigue, sleep
disturbances, anxiety, and depression were essentially unchanged over a
followup period of approximately eight years. Similarly, in the author’s
experience at a referral rheumatology center, there has been little change
in the patients’ symptoms. (FIB)
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The authors use both the evidence base and their personal experience to support the
chronicity and perseverance of symptoms even with treatment and advise that “patients
need to appreciate that their symptoms will wax and wane but that the pain and fatigue
generally persist” (FIB).
The authors also point out that ambiguity exists about what type of health care
professional is responsible for treatment—the specialist or the primary care physician:
The issue of who should be in charge of the treatment of patients with
fibromyalgia has been controversial. Most specialty groups recommend
that the initial management of patients with fibromyalgia can and should
be carried out in the primary care setting. Ideally, treatment should
include an integrated, multidisciplinary nonpharmacologic and
pharmacologic approach, but there have been relatively few trials that
have formally evaluated such a combined approach to therapy. (FIB)
Physiotherapists, psychologists, psychiatrists are all acknowledged as be potential
members of a multidisciplinary approach to care. The challenges that patients face in
receiving a diagnosis of fibromyalgia complicate the ownership of professional
responsibility for care and affects the patient experience.
Most patients have had fibromyalgia for years before the diagnosis is
finally made. They often have undergone multiple diagnostic evaluations
and have consulted with many different specialists. Some patients may
feel rejected by the medical profession, while others may fear that a
lifethreatening illness will eventually be found. (FIB)
The authors acknowledge that, for many patients, their contact with health care
professionals has not always been positive or affirming. While the fibromyalgia
controversy is well documented, the authors allude to, but do not overtly acknowledge,
that doctors and other health care professionals who have previously cared for patients
may not accept the diagnosis of fibromyalgia as legitimate. The authors situate their
position in this argument by emphasizing that patient education must include reassurance
that the illness is real. In the main professional entry for this case they identify
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reassurance and validation as key to the patient-physician relationship. However, they
also emphasize that patients must understand the condition is not progressive or lifethreatening:
Reassurance that fibromyalgia is a real illness – The patient must be
reassured that fibromyalgia is a real illness and is not imagined or “in your
head.” The benign nature of the disorder should also be emphasized. As
an example, patients must be told that this is not a deforming or
deteriorating condition and that it is neither a life-threatening nor a
cosmetic problem. (FIB)
This passage highlights the challenge of balancing the validity of the condition with its
relatively benign nature. Other elements of patient education include the role of stress
and mood disorders, the role of sleep disorders and sleep hygiene, the role of exercise,
the prognosis for fibromyalgia, and the lack of evidence of persistent infection. Patient
education “should also include family members” (FIB). The authors emphasize that
patient education should reassure patients that “the great majority of patients live normal
and active lives.” In contrast, the prognosis section underscores that there is “little
change in patients’ symptoms” for those receiving treatment and fibromyalgia patients
report a high incidence of being work-disabled. Multiple tensions within the patientphysician relationship are highlighted in this entry, particularly with respect to ensuring
balance in messages to patients.
Patients’ role in treatment includes their engagement in non-pharmacological
approach to treatments, including adopting proper sleep routines, exercise programs,
relaxation techniques, and cognitive behavior therapy. The authors indicate that some
patients respond so well to non-pharmacological measures that they do not require
medications. They emphasize the importance of the patient maintaining a positive
outlook to improve prognosis. Because of the complexities involved with this condition,
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the treatment trajectory for fibromyalgia appears to be primarily the responsibility of the
primary care physician, not the patient.
Patient Education. UpToDate provides patient information in two formats for
fibromyalgia, The Basics and Beyond the Basics.
The level of comprehensiveness and sophistication of the Beyond the Basics
patient information for fibromyalgia is noteworthy. As well as being lengthy, the level of
sophistication and knowledge required to understand the content appears to be much
higher than other Beyond the Basics patient information entries. Indeed, the information
provided appears not to be directed towards the patient, but rather at physicians who
provide patient education. For example, the entry states: “Balanced and accurate patient
information is critical to allow fibromyalgia patients to take charge of their illness and to
best manage this disorder” (FIB). In contrast, The Basics patient information is targeted
at patients and has a comparable level of sophistication and complexity to the other
similar entries.
Patients often seek medical care to be find a cure for an illness, however for
patients with fibromyalgia, there is no cure currently available. The patient information
included in The Basics clearly communicates that while physicians are able to treat the
symptoms of fibromyalgia, they cannot cure it.
Some people seem to get over fibromyalgia. But in most people it cannot be
cured. Even so, people can learn to deal with the condition and lead fairly
normal lives. Fibromyalgia does not get worse over time, and it is not lifethreatening. (FIB Basics)
In light of the lack of cure, patients are asked to “deal with the condition” (FIB Basics). This
same requirement for patient acceptance of the condition and its symptoms are
communicated in the Beyond the Basics:
It is important to have realistic expectations concerning the ability to function
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and manage the condition over the long term. Symptoms often wax and wane
over time, yet some degree of muscle pain and fatigue generally persist.
Nevertheless, most people with fibromyalgia improve, and most patients lead
full, active lives. (FIB Beyond)
(The same passage appears verbatim in the main entry for medical professionals).
In these entries the authors communicate that the uncertainty surrounding the cause of
fibromyalgia extends beyond treatment: “Despite ongoing research, the cause, diagnosis, and
optimal treatment of fibromyalgia are not clear” (FIB Beyond). In order to treat fibromyalgia,
a multi-professional team approach is advocated. The members of the team include: “A
doctor; A physical therapist; Someone trained in mental health (such as a social worker or
counselor)” (FIB Basics). The Beyond the Basics entry echoes this roster of health care
professionals, but places the patient as a member of the team: “Optimal treatment of
fibromyalgia should include the patient, clinician, physical therapist, mental health
professional, and other healthcare professionals” (FIB Beyond). The call for a multiprofessional approach appears in the main professional entry but the patient is positioned as
member of the health care team only in the Beyond the Basics entry.
Both pharmacological and non-pharmacological treatments are addressed in the
patient information sources. The Basics entry indicates that patients will work with their team
to find the right treatment combination:

There are medicines and strategies to help with the symptoms of fibromyalgia.
But there is no one treatment that works for everyone. You and your
healthcare team will need to work together to find the right mix of treatments
for you. In general, treatment can include: Medicines to relieve pain, improve
sleep, or improve mood; Physical therapy to learn exercises and stretches;
Relaxation therapy; Working with a counsellor. (FIB Basics)
A collaborative approach to finding a combination of medications and non-pharmacological
treatments is stressed. Few specifics about medication options are provided in The Basics
although it includes a request for patients to “Be open to medicines” that are often described
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for depression or seizures because “they work on the brain areas that deal with pain” (FIB
Basics). In addition to a willingness to consider medications, the authors also encourage
patients to become more active even though their symptoms may be aggravated initially.
In contrast, in Beyond the Basics the details provided about the medications used to
treat fibromyalgia are extensive. For instance,
As of 2011, three medications had been approved by the FDA for the
treatment of fibromyalgia. These included pregabalin, an alpha-2-ligand
inhibitor, as well as duloxetine and milnacipran, which are selective
norepinephrine and serotonin reuptake inhibitors. However, older medications
that are generic or have not been as extensively studied may also be effective.
(FIB Beyond)
Here, the level of detail and advanced language is striking. There are many instances in the
description of medications in Beyond the Basics patient information in which extensive
background knowledge of medical terminology, medications, and biochemistry would be
necessary for patients to understand the content. For example, “Although cyclobenzaprine is
considered to be a muscle relaxant, its chemical structure and mode of action are very similar
to those of amitriptyline” (FIB Beyond). The descriptions of the medications are
comprehensive and complex; however, there is little information provided about for which
patients the medications are best suited and how these decisions are made. Unlike the patient
information provided in The Basics, the need to tailor treatment to the patient and how such
decisions are made are not addressed in Beyond the Basics.
The Beyond the Basics patient information for fibromyalgia places exercise under the
heading “Complementary and Alternative Treatments of Fibromyalgia.” As in The Basics the
expectation for exercise to initially worsen symptoms is shared. Other complementary and
alternative treatments include relaxation therapies, hypnosis, biofeedback, cognitive
behaviour therapy, acupuncture, and Tai chi and yoga.
As highlighted in the main professional entry, the importance of maintaining a good
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attitude in light of the diagnosis of fibromyalgia and the related experiences is emphasized in
both patient entries. The Basics entry addresses the patient by offering the following words of
encouragement: “It is also really important that you try not to be too negative about your life.
Your outlook has a big effect on how you feel pain. Do your best to be positive” (FIB
Basics). Similarly, the Beyond the Basics section ties the positive attitude of patients to their
prognosis stating: “One of the most important factors in a person's long-term prognosis is the
person's ability to take charge, to avoid ‘catastrophizing,’ and to learn to cope well with
symptoms while remaining as active as possible” (FIB Beyond). In both patient entries, one
of the primary roles of patients is to try to maintain a positive outlook.
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Case Analysis: Chronic Fatigue Syndrome
Chronic Fatigue Syndrome (CFS) is an illness characterized by persistent fatigue for
at least 6 months, and is often accompanied by several other symptoms including headaches,
muscle pain, insomnia, and concentration issues. The condition is complex and not well
understood. There is no clear cause identified and no effective diagnostic test developed for
CFS. As such, it is diagnosed through symptom identification. Chronic fatigue syndrome,
irritable bowel syndrome and fibromyalgia are closely linked and many individuals
concurrently meet the symptomatic criteria for two or three of these conditions. The lack of
cause and diagnostic test has led to questions about and challenges to the legitimacy of the
diagnosis of CFS. Some health care professionals argue that a diagnosis of CFS may be selfvalidating, self-reinforcing and potentially a self-fulfilling prophecy (Huibers & Wessely,
1996). Treatment of CFS is aimed at symptom relief, not cure; however, attempts to find
effective treatments, even for symptom relief, have not been successful.
In February 2015, the United States Institute of Medicine (IOM) published a report
renaming Chronic Fatigue Syndrome as Systematic Exertion Intolerance Disease (SEID), as
well as proposing a redefinition of the diagnostic criteria for CFS. The change to SEID has
been met with some hesitation among patients and health care professionals (Jason,
Sunnquist, MacManimen & Furst, 2015). Nevertheless, the authors of the IOM report hope
that one outcome of the name change will be a shift in the perception of the disease and an
overall increase of the acceptance of the condition (Institute of Medicine, 2015). While the
term disease in the name implies a pathological mechanism, the authors of authors of the
IOM report acknowledge that no disease process has yet been identified.
Descriptive Analysis
The authors of the CFS entry cite 46 references ranging in date of publication from
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1986-2015. Fewer than one quarter (n=10, 22%) of the references were published between
2010 and 2015. Forty-one of 46 references (89%) are published in UpToDate’s core journals.
The most common journals cited in the Chronic Fatigue Syndrome main entry was The
Lancet (cited seven times) and American Journal of Medicine (cited seven times), which are
both identified as core journals by UpToDate.
The UpToDate entry for CFS contains three types of evidence recognized by the 6S
hierarchy: Synopsis of Synthesis, Synthesis, and Study (see Figure 15). Seven of the 46
references (15%) cited fall outside of the 6S hierarchy. All seven of the references that are
not types of evidence included in the 6S hierarchy are non-systematic/narrative reviews.
Only two references in the CFS case are systematic reviews, which are situated in the
Synthesis level of the 6S hierarchy. Thirty-three of the 46 references are quantitative studies.
Approximately half (n=24, 52%) of all references cited in the CFS case are randomized
controlled trials.
Cited
References
46
Not in 6S
7 (15%)

Synopsis of
Synthesis
1 (2%)

Synthesis
5 (11%)

Study
33 (72%)

Quantitative
33 (72%)

RCT
24 (52%)

Qualitative
0 (0%)

Other Quant
9 (20%)

Figure 15: Types of Evidence in CFS Main Entry

The studies took place primarily in the United States and United Kingdom with 12 of
33 (36%) from the US and 11 of 33 (33%) from the UK. Three studies took place in the
Netherlands and two in Belgium. There was one multinational study spanning the United
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States and multiple European countries. One study each took place in Australia, Denmark,
and Norway. It is unknown where one older study took place.
The 46 references making up the CFS case were written by 259 authors. Across the
46 papers, the highest known proportional representation (.32) of the authors had a Medical
Doctor (MD) background followed by Basic Scientists (.25). Proportionally across all 46
papers, .38 of the backgrounds of authors were unknown (Figure 16).
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Figure 16: Relative Contribution by Authors’ Background in the CFS main entry
Textual Analysis
Situating the Author. While the UpToDate Editorial Policy encourages the authors
and editors of UpToDate to make explicit recommendations for treatment, the authors of the
CFS entry did not center the content on their own recommendations for treatment. The
authors make use of the phrase ‘we (do not) recommend’ in only one instance:
In a small double-blind, placebo-controlled crossover study that included 14
patients with CFS/SEID, modafinil, a selective wakefulness-promoting agent,
had a mixed effect on cognition; had no effect on fatigue, quality of life, or
mood; and had a negative effect on mental flexibility and motor speed. We do
not recommend this agent. (CFS)
In this quotation, the authors provide information on a small RCT assessing the effectiveness
of the drug modafinil followed by their own opposition to the use of the drug. This is the
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only use of the ‘we recommend’ phrase in the CFS case. Although the authors do not
concentrate on explicit recommendations, they do provide two accounts of their own clinical
practices. In one instance, the authors simply affirm that they urge patients to push
themselves when engaging in physical activity: “We encourage the patient to gently push
himself or herself” (CFS). In the other instance, the authors provide a more extensive
description of their approach to treating CFS as a form of neurally- mediated hypotension:
We do not routinely perform tilt table testing on our patients with SEID/CFS
since it is expensive, moderately uncomfortable, and without proven utility.
However, after carefully explaining to a patient that the efficacy is not
established, we are willing to try atenolol alone or with fludrocortisone, if the
patient wishes. We start with low doses which are increased slowly over
several weeks. (CFS)
The authors do not center the content on their explicit recommendations; however, by
providing accounts of their own practices, there is an implied endorsement of the approach.
In the CFS case, the authors used the term ‘we’ in one additional context, noting that
“if the cause is organic, we do not yet know how to find it or treat it” (CFS). In this example,
the use of ‘we’ places the authors within that community of clinicians and researchers.
Similarly, the authors encourage clinicians to “… emphasize that we have considerable
knowledge and experience with SEID/CFS” (CFS). The authors use ‘we’ not to describe
themselves as authors, but rather to describe themselves as part of the collective of
researchers and clinicians.
Situating the Evidence. Throughout the case the authors make it clear that there have
been many attempts to find an effective treatment for chronic fatigue syndrome but there is
no cure and there has been little success in finding a treatment that will alleviate symptoms.
In the introduction of the main entry for CFS, the authors point out that the evidence has
identified only two therapies that produce what they describe as ‘meaningful benefit’.
Many therapies have been tried in chronic fatigue syndrome (CFS), also called
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systemic exertion intolerance disease (SEID), but only counseling therapies
(eg, cognitive behavioral therapy) and graded exercise therapy appear to
produce meaningful benefit. (CFS)
They note further that “neither of these modalities are curative. There is no known
specific medical therapy for CFS/SEID” (CFS). The variety of options for delivery of
these two non-pharmaceutical treatments is shared by way of the evidence that supports
the approach. For example, cognitive behaviour therapy can be provided individually or
in a group.
Another way to administer CBT is in a group setting. In a randomized
trial, cognitive behavioral group therapy was more effective than
enhanced usual care (defined as management by a primary care physician
or medical specialist) at improving physical functioning, bodily pain, and
vitality at 16 months among patients with a variety of somatic syndromes,
including CFS/SEID; the patients who received cognitive behavioral
group therapy participated in nine three and a half hour sessions over four
months. CBT appears to be more useful than participation in a support
group. In one three-arm trial, 278 patients were randomly assigned to
CBT, a support group, or no active intervention with follow-up at 8 and
14 months. The CBT group had significantly improved fatigue severity,
strength, overall sense of improvement, and lower sickness profile scores
compared with the other groups at both time points. (CFS)
The efficacy of CBT through group therapy is demonstrated by two randomized trials
with two different types of comparisons (i.e., usual care and non CBT support groups).
The demonstration of the efficacy of CBT and graded exercise therapy relies heavily on
individual studies, citing only one systematic review on these treatments.
In the CFS entry, substantial attention is paid to the research examining the
treatments that have been trialed but have not demonstrated efficacy or for which the
efficacy remains uncertain. The lack of proven effective treatments is made transparent.
Throughout the case, the authors make clear that many treatments have been trialed but
there has been little success:
A number of medications and special diets have been evaluated in patients
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with CFS/SEID, but none has proved successful. Among the modalities
that have been tried are serum globulin, arituximba, acyclovir,
galantamine, fluoxetine, and other antidepressants, methylphenidate and
modafinil (simulants), glucocorticoids, amantadine, doxycycline,
magnesium, evening primrose oil, vitamin B12, Ampligen, essential fatty
acids, bovine or porcine liver extract, dialyzable leukocyte extract
cimetidine, ranitidine, interferons, exclusion diets, BioBran MGN-3 (a
natural killer cell stimulant), and removal of dental fillings. (CFS)
After this extensive list of trialed and ineffective treatments, the authors go on to describe
the evidence that has not been able to yield results to support the use of certain therapies
in the treatments of CFS. For example, the association of CFS with the Epstein Barr virus
infection lead researchers to try an antiviral drug but showed no benefits: “A controlled
trial of intravenous and oral acyclovir was based upon the possible association with
Epstein-Barr virus infection. The outcome showed no benefit of treatment” (CFS). In
some instances, the authors provided details about specific trials. For example, the
authors describe an RCT that assessed the efficacy of galantamine, a drug has been used
in Alzheimer patients, in treating fibromyalgia.
In the largest and best-designed randomized, double-blind, controlled trial
that has been performed for the treatment of CFS/SEID, 434 patients at
multiple centers were randomly assigned to one of four doses of
galantamine or placebo. At 16 weeks, there was no benefit from
galantamine in the primary end point (improvement in the Clinical Global
Impression Scale) or in any secondary end points. (CFS)
The authors selected this study because it best demonstrated the effect of the drug on
fibromyalgia, and in turn, they also provided details about the patients, intervention, and
outcomes of the study were provided. The authors describe in varying level of detail the
evidence that refutes the many possible treatments that have been trialed as potential
therapies for CFS.
Over half of the referenced evidence cited in the case were studies; however, the
length of descriptions and amount of detail that the authors provided varied greatly across the
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24 studies. The extensiveness of the details extended from only parenthetical reference to
minimal details about one or two of the study’s PICO elements to extensive details about all
four PICO elements of a study. A single trial for rituximab was described in the following
paragraph:
In a double-blind, placebo-controlled trial, 30 patients with CFS/SEID were
randomly assigned to receive rituximab (500 mg/m2) or saline, given twice
two weeks apart. There were no differences in the primary endpoint, defined
as effects on the fatigue score at three months after the intervention.
However, a major or moderate response, defined as lasting improvements in
self-reported fatigue score during follow-up, was seen in 10 of 15 patients
(67 percent) who received rituximab and in 2 of 15 patients (13 percent) who
received placebo. The mean duration of response within a one-year followup period among the 10 responders in the rituximab group was 25 weeks
(range 8 to 44 weeks). There were no differences in B cell levels between
patients in the rituximab group who achieved a response compared with
those who did not achieve a response. (CFS)
In these examples, the authors highlight the study design (i.e., randomized controlled
trial) and provide details about all four PICO patients (i.e., 30 patients with CFS),
intervention (500 mg/m2 rituximab), comparison (i.e., saline) and outcomes (i.e., fatigue,
B cell levels) of the study in order to demonstrate the effectiveness or lack of
effectiveness of the therapies tested in the trial. In contrast, a study evaluating patient
beliefs and outcomes was described as: “In one study, belief in a viral cause of the illness
was associated with prolonged functional impairment” (CFS).
The authors’ descriptions of the evidence in the CFS main entry extend beyond
the description of the patient, intervention, comparison and outcome to include
commentary or analysis of the research study itself. For example, they point out when
studies examining drug treatments were not designed as a randomized controlled trials:
“Although these results appeared intriguing, these studies were not placebo controlled,
blinded, or randomized” (CFS). The authors suggest caution in interpreting the results
based on the study design.
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In addition to providing analysis of individual studies, the authors also highlight
overarching issues with the interpretation and application of the body of research
examining treatment for CFS. For example,
A major problem with evaluating the effect of therapy in CFS/SEID is that the
symptoms fluctuate over time, may remit spontaneously, and are subject to
substantial response rates to placebo. (CFS)
The authors also draw attention to insufficiency of evidence to support treatments. The
description of rituximab treatment provides a good example of how they caution readers
about the need for additional study despite the presence of positive results from a single
study.
Though intriguing, these findings are too preliminary to support the use of
rituximab, a drug that can cause immunosuppression and serious
complications. This study needs to be repeated with a larger number of
patients. (CFS)
The repeat this caution with respect to the use of the drug rintatolimod.
Rintatolimod is an investigational immune modulator and antiviral drug that
has been approved for the treatment of CFS/SEID in Canada and Europe. It
improved measures of exercise performance in two randomized trials;
however, the clinical implications were unclear. Treatment with this drug
should be considered experimental until more studies have been done. (CFS)
Although rintatolimod is approved for the treatment of CFS in Canada and Europe the
authors advise that it should be considered ‘experimental’ until more research is completed.
The clinical implications are considered to be unclear despite approval of the drug for
treatment of CFS in Canada and Europe. The lack of clear understanding of what is
considered to be ‘sufficient’ research is underscored in the CFS case.
The authors acknowledge that the body of CFS studies often yields conflicting
conclusions. In addition to commenting on the uncertainty regarding the long-term prognosis
for the condition, they also point out divergent results found with respect to specific
treatments.

131
Intramuscular immunoglobulin injections appeared to be beneficial in one
small controlled trial. However, this finding is in contrast to the more general
experience. Controlled trials of intravenous immune globulin yielded
conflicting and unimpressive results with a high incidence of adverse effects.
(CFS)
Interestingly, in this instance the authors note that the benefits shown in one study do not
align with others results but provide few details about the specifics of the cited research,
yet they include other examples in which they provide considerable detail about the
conflicting results. For example,
The results of studies evaluating glucocorticoids have also been
inconsistent. A double-blind, randomized, placebo-controlled trial of 25 to
35 mg/day of oral hydrocortisone for 12 weeks in 70 patients showed
modest benefit at the expense of adrenal suppression. By comparison, in a
randomized crossover trial, clinical improvement was observed in
response to 5 to 10 mg/day of hydrocortisone among 32 patients with
chronic fatigue but without a comorbid psychiatric disorder. No adrenal
suppression was observed, but the duration of therapy was only one
month. (CFS)
Here, by providing the descriptions of two studies, the authors highlight the inconsistent
conclusions in the evaluation of glucocorticoids. Differences in the patients (i.e., number,
comorbidities), and interventions (i.e., dosage), and outcomes (i.e., adrenal suppression) are
noted as a means to demonstrate inconsistency in the evidence base.
Situating the Patient-Physician Relationship. While the authors acknowledge in
one instance that there is an opportunity for interprofessional care: “Graded exercise therapy
should be supervised by a physical therapist or exercise therapist” (CFS), the primary focus
of the content is the provision of care from a physician. The relationship between the patient
and physician is acknowledged in the case as an important element of treatment. Under the
heading ‘Treatment,’ the authors include three subheadings: the two treatments judged to be
effective (i.e., Cognitive Behaviour Therapy and Graded Exercise Therapy), and ‘Supportive
Approach’. The authors advise physicians to “establish rapport with the patient to be able to
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provide support and reassurance” (CFS). They describe six specific elements that comprise a
supportive approach. For example, one bullet describes the physician’s role in validating the
patient’s experience and diagnosis:
Explain to the patient that the severity is variable but can be completely
incapacitating and that the symptoms are real. CFS/SEID is a real illness, and
the symptoms are not due to malingering. Because of the lack of laboratory
abnormalities, most patients struggle with the validity of their disease (as do
many of their clinicians) and may experience feelings of guilt. The patient
must believe that you understand that they have a real disease or you will not
be able to help them. (CFS)
Physicians’ confirmation of CFS as a ‘real illness’ is repeatedly highlighted as a critical
element of the physician-patient relationship. In addition to validation, the authors emphasize
the importance of being honest, addressing patients’ concerns without engaging in unhelpful
debates and demonstrating a commitment to patients’ treatment process. The physicians’
adoption of a supportive approach is identified as a key component of a treatment regime for
patients.
Within the section advocating for a supportive approach to treatment, the ways in
which CFS can challenge the relationship between patient and physician are also
interspersed. For example, the authors acknowledge that these patients are often timeconsuming: “It is often tempting to avoid such patients, since they can take up a great deal of
time” (CFS). Further, they point out that CFS patients have complex needs and encourage
the physicians to: “Accept the fact that you will not be able to satisfy all patients with this
disease” (CFS). They also acknowledge that patients’ desire to understand the cause of CFS
can strain the relationship and they advise physicians to “Avoid debate over the psychogenic
versus organic origin of symptoms” (CFS) because there is no benefit to the patient. While
the importance of demonstrating support for patients is emphasized, the authors also concede
that providing care for CFS patients can be challenging for physicians.
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Patient Information. The transition from healthy individual to patient with CFS
is described in both patient information entries, The Basics and Beyond the Basics. For
instance:
Chronic fatigue syndrome is hard to deal with, because people who get it were
usually active before. They did not tend to worry about being sick. Then, all
of sudden, they feel tired and can’t figure out what is wrong with them. Even
the doctor often can’t find a cause for the symptoms. And to make matters
worse, other people sometimes think their symptoms are “all in their head.”
This can make people with chronic fatigue syndrome feel angry, helpless, and
sad. (CFS Basics)
Both patient information sources also repeatedly validate the existence of the illness.
If you have chronic fatigue syndrome, try to remember that you have a real
medical condition. You are not imagining your symptoms, and your problem
is not “made up.” Scientists have not yet figured out how to explain or cure
chronic fatigue syndrome, but they do know that it is real. (CFS Basics)
Here, the intention is to reassure patients that CFS is a ‘real medical condition’ and that,
while scientists do not yet know the cause or cure of CFS, they too believe it to be real. In the
Beyond the Basics entry, there is recognition that the condition may not be a physical
abnormality but rather may originate in the mind.
There is no point to debating whether symptoms of CFS/SEID originate in
your mind or are the result of a not-yet identified abnormality. If the cause is
in your mind, the symptoms are no less real (a difficult concept for some
patients and/or their families). If the cause is an abnormality in your body, it is
not yet known how to find it or treat it. (CFS Beyond)
The importance of validation by the patient’s own health care professional is asserted
repeatedly in The Basics and Beyond the Basics.
The most important thing you can do to deal with your condition is to find a
doctor or nurse whom you trust and like and who believes that your condition
is real. Only that way can the 2 of you work together to figure out how best to
deal with your symptoms. (CFS Basics)
In both entries the need for physicians to accept CFS as a real condition is emphasized as ‘the
most important’ element of their treatment. The Beyond the Basics information also
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emphasizes the importance of building a relationship that “include[s] trust on both sides and
a willingness to believe that CFS/SEID is both real and disabling” (CFS Beyond). Both
patient information sources emphasize the necessity for finding a health care provider who is
‘willing’ to believe that CFS is real; however, there is also recognition that many healthcare
providers are not knowledgeable abut the condition.
Living with CFS/SEID can be frustrating because most people, including
healthcare providers, have a limited understanding of why or
how CFS/SEID develops. In addition, there are limited treatment options.
(CFS Beyond)
In light of the lack of cure, the goal of treatment for CFS is reduction of fatigue.
There is no cure for chronic fatigue syndrome (CFS), also called systemic
exertion intolerance disease (SEID); the goal of treatment is to reduce
symptoms of fatigue and help you to cope. Many therapies have been tried in
CFS/SEID but none has been consistently successful. Cognitive behavioral
therapy and graded exercise appear to be the most effective treatments. (CFS
Beyond)
The content presented in this excerpt from Beyond the Basics (i.e., lack of cure, the goal to
reduce fatigue, the many trialed therapies, and identification of cognitive behavioural therapy
and graded exercise therapy as CFS treatments) aligns with the content presented in The
Basics as well as the main entry. Short descriptions of cognitive behaviour therapy and
graded exercise therapy are provided in both patient information sources.
Following the identification of the two proven therapies, both patient information
sources highlight that other therapies have been trialed but with little success.
Researchers have also checked whether different medicines, supplements, and
special diets help with chronic fatigue syndrome. So far, none of these
approaches has proven helpful (CFS Basics).
Indeed, Beyond the Basics provides a list of five treatments that have been trialed and
“not proven to improve symptoms of CFS/SEID include the following” (CFS Beyond,
emphasis in original). The trials and unproven efficacy of multiple treatments are also
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highlighted in the main CFS entry.
Particular attention is brought to the lack of a role for antibiotics in treating CFS. This
matter is highlighted with considerable detail in both The Basics and the Beyond the Basics
patient entry.
There is no role for antibiotics in the treatment of CFS/SEID, and there is the
potential for serious side effects from prolonged use of antibiotics. Your
doctor might offer you antibiotics, especially if you test positive for Lyme
disease. But antibiotics do not work on chronic fatigue syndrome. And testing
positive for Lyme does not mean that your symptoms are caused by Lyme
disease. Plus, taking antibiotics for a long time when you do not need them
can cause health problems. (CFS Beyond)
In this case, the content of the two patient information sources and the main entry written for
professional are well-aligned.
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Case Analysis: Grief and Bereavement
The question of whether grief arising from the death of a loved one is a natural human
process or a serious condition that may require medical attention is longstanding (Breen &
O’Connor, 2007; Engel, 1961; Glass, 2005). In 1917, Freud explored this very tension in his
classic essay “Mourning and Melancholia” and distinguished between two different
responses to loss. Mourning while painful and difficult, was recognized to be also timelimiting, natural, and normal. In contrast, melancholia affects one’s sense of self-worth, and
is long-lasting and pathological. This distinction between ‘normal’ and ‘abnormal’ grief has
been discussed for a century, and in turn, the ways in which physicians and health care
professionals treat grief have also been debated.
A change to the foundational psychiatric text, the Diagnostic Statistical Manual of
Mental Disorders (DSM), in 2013, may start to define treatment of grief more clearly and
affect the way grief is understood and, in turn, how the medical profession handles grief. In
the fifth edition, a feature termed the “grief exemption” or “bereavement exclusion” was
removed (American Psychiatric Association, 2013). Prior to 2013, bereavement was the only
life event or stressor specifically excluded from a diagnosis of major depression in DSM-IV.
In removing the so-called bereavement exclusion, clinicians can diagnose major depression
in persons who have experienced the death of a loved one after only two weeks of depressive
symptoms. The goal of the change is to identify individuals who require treatment for major
depression, which has been triggered or precipitated by the death of a loved one. However,
the unintentional effect of this proposed change could be the medicalization of grief and an
increase in the labelling of healthy, but grieving people with a psychiatric diagnosis.
Further complicating the treatment and handling of grief and bereavement is the
proposed disorder of ‘complicated grief’. Complicated grief disorder, officially named
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‘persistent complex bereavement disorder’ by a DSM working group, is a proposed disorder
assigned to individuals experiencing grief that is prolonged, intense and debilitating. Grief is
considered prolonged if patients have not demonstrated adaptation to the loss and integration
of bereavement into their lives by six months (Bonanno et al., 2002). Complicated grief is
differentiated from other mental disorders including major depression and post-traumatic
stress disorder.
In consideration of this context, the case study on grief and bereavement includes two
UpToDate entries written by the same authors: Grief and Bereavement in Adults:
Management (NGB) which addresses the treatment of what is often coined normal grief and
bereavement, and Complicated Grief in Adults: Treatment (CGB), which addresses the
treatment of complicated grief in adults. The two entries were chosen to represent the single
case because the degree of medicalization was a key factor in the selection of cases; as such,
the overlap across and the distinction between the two entries is very important.
Descriptive Analysis: Normal Grief and Bereavement (2015)
The normal grief and bereavement (NGB) entry includes 20 cited references, the
fewest number of references across the eight entries analysed. The 20 references were all
published between 2000 and 2014 with more than half (n=11, 55%) published between 2010
and 2015. Only seven of the 20 references were published in UpToDate’s core journals.
Half of the references (n=10) cited in the NGB entry are not recognized as types of
evidence within the 6S hierarchy classification (see Figure 17). All six studies cited in the
main entry for the NGB were quantitative, of which four were randomized controlled trials.
The locations of study for the six studies were the United Kingdom (n=2), United States
(n=2), the Netherlands (n=1), and one multinational spanning the United Kingdom and the
United States. Two systematic reviews were cited, as well as two summary level resources.
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The two summary resources included in the NGB main entry were clinical practice
guidelines.
Cited
References
20
Not in 6S
9 (45%)

Summary
2 (10%)

Synthesis
3 (15%)

Study
6 (30%)

Quantitative
6 (30%)

RCT
4 (20%)

Qualitative
0 (0%)

Other Quant
2 (10%)

Figure 17: Types of Evidence in NGB Main Entry
The 20 references included in the main entry for NGB were written by a total of 88
authors. Across the 20 papers, the highest known proportional representation (.41) of the
authors had a Basic Scientist (PhD) background. The relative proportion of authors with a
Medical Doctor (MD) background was .24. The proportion of authors where the background
authorship was unknown was .29 (see Figure 18).
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Figure 18: Relative Contributions by Author Background for NGB main entry
Descriptive: Complicated Grief (CGB, 2015)
The main professional entry addressing complicated grief (CGB) cited 30 references.
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There is minimal overlap of references across the NGB and CGB entries (only two sources
were cited in both entries). The 30 references were published between 1998 and 2015.
Seventy per cent (n=21) were published between 2010 and 2015. Only nine of the 30
references (30%) were published in UpToDate’s core journals. The most commonly cited
journal was Death Studies, which is not identified as a core journal by UpToDate.
Seventy-seven per cent of references (n=23) cited in the CGB entry were studies; all
but one was quantitative. Eleven of the 22 quantitative studies were randomized controlled
trials. Three systematic reviews were cited. Only four references cited (13%) in the CGB
entry were not sources of evidence recognized as evidence by the 6S hierarchy classification.
Cited
References
30
Synthesis
3 (10%)

Not in 6S
4 (13%)

Study
23 (77%)

Quantitative
22 (73%)

RCT
11 (37%)

Qualitative
1 (3%)

Other Quant
11 (37%)

Figure 19: Complicated Grief and Bereavement in Adults: Treatment (CGB)
The 30 references included in the main entry for CGB were written by a total of 127
authors. Across the 30 papers, the highest known proportional representation (.35) of the
authors had a Basic Scientist (PhD) background. The relative proportion of authors with a
Medical Doctor (MD) background was .24. The proportion of authors whose background was
unknown was .36.
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Figure 20: Relative Contributions by Author Background for NGB main entry
Textual Analysis
Situating the Author- Normal Grief and Bereavement (NGB, 2015). In the main
entry for NGB the authors do not readily provide their recommendations, nor do they readily
position their expertise within the content. The authors provide explicit recommendations
only three times in the entry. For example, the authors offer their recommendation for
treatment for bereaved patients who do not have mental disorders: “For bereaved individuals
who do not have mental disorders, we suggest not routinely administering grief counseling or
other psychotherapies” (NGB). In one additional instance, the authors provide their
endorsement for treatments implicitly by describing their own approach to care: “For
bereaved individuals who do not have mental disorders, we generally do not use
benzodiazepines” (NGB). Their strategy to avoid prescription of these psychotropic drugs is
reinforced more explicitly later in the entry by using the phrase ‘we suggest.’ Explicit
recommendations are infrequent in the main entry for NGB.
There are sections of the NGB entry where the source of the knowledge is unclear.
The authors do not always attribute the information to themselves or to published materials.
For example, the authors describe patients’ experience before and following death:
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If possible, clinicians should summon families prior to an expected death. If
this is not possible and the patient dies, the clinician should promptly call
immediate family members who are not present at the bedside in order to
inform them, express condolences, answer questions, and offer them the
option of viewing the body. (NGB)
For patients who are worried about their reaction to the death, education may
be helpful. As an example, patients without mental disorders may be alarmed
by hallucinations of the deceased, and can be reassured that this is not a
manifestation of psychotic illness. Some people worry about the intensity or
uncontrollability of emotions; this too is a typical feature of acute grief.
(NGB)
In the first excerpt the authors provide guidance about what the clinician should do prior to
the death of a patient. In the second the authors advise physicians about how patients might
react when faced with the death of a loved one, and how best to respond to such reactions.
The sections without any attribution to a source, neither evidence nor expertise, often relate
to the role of the physician, as demonstrated in the first excerpt, or the experience of the
patient, as demonstrated in the second exerpt. The ambiguity of the source of knowledge and
the nature of the information provided suggests that the authors are providing implied
guidance and recommendations based on tacit knowledge gained through their own
experience.
Situating the Author- Complicated Grief and Bereavement (CGB). In the
Complicated Grief entry, the (same) authors are more forthcoming with their own
recommendations and refer predominantly to their own expertise through their explicit
recommendations. Seven recommendations made by the authors in the CGB explicitly use
the phrase ‘we recommend’ or ‘we suggest,’ as encouraged by the Editorial Policy of
UpToDate. The recommendations endorse specific therapies and are often followed up by
published evidence.
For patients with complicated grief, we recommend CBT adapted for
complicated grief as first-line treatment. CBT has been widely studied and
multiple randomized trials indicate that CBT targeted for complicated grief is
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efficacious; the evidence supporting CBT includes head-to-head trials
comparing CBT with other active treatments (rather than waiting list controls
or usual care). As an example, a 12-week trial compared CBT with grief
counseling in 54 patients, and found that improvement of complicated grief
was greater with CBT and that its clinical effect was large. (CGB)
Not all recommendations were followed by evidence. For example, the authors provide
guidance for physicians caring for patients who have not responded to cognitive behaviour
therapy:
If patients are not responding to first-line treatment with complicated grief
therapy or other forms of CBT targeted for complicated grief, we suggest reevaluating patients with respect to psychosocial problems that can derail
treatment, and addressing any such problems. As an example, patients may
have serious financial, occupational, or interpersonal problems such as
lawsuits related to the death, disability due to incapacitating symptoms, or
conflicts with family members in settling the estate. (CGB)
The lack of clarity about the origin of information included in the CGB entry is
common. In one instance, the authors infer their endorsement of treatment through accounts
of their typical practice. In the Summary and Recommendations, the authors reinforce their
endorsement of complicated grief therapy by describing their choice of this therapy in their
own practice stating “We typically use a form of CBT called “complicated grief therapy”
(CGB). While the authors do no overtly share their recommendation using ‘we recommend,’
their account of their typical practice endorses the practice implicitly.
Situating the Evidence, Normal Grief and Bereavement (NGB, 2015). Almost
half of the references cited (9 of 20) in the entry for NGB are not types of evidence
recognized within the 6S hierarchy of evidence. Six quantitative studies were cited in the
NGB entry. The authors provided short description of two of the six studies cited in the NGB
entry, both were randomized controlled trials:
A six-week randomized trial compared diazepam (2 mg, up to three times per
day) with placebo in 30 individuals who were bereaved within the past two
weeks; patients were allotted 20 tablets for the entire study. Outcomes were
comparable at the end of the treatment and at the six-month follow-up. (NGB)
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A subsequent randomized trial compared psychoeducation (four sessions,
each lasting two hours, administered during home visits) with no intervention
in 83 individuals bereaved through suicide; improvement of depressive
symptoms (including suicidal ideation) and complicated grief symptoms in the
two groups was comparable. (NGB)
As shown in the excerpts, the category of high quality trial (i.e., randomized controlled trial)
was highlighted in both descriptions. The information about the intervention, comparison,
and outcomes was provided; however, information about the patients was scant. Both
descriptions describe studies in which the intervention did not result in a meaningful benefit.
The NGB main entry cited three synthesis level evidence sources, the meta-analysis
comparing the efficacy of various grief interventions including counseling, psychotherapies,
and support groups with control groups. Short descriptions were provided about all metaanalysis. A meta-analysis evaluating grief interventions with usual care was described briefly
as:
A meta-analysis of nine trials compared interventions (eg, support groups)
intended to prevent complicated grief with control conditions (eg, usual care
or minimal treatment) in 1545 bereaved individuals, and found that the
incidence of complicated grief was comparable. (NGB)
Once again, the authors are transparent that these interventions are not beneficial to the
patient. Despite the outcomes of this meta-analysis and other research showing no benefit to
grief interventions for normal grief and bereavement, the authors go on to explain when grief
counselling can be helpful:
However, grief counseling can be helpful specifically for bereaved individuals
who request it, and may also be helpful when it is coupled with other efforts
that are focused upon new activities as well as experiences intended to restore
one’s life. (NGB)
The authors assert that grief counselling can be helpful for those who request it, citing a 2007
systematic review.
Finally, two World Health Organization (WHO) clinical practice guidelines were
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cited. The guidelines cited addressed the use of benzodiazepines. The authors’ aversion to
using benzodiazepines was compared to the WHO guidelines: “Our approach is consistent
with treatment guidelines from the World Health Organization” (NGB). The citation of
clinical practice guidelines was used as a means to further validate their recommended
approach.
Situating the Evidence, Complicated Grief (CGB). In contrast with the NGB main
entry, the authors rely heavily on studies as evidence for the content presented in the
complicated grief main entry. Specifically, 23 of the 30 cited references (77%) were studies the highest proportion across the eight main entries analysed for this multiple case study.
The authors present their recommendation for first-line therapy for complicated grief
as cognitive behaviour therapy (CBT) adapted for complicated grief. The strength of their
recommendation is directly connected with the evidence.
CBT has been widely studied and multiple randomized trials indicate that
CBT targeted for complicated grief is efficacious; the evidence supporting
CBT includes head-to-head trials comparing CBT with other active treatments
(rather than waiting list controls or usual care) For example, a 12-week trial
compared CBT with grief counseling in 54 patients, and found that
improvement of complicated grief was greater with CBT and that its clinical
effect was large” (CGB)
This approach of acknowledging a larger body of evidence and then selecting examples from
the body was also used when describing a specific therapy called “complicated grief
therapy”:
Evidence for the efficacy of complicated grief therapy includes randomized
trials that studied the treatment in different age groups:
One trial compared complicated grief therapy with interpersonal
psychotherapy in 95 patients (mean age approximately 48 years). Both
treatments were administered in 16 weekly sessions, and patients were
allowed to continue antidepressants initiated prior to study intake. Response
occurred in more patients who received complicated grief therapy than
interpersonal psychotherapy (51 versus 28 percent).
A second trial by the same principal investigator, using similar methods,
compared complicated grief therapy with interpersonal psychotherapy in 151
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patients (mean age approximately 66 years). More patients responded to
complicated grief therapy than interpersonal psychotherapy (70 versus 32
percent), and response was sustained six months post-treatment. (CGB)
The authors select two studies from the body of randomized trials for which to provide
descriptions that included details about the patients, intervention, comparators and outcomes
of the study as well as the study design (i.e., randomized controlled trials). Study design is a
common element highlighted in the CGB entry. The authors’ preference for randomized
trials is implicit in the entry.
No randomized trials have demonstrated that antidepressants are efficacious
for complicated grief, and these drugs are often not used. However, several
small observational studies suggest that these drugs may be helpful. (CGB)
The authors highlight that while observational studies suggest efficacy, randomized trials
have not demonstrated efficacy. When describing three observational studies, the authors
present outcomes with tempered certainty using words such as suggest and may (be helpful).
The authors provided a short description of one of the three synthesis level evidence
sources.
Randomized trials indicate that the best treatment for complicated grief is
psychotherapy that is specific for complicated grief. As an example, a metaanalysis of five trials compared psychotherapies (eg, cognitive-behavioral
therapy [CBT]) adapted for complicated grief with control conditions (eg,
nonspecific supportive psychotherapy) in 368 patients. Improvement was
greater with psychotherapies adapted for complicated grief and the clinical
benefit was moderately large. In addition, one study followed patients beyond
the end of treatment and found that improvement remained greater in patients
who received active treatment. However, the heterogeneity across the five
trials was large. (CGB)
In this excerpt, the authors highlight that the meaningful clinical benefit of delivering
psychotherapies specific for complicated grief. They also emphasize one of the five studies
that demonstrated that improvements extended beyond the duration of the treatment. The two
other systematic reviews cited in the entry appeared only as parenthetical references in a list
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of possible treatments for non-responsive patients. In addition to proof of efficacy,
descriptions of the way in which cognitive behaviour therapy is designed and delivered are
provided in the CGB entry.
The second-line treatment, behavioural activation, is presented more briefly in the
CGB main entry. Much less explanation about what behavioural activation is or how it is
delivered is included. Only one randomized controlled trial was described in order to
demonstrate the efficacy of behavioural activation in complicated grief:
Evidence for the efficacy of behavioral activation includes a 12-week
randomized trial that compared behavioral activation with a waiting list
control in 25 patients; after 12 weeks, patients in the control group received
behavioral activation. Behavioral activation was administered in 12 to 14
individual sessions, and included education about complicated grief, selfmonitoring of activities, identifying patterns and reinforcers of avoidant
behavior, and scheduling alternative rewarding activities. Improvement was
greater with active treatment; among the 25 patients, response at posttreatment
occurred in 45 percent. At the follow-up assessment 12 weeks after treatment
ended, response was observed in 60 percent of patients. In addition, symptoms
of depression and PTSD also improved. (CGB)
Interestingly, the account of the behavioural activation therapy included in this study
description is the only explanation of the intervention in the main CGB entry.
Cognitive behaviour therapy and behavioural activation are considered the first- and
second-line therapies and, as such, the authors provide evidence of their efficacy. When these
first- and second-line therapies fail, the presentation of evidence and the strength of evidence
provided in the entry are markedly reduced. When these therapies fail, the authors suggest an
amalgamation of approaches including: education about complicated grief, counseling and
support, encouragement, correcting dysfunctional thoughts, anticipating anniversary dates,
antidepressant medications. With the exception of the use of antidepressants, for which the
authors state a lack strong evidence, these approaches are not situated within a body of
evidence but rather are only presented as a list in the CGB main entry. Following failure of
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these interventions, another list of possible therapies is presented.
For patients with complicated grief who do not respond to this combination of
interventions, we suggest interpersonal psychotherapy, narrative therapy,
meaning making therapy, psychodynamic psychotherapy, family therapy, eye
movement desensitization and reprocessing, or art therapy. (CGB)
While no descriptions of these therapies or descriptions of the evidence supporting these
therapies are provided, each of these therapies does include at least one parenthetical citation,
either a systematic review or a study.
Situating the Patient-Physician Relationship, NGB
The authors of the normal grief and bereavement entry address the normalcy of the
grief process by declaring that many people do not require treatment when they are going
through the processes of grief and bereavement.
Acute grief does not typically require treatment. Most bereaved individuals
are resilient and grief is transformed and integrated during a natural adaptive
process that typically unfolds with the support and encouragement of close
family and friends, as well as clergy. (NGB)
The resiliency of bereaved individuals is highlighted alongside the need for the support and
encouragement of others. Grief, as a natural process that does not require treatment but rather
support, is reinforced throughout the case and informs the way in which the patient-physician
relationship is described in the main entry for NGB.
While it is often not necessary for physicians to provide treatment for the bereaved,
the authors do emphasize that patients often welcome the physician’s acknowledgement of
and support for their loss. Throughout the entry, the authors provide strategies and tactics for
physicians to support the bereaved.
Support from clinicians for acute grief typically includes empathic listening,
information about the wide range of typical grief symptoms, reassurance, and
monitoring. Condolence letters, telephone calls, attending the funeral or memorial
service, and home visits may be helpful as well. (NGB)
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Clinicians are advised also to be aware of social and environmental issues that may
hamper the bereavement process:
Clinicians can guide bereaved patients in managing social or environmental
problems that supervene in the aftermath of a loss and become the focus of
thoughts and behaviors. As an example, if a widow is left with insufficient
funds to support herself, her partner’s affairs are in disarray, or she is
ostracized or blamed after the death of a loved one, these situations demand
attention because they may interfere with adaptation, trigger a depressive or
anxiety disorder, or lead to complicated grief. (NGB)
To further assist physicians, the authors provide suggestions for what to say to grieving
patients and identify times and ways that physicians can support their patients through the
grieving process.
The physician is not positioned as the main source of bereavement support, but rather
a natural one.
Primary care clinicians are a natural source of support for bereaved
individuals and typically view bereavement care as important and satisfying;
however, many clinicians feel inadequately trained. (NGB)
The limitations of physicians’ comfort in treating patients is also underscored when the entry
addresses the need to rule out other conditions including “Suicidal ideation and behaviour;
Complicated grief; and Other mental disorders, such as major depression, posttraumatic
stress disorder (PTSD), insomnia disorder, and anxiety disorders” (NGB). The authors advise
that: “Primary care clinicians who are not comfortable diagnosing and treating mental
disorders should refer patients to mental health clinicians” (NGB). The entry acknowledges
that while physicians can be a helpful source of support, clinicians often feel underprepared
to treat the bereaved, especially when complications and comorbidities develop.
Through the identification of opportunities for support throughout the bereavement
support, the authors also provide insight into the experiences of the patient. Patient
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experiences are exposed through the description of ways in which patient education and
patient encouragement can assist patients and:
For patients who are worried about their reaction to the death, education may
be helpful. As an example, patients without mental disorders may be alarmed
by hallucinations of the deceased, and can be reassured that this is not a
manifestation of psychotic illness. Some people worry about the intensity or
uncontrollability of emotions; this too is a typical feature of acute grief.
(NGB)
Encouraging patients to maintain regular patterns of activity, sleep, exercise,
and nutrition may help adaptation to the loss. Bereaved individuals may forget
to care for themselves and may withdraw socially. If the deceased person
lived in the same house, meals can trigger intense feelings of missing the
person. Patients may eat food that a loved one especially enjoyed in order to
feel close to the person, or avoid foods that serve as reminders of the loss.
Sleep can be disrupted as well. (NGB)
The intensity and uncontrollability of the patient emotions and reactions are described, as
well as the resulting effect on daily life. More extensive descriptions of the patient
experience are covered in the related UpToDate entry Grief and Bereavement: Clinical
Features, however by exploring the opportunities for the physician to provide support,
physician observation of the patient experience is also underscored.
Situating the Patient-Physician Relationship, CGB
Complicated grief is acute grief that becomes “unrelenting, intense, and functionally
debilitating” (CGB). Unlike normal grief and bereavement, the authors claim that
complicated grief requires treatment. The patient-physician relationship in complicated grief
is dictated by the goal of treatment, which is outlined in the CGB entry as “resolving grief
complications and fostering adaptation to the loss” (CGB). The authors reinforce that the
goal of the treatment is not the elimination of all symptoms. They provide indicators of when
the treatment is successful including improved emotion regulation, an ability to envision a
positive life, and engagement in activities and relationships.
One of the keys to providing treatment is educating the patient about complicated
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grief as a disorder. The education is intended to assist patients by validating their experience
and providing a diagnosis:
Many patients with complicated grief are discouraged by the prolonged acute
grief and feel hopeless, and are relieved to receive the diagnosis as well as
education about the disorder. In addition, family and friends who initially
were supportive may be critical and tired of trying to help because they do not
realize the patient has a treatable condition. (CGB)
The authors reinforce the validity of complicated grief as ‘real’ by describing it as a
“treatable condition” (CGB). Patient education and validation of complicated grief as a
disorder is presented as a key attribute of the patient-physician relationship.
First- and second-line therapies for complicated grief are identified in the CGB
treatment entry. Physicians are encouraged to treat patients first with cognitive behaviour
therapy adapted for grief. If patients fail to respond, behavioural activation is suggested as
the second line treatment. Prior to moving onto second line treatment clinicians are
encouraged to assess for “psychosocial problems that can derail treatment” (CGB). Issues
that may arise may relate to legal, occupational or financial problems as a result of the death.
Physicians are encouraged to “address any such problems” (CGB). The complexity of the
grieving patient is acknowledged by the authors stating:
In addition, many patients with complicated grief have comorbid major
depression, anxiety disorders, PTSD, or substance use disorders. If a disorder
other than complicated grief is more salient, treatment should refocus upon the
primary problem. (CGB)
Repeatedly, complicated grief is framed as “a unique and recognizable condition that can be
differentiated from other mental disorders” (CGB), however, the presence of complex
psychosocial issues and comorbidities do raise questions about the simple description of
complicated grief as a treatable condition.
The responsibility for delivery of the first- and second- line treatments is ambiguous
in the CGB entry. No clear indication is provided about what type of professional delivers
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these treatments and what relationship exists between the patient, the primary care providers,
and the treatment provider.
UpToDate does not provide patient information for either normal or complicated
grief.
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Case Analysis: Intimate Partner Violence
Intimate Partner Violence (IPV) describes physical, sexual, and emotional abuse by a
current or former partner or spouse; it is differentiated from bi-directional conflict in
relationships. Most victims of IPV are female; most perpetrators are male. Alongside the risk
of death, very significant non-fatal outcomes and consequences include injuries and
disabilities; mental health and behavioural consequences; and poor reproductive health
(WHO, 2010). Because of the serious and pervasive health impacts, intimate partner violence
is increasingly recognized as a public health concern requiring physician awareness and
involvement.
Physician support for a patient experiencing abuse is often initiated when IPV is
detected, disclosed, and “diagnosed.” Physicians and health care workers are increasingly
encouraged to talk about, assess risk, and provide options for support when intimate partner
violence is disclosed (American College of Obstetricians and Gynecologists, 2012;
Cronholm, Fogarty, Ambuel & Harrison, 2011; Society for Obstetricians and Gynecologists
of Canada, 2009). Preventing IPV and ensuring supports and resources are available to those
experiencing abuse is recognized as a priority, and the potential issues and consequences that
emerge from these actions are numerous and complex. As such, the role of health care
workers in identifying and providing intervention options for IPV has been debated
extensively (Cole, 2000; Wathen & MacMillan, 2012).
Descriptive Analysis
The authors of the IPV case cite 28 references ranging in date of publication from
1984-2015. Almost half (n=13, 46%) are published between 2010 and 2015. Forty-six (n=13)
are published in UpToDate’s core journals. The most commonly cited journal in the IPV case
was The Lancet, cited four times.
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The UpToDate entry for IPV contains three types of evidence from the 6S hierarchy:
Summary, Synthesis, and Study (see Figure 21). Half of the references (n=14) cited in the
IPV case are not sources recognized as evidence within the 6S hierarchy; five nonsystematic/narrative reviews; four public websites, three published reports, a textbook and a
resource manual. Five systematic reviews (Synthesis level), are cited, along with seven
studies, including one qualitative, two RCTs and four non-RCT quantitative studies. Six of
the seven studies took place in the United States and one in Australia.
Cited
References
28
Not in 6S
14 (50%)

Synthesis
5 (18%)

Summary
2 (7%)

Study
7 (25%)

Quantitative
6 (21%)
RCT
2 (7%)

Qualitative
1 (4%)

Other Quant
4 (14%)

Figure 21: Types of Evidence in IPV Main Entry
The 28 references cited in the IPV case were written by a total of 108 authors. Across
the 46 papers, the highest known proportional representation (.22) of the authors was from
professional organizations. Proportionally, medical doctors comprise .17 of the authors and
other health professionals made up .21 of the authorship. The relative proportion of authors
who are Basic Scientists is .20 (see Figure 22). Proportionally across all 46 papers, .21 of the
authors’ backgrounds are unknown.
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Background of Authors - IPV Entry
0.25
0.2
0.2

0.21

0.22

0.21

0.17

0.15
0.1
0.05
0

MD

PhD

Non-MD

Prof Org

Unknown

Figure 22: Contributions by Authors’ Backgrounds for IPV main entry

Textual Analysis
Situating the Authors. The authors of the IPV case do not overtly locate themselves
within its content. Unlike other cases, the authors never refer to themselves as “we” to
designate content emerging from their own recommendations, practices, or expertise.
Nevertheless, there are indications that selected guidance provided to the reader is based on
authors’ expertise.
Significant sections of the case are not anchored to a cited reference. For example, the
authors provide the reader with sample phrases that may be used within the clinical
encounter, e.g., “I want to help you through this in any way I can” (IPV). This type of advice
commonly permeates the general literature on responding to IPV. Similarly, there are
multiple instances of guidance and advice to the reader that align with general knowledge
about supporting victims of IPV, without overt attribution as to where the advice originated:
The clinician should ask the patient how afraid they are and what they think
are their immediate and future safety needs. Unfortunately, many people
minimize or deny their danger. Clinicians may be surprised or frustrated with
the severity of abuse patients are willing to tolerate and should understand that
love and other family concerns, such as children in the home and economic
factors, often confound the picture. (IPV)
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Providers should assure the abused patient that they are available for support.
In addition the patient should be offered referral for counseling about options
and safety, often to an onsite or local domestic violence agency where
available. Patients may be reluctant or resistant to talking with anyone else
because of fears about safety. On subsequent visits, you may emphasize
ongoing support and concern and ask the patient again to consider referral to
someone who can help think about options. (IPV)
The authors provide the reader with guidance about how to communicate with and advocate
for the IPV victim by explaining what the physician should do. They guide the physician
through a patient encounter and offer insights into what the physician might expect when
caring for victims of IPV. While the authors do not explicitly refer to themselves in this case,
in the presence of advice and in the absence of published evidence, they do appear to be
sharing their own experiences, knowledge, and expertise.
Situating the Evidence. As noted above, significant sections of the IPV case are not
attributed to published evidence. The case contains only seven studies: two RCTs, four nonRCT quantitative studies (two U.S. National surveys, a tool validation, and a
cohort/longitudinal study) and one qualitative study. (One RCT was misidentified as a metaanalysis in the UpToDate entry). The descriptions of the evidence used within the case vary
in the amount of detail provided.
The case unusually contained one qualitative study (of two such studies in all the
cases reviewed). No details about the study were provided other than its conclusion:
“Attempting to or leaving a relationship with a perpetrator often increases the risk of injury.
Providers should not encourage their patients to leave a relationship” (IPV).
Importantly, one of the key messages communicated in the IPV main entry is that
there is little evidence that demonstrates meaningful benefits of IPV interventions: “The
effectiveness of interventions for domestic violence has been studied and have shown limited
benefits for most women” (IPV). The authors call upon a systematic review and clinical
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practice guidelines to support this claim:
Studies have not shown conclusive benefits for advocacy or counseling
interventions. A 2009 systematic review found insufficient evidence to
determine if advocacy (providing information, support, and resource access)
in healthcare settings is effective for women who live with their abusing
partners. Intensive advocacy for women in shelters decreased physical abuse,
but its effect on depression, quality of life, and psychological distress was
uncertain. A subsequent multicenter trial randomized women who screened
positive for IPV to an intervention of one to six counseling sessions or to no
intervention. The response to a mailed survey at one year found no differences
in the primary outcomes of quality of life, psychological health, or planning
for safety, although the risk of depression was reduced in the intervention
group. (IPV)
The 2013 World Health Organization guidelines concluded that, except for
women who have spent at least one night in a shelter or for pregnant women
experiencing IPV, there is insufficient evidence that interventions for IPV
improve health outcomes.
While the conclusions of the systematic review and the clinical practice guidelines indicate
that IPV interventions are not effective, the authors resist the notion that no intervention is
necessary. Specifically, they state: “Counseling may strengthen the victim’s self-worth and
provide ongoing support, although objective evidence to support these benefits is limited”
(IPV). While there is not sufficient evidence to support the benefits of counselling, the
authors suggest counselling as a means to provide support to the victim.
The authors do bring attention to areas of IPV research in which there have been
conflicting results across studies, particularly regarding the efficacy of treatments for
pregnant women:
In a 2012 meta-analysis of four trials, counseling interventions reduced IPV,
improved birth outcomes for pregnant women, reduced IPV in the postpartum period, and reduced unsafe relationships and pregnancy coercion for
women seen in family planning clinics. However, a subsequent 2014
systematic review looking at 9 studies concluded that there was insufficient
evidence to assess the effectiveness of interventions for domestic violence on
pregnancy outcomes due to the heterogeneity and poor quality of studies
overall. (IPV)
Throughout the case the authors are transparent in describing research that addresses the care

157
of IPV as inconsistent and inconclusive.
The clinical practice guidelines from the World Health Organization, which occupy
the summary level of evidence, are mentioned twice in the entry.
The World Health Organization issued guidance in 2013 for responding to
intimate partner violence and sexual violence against women. The guidelines
stress the importance of woman-centered care as first-line support, to include
confidentiality when possible, privacy, nonjudgmental support, validation, and
not pressuring the woman to leave the relationship. The guidelines incorporate
recommendations for initial support, care for survivors, clinician training,
healthcare policy, and mandatory reporting. (IPV)
The focus on a supportive, patient-centred approach to caring for the IPV victim is clearly
conveyed in both the clinical practice guidelines and the UpToDate entry. The second
reference to the guidelines addresses the lack of efficacy of IPV treatments. While not
explicitly stated, the approach put forth by the authors does align with WHO guidelines.
Situating the Physician-Patient Relationship. The authors explicitly and repeatedly
state throughout the case that providing care for the patient requires supports beyond the
physician: “Care of the patient experiencing IPV requires a team approach involving
medical, institutional, and community resources” (IPV). Potentially helpful supports include
social workers, women’s shelters, legal aid, hospital or community advocates, and
community hotlines. The willingness of physicians to connect IPV victims with support is
dictated by patient needs and experience. In particular, the authors highlight the importance
of readiness:
For patients who are not ready or are too fearful to proceed with referral,
support and concern should be discussed on subsequent visits, and the patient
should again be asked to consider referral to someone to help him or her think
about their options. (IPV)
The authors emphasize that patients’ needs and experiences guide care as well as referrals.
The IPV main entry highlights that the focus of care in IPV is support: “Providers
should assure the abused patient that they are available for support” (IPV). Throughout the
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case, the authors provide clarification about what ‘support’ entails.
When IPV has been identified, the most important first consideration is to
offer support to the patient. It is crucial that providers affirm their
understanding of how difficult it must be for the patient to share this
information, recognize the patient's strength in doing so, and provide
assurance that they will be available to the patient for the future. This should
be immediately followed by an assessment of the victim's safety. (IPV)
The authors describe the importance of physicians being able to demonstrate their
understanding, compassion, and respect.
The immediate expression of empathy, acknowledgement, and continued
ability to support and assist the patient are the most important components of
care after a patient has disclosed abuse. (IPV)
The authors provide further guidance about how to deliver this type of support. Specifically,
they list possible statements that will help the physician convey empathy, validation, and
assistance.
The need for the clinician to recognize the uniqueness of patient experiences and
situations is emphasized. Some differences across patients that are underscored in the entry
include the level of danger victims are experiencing, as well as their readiness to change their
situation, and the supports they have available. The authors are explicit that it can be
challenging to provide care for victims of IPV. One of the key challenges is the clinicians’
disbelief that victims are willing to tolerate the abuse. While it may be difficult for physicians
to understand the situations and choices of victims, the authors are very clear throughout the
IPV case that decision-making is the right and responsibility of the patients: “Patients should
be allowed to make autonomous decisions regarding health advice” (IPV). The authors
reinforce the importance of this by calling on the WHO clinical practice guidelines outlining
the need to provide the environment that will allow victims to make their own decisions.
The guidelines stress the importance of woman-centered care as first-line
support, to include confidentiality when possible, privacy, nonjudgmental
support, validation, and not pressuring the woman to leave the relationship.
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(IPV)
The clinical practice guidelines reinforce the responsibilities of physicians to ensure patient
autonomy. Within this context, the legal aspects of providing care for IPV are acknowledged
as one caution and limitation to patient autonomy. The compounding safety and legal issues
that arise when children are exposed to IPV are emphasized: “Health providers and law
enforcement officers, as well as teachers and child care providers, are mandated reporters in
most states” (IPV).
It is noteworthy that throughout the IPV entry, patients experiencing IPV are not
limited to female victims. Although women are most at risk for experiencing IPV, the authors
position the content as gender neutral, referring most often to their, and sometimes including
both binary genders by referring to he/she or him/her.
UpToDate provides no patient information for intimate partner violence.
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Cross-Case Analysis
Descriptive Analysis:
In this cross-case descriptive analysis, the 427 references cited across the eight
professional entries that make up the multiple case study are examined. Comparisons across
the seven cases and eight entries are highlighted.
Currency. One of the highly regarded benefits of online medical information is the
capacity to update information with the most recent developments in a timely and efficient
manner. In this way, new medical knowledge can be integrated into online point of care
resources such as UpToDate, into clinical practice, and into a patient’s care more quickly
than ever before. According to its Editorial Policy, the content of UpToDate is “revised
whenever important new information is published” (UpToDate, “Editorial Policy,” 2016).
Table 22 provides an overview of the publication dates of the references cited across the
professional entries across the cases analysed in this investigation. All but the Grief and
Bereavement (NGB) entry cited at least one publication published in the year of download,
2015. The two entries with the highest percentage of references published between 2010 and
2015 were the Grief and Bereavement (NGB) and Complicated Grief and Bereavement
(CGB), both citing more than 50% of references published in a 5-year period prior to the
review current date. It is noteworthy that these two entries were new entries in 2015 and are
labelled version 1.0. In 2015, these two entries (NGB and CGB) replaced a single entry
addressing all issues relating to bereavement. Because these two entries originated in 2015,
older publications may not have been included in the entry with the result that the proportion
of articles published in the last five years increased. In contrast, the two entries that have the
lowest percentage of references published between 2010 and 2015, Acute Otitis Media and
Chronic Fatigue Syndrome, are on versions 29.0 and 31.0 respectively. The high percentage
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of articles published prior to 2010 in entries with a higher version number suggests that older
articles may not be removed or updated when new versions are created.
UpToDate

Review

Earliest

Most Recent

Most

Main Entry

Current

Publication

Publication

Common

Sate

Year

Year

Year(s)

2010-2015

(Mode)
Acute Otitis

08/2015

1980

2015

1999

Media

22%
(18/81)

Androgenetic

10/2015

1987

2015

2002

Alopecia
Irritable Bowel

12/41
10/2015

1984

2015

2012

Syndrome
Fibromyalgia

29%

39%
(35/89)

11/2015

1986

2015

2008

41%
(37/91)

Chronic Fatigue

12/2015

1986

2015

2001

Syndrome
Grief and

(10/46)
11/2015

2000

2014

Bereavement
Complicated

22%

11/2015

1998

2015

2005; 2010;

55%

2011; 2013

(11/20)

2013

70%

Grief

(21/30)

Intimate Partner
Violence

10/2015

1984

2015

2015

46%
(13/28)

Table 5: Overview of publication dates of references cited across the eight professional
entries
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Journal Titles. UpToDate provides a list of 466 key journals that are identified as
highly relevant and of high quality, which warrant hand-searching by the community of
physician-authors that is responsible for selecting the evidence to be included in UpToDate.
Hand-searching is a method that involves the examination of the entire contents of
preselected journals to identify articles of interest. In this study, these journals are referred to
as UpToDate’s core journals. Across the eight entries, of the total 427 cited references, 402
were published articles from a total of 143 journal titles. Of the 143 journals cited, 43%
(n=62) were part of UpToDate’s core journal list and represented 72% (n=285) of the 402
cited journal articles. The percentage of references from core journals in each of the eight
entries is presented in Table 6. Eighty-nine per cent of references cited in the Chronic
Fatigue Syndrome main entry were published in the core journals. For three topics, Grief and
Bereavement (normal), Complicated Grief and Bereavement, and Intimate Partner Violence,
fewer than half of the references cited were published in the core journals.
AOM

AGA

IBS

FIB

CFS

NGB

CGB

IPV

Total

n=82

n=41

n=89

n=91

n=46

n=20

n=30

n=28

n=427

% from

74%

63%

70%

73%

89%

35%

30%

46%

67%

Core

(61)

(26)

(62)

(66)

(41)

(7)

(9)

(13)

(285)

Journals
Table 6: Percentage of references cited from a core journal
The five most cited journals are listed in Table 7. Across the eight professional
entries, the most commonly cited journal was the Cochrane Database of Systematic Reviews.
This title is not always considered a journal; however, because of its inclusion in the list of
journals hand-searched, it is considered a journal for this analysis. The second most
commonly cited journal was JAMA. Across all the topics the most commonly cited journal is
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included on the core journal list with the exception of the entries for Normal Grief and
Bereavement (NGB) and Complicated Grief (CGB) where Death Studies, the most frequently
cited journal is not included among UpToDate’s core journals.
Entry Most Commonly Cited Journal

Core

AOM

Pediatric Infectious Disease Journal (n=16)

Yes

AGA

Journal of the American Academy of Dermatology (n=13)

Yes

IBS

American Journal of Gastroenterology (n=14)

Yes

FIB

Arthritis and Rheumatology (n=18)

Yes

CFS

Lancet (n=7)

Yes

American Journal of Medicine (n=7)

Yes

JAMA (n=2)

Yes

Journal of Palliative Medicine (n=2)

Yes

Death Studies (n=2)

No

CGB

Death Studies (n=4)

No

IPV

Lancet (n=4)

Yes

NGB

Table 7: Most Commonly Cited Journals by UpToDate Main Entry
Types of Evidence Resources. The corpus of cited references (n=427) that make up
the evidence base of the eight entries is dominated by studies. Sixty-three per cent of the
cited references are sources located at the study level of the 6S hierarchy of evidence
whereas only 15% are meta-analyses or systematic reviews from the synthesis level of
research. Eighteen per cent of the references cited across the eight entries are not types of
resources identified as evidence in the 6S hierarchy.
Table 8 describes the distribution of the references across the 6S hierarchy across the
cases.
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AO

AGA

IBS

FIB

CFS

NGB

CBG

IPV

Tota

M

n=41

n=89

n=91

n=46

n=20

n=30

n=28

l

n=82

n=42
7

Not in 6S

3%

22%

12%

8%

15%

45%

13%

50%

18%

Hierarchy

(15)

(9)

(11)

(7)

(7)

(9)

(4)

(14)

(76)

-

-

-

-

-

-

-

-

-

6%

2.4%

3%

3%

-

-

-

7%

3%

(5)

(1)

(3)

(3)

(2)

(14)

System

Summary

Synopsis/ Synthesis
-

Synthesis

Synopsis/ Study
Study

-

2%

2%

10%

(2)

(1)

(2)

-

1%
-

(5)

32%

2.4%

17%

21%

11%

15%

10%

18%

15%

(14)

(1)

(15)

(19)

(5)

(3)

(3)

(5)

(65)

-

-

-

-

-

-

-

-

-

59%

73.2

67%

66%

72%

30%

77%

25%

63%

(48)*

%

(60)*

(60)*

(33)*

(6)*

(23)†

(7)†

(267)

(30)
RCT

26%

59%

56%

35%

52%

20%

37%

7%

40%

(21)

(24)

(50)

(32)

(24)

(4)

(11)

(2)

(168)

* All studies for AOM; IBS; AGA; FIB; CFS were quantitative studies
† One study in both CGB and IPV were qualitative studies
Table 8: Distribution of Resources across the 6S Hierarchy
The entries with the largest percentage of resources not considered to be evidence by
the 6S hierarchy are in the Normal Grief and Bereavement (45%) and Intimate Partner
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Violence (50%) cases. The Androgenetic Alopecia entry contained the highest percentage of
RCTs and the lowest percentage of synthesis articles among its cited references.
While UpToDate does not explicitly provide formal inclusion and exclusion criteria
for evidence in the entries, the UpToDate Editorial Policy does suggest that evidence higher
on the evidence hierarchies is favoured for inclusion:
UpToDate follows a hierarchy of evidence consistent with most evidencebased resources. At the top of the hierarchy are meta-analyses of randomized
trials of high methodological quality, followed by randomized trials with
methodological limitations, observational studies and unsystematic clinical
observations. (UpToDate, “Editorial Policy”, 2017)
Evidence hierarchies suggest that finding evidence higher in the hierarchy negates the need
to evaluate lower level evidence. Across the eight entries analysed, 18.5% of the 351
references considered in the 6S evidence hierarchy were from the synthesis level. In contrast,
over three quarters of the evidence cited was from the lowest level on the hierarchy, the
Studies level.
In order to understand the availability of systematic reviews evaluating the clinical
questions addressed within the UpToDate entries, systematic reviews that address the same
or similar PICO elements (i.e. Patient, Intervention, Comparison, Outcomes) as cited clinical
trials in UpToDate were identified through a portlet provided by PubMed (see Table 9). In
the PubMed record for each trial, the portlet provides links to systematic reviews which cite
that trial. Each individual clinical trial cited in each of the eight entries was evaluated for
inclusion in a systematic review. The bibliographic information for the citing systematic
reviews for each was recorded and compared to the reference list of the corresponding entry.
Systematic reviews identified through the PubMed portlet that were deemed irrelevant to the
topic were not counted (such as a clinical trial cited in the entry for Chronic Fatigue
Syndrome that was cited by an article on post-stroke fatigue).
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AO
M

AGA

IBS

FIB

CFS

CGB

NGB

IPV

A. SRs cited in UpToDate

14

1

15

19

5

3

2

5

B. SRs identified in PubMed

20

2

28

23

12

3

2

1

8

0

12

14

3

0

0

1

5

0

5

2

1

0

0

0

3

0

7

12

2

0

0

1

Portlet*
C. Highly relevant SRs from
Portlet
D. Overlap between A and C
E. Potentially relevant SRs
identified

in Portlet not

cited in UpToDate
*date restrictions applied to limit “Review Current” date
Table 9: Identification of Systematic Reviews (SRs) cited and not cited in UpToDate
The level of convergence between the SRs cited in UpToDate and the potentially
relevant SRs identified by PubMed is quite interesting. In the entries for Acute Otitis Media,
Androgenetic Alopecia, Fibromyalgia, Chronic Fatigue Syndrome, and Intimate Partner
Violence there was at least one potentially relevant systematic review identified through the
portlet that was not cited in UpToDate. For fibromyalgia, there were 12 systematic reviews
identified by the PubMed portlet that were not cited in UpToDate. In contrast, only one
systematic review for Androgenetic Alopecia was identified and it was cited by the authors.
Generally, it appears that that systematic reviews addressing questions that were similar to
those addressed in the entries were not always selected for inclusion. While there are many
reasons that a systematic review may or may not be cited (e.g. perceived quality), UpToDate
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does not provide an explicit statement of how evidence is selected for inclusion.
Across the eight entries, only two qualitative studies were cited, one each in the IPV
and CGB cases. In order to gain an understanding of the availability of qualitative research
that address the case topics, PubMed was searched using search strings targeted at identifying
qualitative research studies and meta-analysis. (Table 3, Chapter 3 outlines the search
strategies used.) All searches except AGA retrieved highly relevant and focused qualitative
research on the treatment of the conditions. The qualitative research retrieved on male
alopecia were related to hair loss as a symptom of another condition (e.g., cancer). Grief and
bereavement (subject headings did not differentiate between complicated and normal grief)
and IPV had the highest number of available qualitative studies. Meta-analyses of qualitative
research were available for the topics of fibromyalgia, chronic fatigue syndrome, grief and
bereavement and intimate partner violence, but not cited in the entries.
Case

MeSH Term

Qualitative

Qual. Meta-

Studies

Syntheses

AOM

"Otitis Media"[Majr]

3

0

AGA

"Alopecia"[Majr] AND "male"[MeSH Terms]

3*

0

IBS

"Irritable Bowel Syndrome"[Majr]

14

0

FIB

"Fibromyalgia"[Majr]

19

3

CFS

"fatigue syndrome, chronic"[Majr]

25

3

N/CGB

("Grief"[Majr]) OR "Bereavement"[Majr])

77

4

IPV

"Domestic Violence"[Majr]

167

6

Table 10: Qualitative Research Assigned with Topic Subject Headings as Major
Subject
Location of Study. There were 237 articles describing research studies cited across
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the eight entries. The majority of studies (58%) were located in the United States. The
breakdown of what continent each study was conducted in is presented in Table 11. Studies
located in North American and Europe made up 96% of all studies cited across cases. The
content of all eight entries in UpToDate was written by authors situated in the United States.
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Author

North

United

s’

Americ

States

Countr

a

Europe

Austral

Asia

ia

Multi-

Unkno

nationa

wn

l

y
AOM
n=48

AGA
n=30

IBS
n=60

FIB
n=60

CFS
n=33

NGB
n=6

CGB
n=23

IPV
n=7

Total
n=237

United

60%

56%

29%

2%

4%

6%

0%

States

(29)

(27)

(14)

(1)

(1)

(3)

(0)

United

70%

67%

10%

0%

10%

7%

3%

States

(21)

(20)

(3)

(0)

(3)

(2)

(1)

United

45%

43%

28%

8%

15%

3%

0%

States

(27)

(26)

(17)

(5)

(9)

(2)

(0)

United

72%

53%

20%

0%

2%

7%

0%

States

(43)

(32)

(12)

(0)

(1)

(4)

(0)

United

36%

36%

53%

0%

0%

3%

0%

States

(12)

(12)

(19)

(0)

(0)

(1)

(0)

United

33%

33%

67%

0%

0%

0%

0%

States

(2)

(2)

(4)

(0)

(0)

(0)

(0)

United

60%

57%

22%

4%

4%

8%

0%

States

(14)

(13)

(5)

(1)

(1)

(2)

(0)

United

86%

86%

0%

14%

0%

0%

0%

States

(6)

(6)

(0)

(1)

(0)

(0)

(0)

65%

58%

31%

3%

5%

0%

0%

(154)

(138)

(74)

(8)

(12)

(0)

(0)

Table 11: Location of Study of Clinical Trials
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Authorship. The 427 references cited across the eight entries were written by a total
of 2230 authors. Among these, the highest known proportional representation (.39) of the
authors were Medical Doctors (MDs) followed by Basic Scientists (.17) (see Table 12). The
relative proportions of physicians across the eight entries are represented in Figure 23. The
Acute Otitis Media entry had the highest relative proportion (0.56) of physician authors,
while the Normal Grief and Bereavement had the lowest relative proportion (0.16).
Basic
# of

Not

Pharm- Public
MD

Nurse Scientis

Authors Known

Prof
Other

acist

Health

Org

t
AOM
(82)
AGA
(41)
IBS
(89)
FIB
(91)
CFS
(46)
NGB
(20)
CGB
(30)
IPV
(28)
ALL
(427)

376

0.25

0.56

0.01

0.08

0.01

0.00

0.02

0.06

203

0.28

0.51

0.01

0.13

0.01

0.01

0.02

0.02

534

0.54

0.33

0.00

0.08

0.00

0.00

0.03

0.02

531

0.38

0.41

0.00

0.17

0.00

0.01

0.03

0.00

259

0.38

0.32

0.01

0.25

0.01

0.01

0.02

0.00

88

0.52

0.16

0.00

0.25

0.00

0.00

0.01

0.05

127

0.60

0.18

0.00

0.22

0.00

0.00

0.00

0.00

108

0.21

0.17

0.06

0.20

0.00

0.01

0.03

0.22

2226

0.35

0.39

0.01

0.17

0.01

0.01

0.03

0.04

Table 12: Background of Authors Across the Eight Cases
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Relative Proportion of Authors
with a Physician (MD) Background

0.6
0.5
0.4
0.3
0.2
0.1
0

AOM

AGA

IBS

FIB

CFS

G&B

CGB

IPV

Figure 23: Relative Proportion of Authors with Physician Background
Because the publication in core journals and the presence of physician authors
followed a similar pattern across the cases, a two-sample t-test was conducted to determine
whether there is a relationship between the proportion of physician authors and the
publication in a journal identified as a core by UpToDate. The t-test indicates that the mean
relative proportion of authors with a physician background was higher in cited articles
published in core journals (M=.447, SD=.4) than in non-core journals (M=.2864, SD=.4,
t(283)=3.87, p < .001, d = .16). (Note that Levene’s test indicated unequal variances (F =
6.16, p = .433), so degrees of freedom were adjusted from 425 to 283).
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Cross-Case Textual Analysis
Situating the Authors. The degree to which the authors position themselves within
the content varies greatly across the eight cases. As an indicator of this variance, the terms
‘we’ and ‘our’ were used 34 times in the Fibromyalgia entry, but never used in the
UpToDate entry for Intimate Partner Violence.
The UpToDate authors position themselves in the content and share their expertise
via the recommendations sections of the entries, although the frequency of explicit
recommendations varied across the eight entries. Only the authors of the IPV entry chose not
to make explicit recommendations using the phrases “we recommend” or “we suggest.” In
the entries for Androgenetic Alopecia and Chronic Fatigue Syndrome, the authors only
offered an explicit recommendation once. In contrast, recommendations were denoted with
either the phrase “we recommend” or “we suggest” by the authors of the Acute Otitis Media,
Fibromyalgia, and Irritable Bowel Syndrome cases 22, 16, and 15 times, respectively. The
remaining three cases used the explicit phrases between three and 10 times.
When authors provided explicit recommendations they did so most often by
addressing the tailoring of treatments to meet patient needs or by providing details as to how
to best operationalize treatment regimens:
We suggest initiating therapy with a low dose of a tricyclic
medication (eg, amitriptyline 10 mg) at night time, especially since
these drugs are effective, widely available, and far less costly for
most patients than some of the newer agents. (FIB)
This focus on details about how and to whom to deliver treatment regimens was common
across the recommendations provided by authors. In the case of IBS, however, the details
included in the recommendations focused overwhelmingly on the authors’ approach to the
order of and execution of treatments following up from ineffective or incompatible
treatments:
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In patients with IBS with constipation (IBSC) who have failed a trial of
soluble fiber (eg, psyllium/ispaghula), we suggest polyethylene glycol
(PEG). We treat patients with persistent constipation despite treatment
with PEG with lubiprostone or linaclotide. (IBS)
Because of the differences among IBS patients, particularly in terms of their symptoms and
their responses to treatments, these patients often undergo multiple attempts to find treatment
success. The recommendations provided by the authors are intended to assist physicians to
navigate treatment options over the course of multiple failed treatment attempts. Likewise,
the entries for Chronic Fatigue Syndrome and Fibromyalgia refer to the need to try multiple
treatment strategies, although the ordering of attempts was not explicit in these entries.
In addition to the explicit recommendations indicated by the phrases “we
recommend” or “we suggest,” the authors also endorse treatment approaches implicitly by
sharing their approaches to care used within their own practices. For example, the authors of
the Normal Grief and Bereavement entry implicitly advise against using benzodiazepines for
patients without mental disorders: “For bereaved individuals who do not have mental
disorders, we generally do not use benzodiazepines” (NGB). Similar to explicit author
recommendations, the accounts of the authors’ practices also include specific details about
how the authors implement treatment. For example, in the Fibromyalgia entry, the authors
provide details about the ways in which they introduce and increase the drug Milnacipran for
the treatment of fibromyalgia:
Milnacipran is an alternative to duloxetine in patients with severe fatigue in
addition to pain. We initiate therapy with 12.5 mg each morning, gradually
titrating as tolerated to 50 mg twice daily. Some patients will require a higher
dose; up to 100 mg twice daily may be needed … In those patients with more
severe problems with sleep, we use pregabalin taken at bedtime. (FIB)
The authors’ personal accounts of how they provide care for their patients convey an implied
endorsement of those practices. This sharing of expertise was common in six of the eight
entries: Acute Otitis Media, Irritable Bowel Syndrome, Fibromyalgia, Chronic Fatigue

175
Syndrome, Normal Grief and Bereavement, and Complicated Grief.
Though some recommendations were followed up with supporting evidence
(discussed in detail below in the Situating the Evidence section), explicit recommendations
were also provided in lieu of or in the absence of strong evidence in the entries for Acute
Otitis Media, Irritable Bowel Syndrome, and Fibromyalgia. The Acute Otitis Media entry
provides a good example of authors providing a recommendation in the absence of strong
evidence:
There are no randomized trials to guide treatment of recurrent AOM in
children. […]
When recurrence occurs within 30 days of completion of antimicrobial
treatment for the previous episode, we suggest [list of antibiotics]. (AOM)
Similarly, the authors of the entry for fibromyalgia concede that there is limited evidence for
the drug gabapentin; however, they do acknowledge their own use of the drug as an
alternative to pregabalin:
We use gabapentin, for which evidence is more limited, as an alternative to
pregabalin in patients for whom cost of the medication or regulatory
requirements limit the use of pregabalin. (FIB)
The entries for Acute Otitis Media, Irritable Bowel Syndrome and Fibromyalgia all contained
authors’ recommendations in spite of a lack of clear evidence. These recommendations are in
line with the UpToDate editorial policy, which states: “When there is no published
systematic evidence available (e.g., prednisone dosing regimen in pulmonary sarcoidosis),
recommendations are based on the unsystematic clinical observations of our experts and
reviewers, and on pathophysiologic rationale” (UpToDate, “Editorial Policy”, 2017).
In the Fibromyalgia entry, the sharing of expertise extended beyond implicit and
explicit recommendations. Here, the authors provided insight about what they have learned
from their experiences and ultimately made comparisons between their own experiences and
the outcomes of clinical trials. When the authors shared knowledge acquired from their
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experiences, they framed that knowledge using the phrase “in our experience.” For example,
the authors share elements of patient education that they have found to be helpful: “In our
experience, a discussion of the role of muscle ‘spasm’ and deficient muscle blood flow is
useful when prescribing exercise and physical therapy” (FIB). The use of the phrase “in our
experience” makes it clear that this knowledge is coming from their patient encounters.
The authors of the Fibromyalgia entry are also forthcoming about disconnects
between their own experiences with patient care and the results and conclusions garnered
from clinical research. For example, they point out that: “In practice, it has been difficult to
start and maintain fibromyalgia patients in a structured cardiovascular exercise program,
because patients generally perceive that their pain and fatigue worsen as they begin to
exercise” (FIB). Nevertheless, exercise remained a key recommendation for treatment based
on clinical studies. The authors also refer to their own tacit knowledge: “Despite the clinical
trial efficacy, in ‘realworld experience’ the majority of fibromyalgia patients do not achieve
great benefit from any single medication” (FIB). Here it is not the clinical trial but the realworld experience of the authors that is used as evidence for ineffectiveness.
In the entries addressing Intimate Partner Violence and Normal Grief and
Bereavement, explicit recommendations or sharing of expertise by the authors are largely
absent. However, within these entries there is also substantial content for which the origin of
knowledge is unclear and not attributed to a source—neither published evidence nor the
authors’ tacit knowledge. For example, the authors provide accounts of how people
experience may react. Similarly, the authors of Intimate Partner Violence describe the
complexities of providing care for the victim experiencing IPV. The authors here provide
insight into what clinicians may witness from patients experiencing these challenges, in turn,
tell the reader what the physician should do.
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The entry for Intimate Partner Violence was different from all other entries in that the
authors did not once refer to themselves as “we”. In all other entries, ’we’ references were
connected to an explicit or implicit recommendation. In the entry for Chronic Fatigue
Syndrome, the authors apply the term “we” in a unique way not seen in any other entries.
They twice describe the collective community of clinicians and researchers, in which they
themselves and the reader belong, in this way. Specifically, the authors encourage clinicians
to “… emphasize [to the patient] that we have considerable knowledge and experience with
SEID/CFS” (CFS).
Situating the Evidence. The descriptive analysis of the eight entries demonstrates the
dominance of sources of evidence from the Study level of the 6S hierarchy in the UpToDate
content. While synthesized resources are encouraged, systematic reviews and meta-analyses
are much less common in the entries than are individual studies, even when these are
available. There was considerable variability in the extent to which authors provided details
about and descriptions of the studies and systematic reviews cited in the entries. For some
evidence, no description was provided, but rather only a parenthetical reference following a
statement arising from the source conclusions; for others the authors provided extensive
details about all four elements of the clinical question: the patient, the intervention, the
comparators and the outcomes (PICO). The outcomes of the study sometimes appeared to
affect the level of detail provided about it. For instance, in the entry for acute otitis media, a
single meta-analysis that demonstrated benefit of antibiotic care was described in
considerable detail while the description of five systematic reviews that do not support the
use of antibiotics was captured in a single sentence.
A common attribute often included is the descriptions of a study’s design, particularly
those using randomized controlled trials, the ‘gold standard’ in EBM hierarchies. The quality
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and certainty of the results presented in the entries appear to rely heavily on this type of
study, e.g.:
No randomized trials have demonstrated that antidepressants are efficacious
for complicated grief, and these drugs are often not used. However, several
small observational studies suggest that these drugs may be helpful. (CGB)
In this instance, randomized trials are presented to demonstrate effectiveness, while
observational studies suggest effectiveness. The inclusion of study design emphasizes the
importance placed on RCTs as a source of certainty. The authors also emphasized
information that was based on conclusions from systematic reviews.
The authors’ choice to highlight study attributes when citing RCTs contrasts sharply
with their treatment of qualitative studies. Only two qualitative studies were cited across the
cases, one in the Intimate Partner Violence entry and the other in the Complicated Grief &
Bereavement entry. In neither instance was the qualitative nature of the study design
acknowledged by the authors, nor was any information about the study provided other than a
parenthetical reference. The authors also rarely acknowledged the type of resource used if
they cited sources not included as evidence within 6S hierarchy. For example, the authors of
the Irritable Bowel Syndrome entry note that “Patients with IBS should be advised to exclude
foods that increase flatulence (e. g., beans, onions, celery, carrots, raisins, bananas, apricots,
prunes, Brussels sprouts, wheat germ, pretzels, and bagels), alcohol, and caffeine” without
acknowledging that the source of this information is the Textbook of Gastroenterology.
While the UpToDate Editorial Policy acknowledges that in some instances “the type of study
or the data are not stated explicitly,” there does appear to be a pattern in what authors chose
to highlight (or not).
In addition to underlining the PICO elements and study design of evidence, the
authors’ descriptions of the evidence often extended to include depictions of shortcomings
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within individual research studies and deficiencies within the evidence base as a whole. The
authors of the entries provided caveats on individual studies based on shortcomings or
limitations of the research design:
However, the results of this study should be interpreted with caution due
to methodological limitations and small sample size. (IBS)
However, many of the studies included in the meta-analyses had increased
risk of bias (related to nonstringent diagnostic criteria, inclusion of children
with mild disease, exclusion of patients <2 years of age, use of an
inappropriate antibiotic or inappropriate dose, etc), making the results difficult
to interpret. (AOM)
Across the seven cases authors also point out where more studies and attention are needed to
create a stronger evidence base and advocate prudence when they consider evidence to be
uncertain or inconclusive.
The authors’ choice to use particular evidence is evident throughout the cases. At
times, they are transparent about their selection of what they consider to be the best example
from the evidence available to them. For example,
The efficacy of these agents was best described in a metaanalysis of five
placebocontrolled randomized trials (four with pregabalin and one with
gabapentin) consisting of 2918 patients with fibromyalgia. Compared with
placebo, active therapy significantly reduced pain and improved sleep and
quality of life. Evidence in support of the efficacy of each agent is described
separately below. (FIB)
Likewise, when making recommendations, the authors follow a similar pattern, first
providing their recommendation for treatment then following up with evidence that supports
that recommendation. For example, the authors of the Acute Otitis Media entry recommend
against the use of decongestants and antihistamines and then provide support for the
recommendation with evidence:
We recommend not using decongestants and/or antihistamines in the
symptomatic management of AOM in children.
Studies of the efficacy of antihistamines and decongestants in treating
AOM suggest a lack of benefit and a potential for delayed resolution of
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middle ear fluid. A 2007 systematic review found that decongestants and
antihistamines alone or in combination were associated with increased
medication side effects and did not improve healing or prevent surgery or
other complications in AOM [cited reference, systematic review]. In
addition, treatment with antihistamines may prolong the duration of middle
ear effusion [cited reference, study]. (AOM)
Here, the authors supported their recommendation against these two classes of drugs with
descriptions of studies and systematic reviews that demonstrate a lack of benefit and the risk
of side effects. The sequence of providing a recommendation and then supporting evidence is
common in the entries for Acute Otitis Media, Fibromyalgia, and Irritable Bowel Syndrome,
where recommendations lead the content. The authors of all eight entries acknowledge that
multiple treatments have been evaluated unsuccessfully for effectiveness (particularly so in
the entry for Chronic Fatigue Syndrome) and compare their approaches with clinical practice
guidelines provided by key associations.
Situating the Physician-Patient Relationship.
The authors make overt reference to the physician-patient relationship in the entries
for Irritable Bowel Syndrome and Chronic Fatigue Syndrome. The authors in the Irritable
Bowel Syndrome entry advocate that physicians establish a “therapeutic clinician-patient
relationship” as a key component of treatment. Details about the relationship include
validation, patient education, and shared decision-making. Similarly, a supportive approach
is identified as a treatment strategy in the Chronic Fatigue Syndrome entry, where the
authors emphasize the importance of providing validation, being honest, addressing patients’
concerns without engaging in unhelpful debates and demonstrating a commitment to
patients’ treatment process. The overt naming of the physician-patient relationship as a
component of treatment and care occurs only in these two entries.
While not overtly named, the relationship between physician and patient is also a core
component of the entries for Intimate Partner Violence and Normal Grief and Bereavement.
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Intervention in both conditions focuses on interactions between patient and clinician. For
normal grief, physicians are described not as a main source of bereavement support, but a
rather natural and important one. Support “for acute grief typically includes empathic
listening, information about the wide range of typical grief symptoms, reassurance, and
monitoring.” (NGB). Similarly, the IPV entry emphasize key components of the physicianpatient interaction:
The immediate expression of empathy, acknowledgement, and continued
ability to support and assist the patient are the most important components of
care after a patient has disclosed abuse. (IPV)
A feature unique to both of the Intimate Partner Violence and Normal Grief and
Bereavement entries is the provision of authors’ guidance to the reader about how to deliver
messages of support.
Validation of the condition as a real illness was a key theme in the entries for Irritable
Bowel Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, and Complicated Grief and
Bereavement. In each of these entries, the physicians’ role in reassuring the patient that they
have a real illness was underlined and emphasized. The authors suggest that patients
experience a sense of relief when they have a diagnosis of a “treatable condition” (CGB).
While not an illness, the importance of validation is also recognized in the entry for Intimate
Partner Violence. Validation is a key element of care across five of the eight entries.
With respect to decision-making, two of the entries place responsibility with the
patient. In the IBS entry, the authors call explicitly for the involvement of the patient in
decision-making: “The clinician should establish realistic expectations with consistent limits
and involve the patient in treatment decisions” (IBS). In the IPV entry, decision-making is
situated overtly and solely as the responsibility and right of the victim. Here, the authors
underline repeatedly that the patient’s autonomy and choice is paramount. They advocate
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that: “Patients should be allowed to make autonomous decisions regarding health advice”
(IPV). In contrast, in six of the eight entries, the primary responsibility for decision-making
is implicitly or explicitly situated with the physician. Presenting decision-making as the sole
responsibility of physicians conflicts with key clinical practice guidelines including those of
the American Academy of Pediatrics and the American Academy of Family Physicians.
Throughout all eight entries, the authors develop content for physicians rather than a
wide variety of health care providers. The majority of the care, including pharmaceutical
treatments, described in the eight entries is treatment delivered by physicians, although the
authors of the entries for Irritable Bowel Syndrome, Fibromyalgia, Chronic Fatigue
Syndrome, and Intimate Partner Violence do acknowledge the need for care beyond that
provided by physicians. For example, the authors of the Irritable Bowel Syndrome entry
mention the need for professional dieticians to provide dietary education if patients are
placed on a low FODMAP diet. Similarly, the authors of the Chronic Fatigue Syndrome
entry call for an exercise therapist to supervise a graded exercise therapy program. The
entries for FIB and IPV advocate for interdisciplinary care more broadly. For example:
“Ideally, treatment should include an integrated, multidisciplinary
nonpharmacologic and pharmacologic approach, but there have been
relatively few trials that have formally evaluated such a combined approach to
therapy.” (FIB)
The authors of the IPV entry also advocate for care by multiple professionals asserting, “Care
of the patient experiencing IPV requires a team approach involving medical, institutional,
and community resources” (IPV). While the content does not address the delivery of
treatment and care delivered by professionals across the health professions, there is
recognition of need for interprofessional care.
The analysis of the patient information provided in the entries for Acute Otitis Media,
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Fibromyalgia 7, Chronic Fatigue Syndrome, and Irritable Bowel Syndrome further provides
insight into the positioning of the patient within UpToDate. The patient information for these
four conditions both diverges from and converges with the clinician information
(interestingly, no patient information is provided for the entries for Normal Grief and
Bereavement, Complicated Grief, or Intimate Partner Violence).
Like the clinician information, the patient information for Fibromyalgia, Chronic
Fatigue Syndrome and Irritable Bowel Syndrome acknowledge that there are treatments to
alleviate symptoms, but physicians are not currently able to cure these conditions. Similarly,
the lack of understanding and knowledge about these conditions is highlighted. For example,
the Beyond the Basics patient information for FIB states that “despite ongoing research, the
cause, diagnosis, and optimal treatment of fibromyalgia are not clear” (Beyond FIB). CFS
advice repeatedly highlights the authenticity of the condition and validates the patient
experience. The long-term trial and error nature of treatment for IBS is acknowledged in the
patient information. Patients with IBS are encouraged to be open to treatment options, but
recognize the need for long-term management.
Compared to the clinician entries, decision-making is presented as a more
collaborative process in the patient information for FIB, CFS, and the Basics patient
information for AOM. Patients are encouraged explicitly to communicate with their health
professionals and to work together as a team. In contrast, the responsibility for decision
making in the clinician entry and the AOM Beyond the Basics is assigned primarily to
physicians.
The central role of patients in non-pharmacological approaches to treatment is

7

Because the content of the Beyond the Basics was directed towards clinicians and written at a very
high level of sophistication, the cross-case analysis focuses on The Basics patient information for
Fibromyalgia included in UpToDate
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emphasized in the patient information for AOM (i.e., monitoring, follow-up), IBS (i.e.,
exercise, symptom monitoring, dietary modifications), FIB (i.e., maintaining a positive
attitude, exercising), and CFS (i.e., exercise). For example, patients are encouraged to
understand, monitor, and alter their fibre intake: “By reading the product information panel
on the side of the package, you can determine the number of grams of fiber per serving”
(IBS, Beyond). While patients are rarely recognized as decision-makers, the patients are
encouraged to take an active role in their care through non-pharmacological treatments.
These patient activities and roles are similarly emphasized in the main clinical entries.
Although largely absent in the clinician entries, psychological elements and factors
are overtly acknowledged in the patient information for AGA, IBS, FIB and CFS. There were
also other examples of divergences between the clinicians’ entry and patient information
provided by UpToDate. For instance, in the AOM Beyond the Basics patient information,
the authors included the side effects and risks of antibiotic use, although this was absent in
the information for clinician. Similarly, only in the Beyond the Basics entry is the preference
to try non-pharmacological approaches for treating IBS prior to medications recommended.
It is possible that such discrepancies between the information directed toward clinicians and
patients may contribute to misunderstandings during the clinical encounter.
Circuit of Culture
In order to bring insight to the position and meaning of UpToDate in medical and
information fields, Hall’s Circuit of Culture was applied to the cross case analysis.
Specifically, an increased understanding of UpToDate emerges using the five elements of the
Circuit of Culture: representation; production; consumption; identity; and regulation (du Gay
et al., 1997).
UpToDate is a commercial product that evolved from an identified need and
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opportunity within medical practice (production). Specifically, the producers and publishers
of UpToDate responded to the observation that medical doctors were confronted with
countless clinical questions that require nuanced approaches. Concurrently, physicians were
faced with an overabundance of research-based evidence, and the emerging imperatives of
evidence-based practice, that required intense translation to be deemed applicable for clinical
practice. In response, UpToDate was developed to sell evidence packaged by physicians, for
physicians. UpToDate recognized the value that physicians place on consultations with other
physicians as a source of information and expertise; as such, the product is closely associated
with physician-experts as content producers. UpToDate represents clinicians’ desire for
certainty in clinical decision-making (representation). Physicians’ certainty is increased by
invoking the available evidence as part of recommendations made by fellow physicians,
themselves recognized as topic experts.
While the creators do not publish a systematic and explicit framework or policies for
the development of content in UpToDate, the content is organized and regulated by the
norms and conventions of EBM, including evidence hierarchies (regulation). For example, as
noted above, the principles of EBM most value systematic reviews and randomized
controlled trials, and therefore privilege such sources for inclusion in the point-of-care tool.
UpToDate is used by students and clinicians faced with clinical uncertainty (consumption),
and, laterally, by patients (directly or via their physicians). Physicians and medical students
(largely unquestioningly) accept and use UpToDate as its creators intended it, as an
evidence-based clinical tool. This use aligns with Hall’s concept of the ‘preferred reading,’
meaning that the audience (i.e. the users of UpToDate) use the product the way the producers
intended (Hall, 1980). UpToDate closely identifies itself with the author-experts. UpToDate
is thus marketed as “an evidence-based, physician-authored clinical decision support
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resource which clinicians trust to make the right point-of-care decisions” (UpToDate, “About
Us,” 2017). While UpToDate is marketed and consumed as an evidence-based tool, the
notion that it is produced and consumed by trustworthy and responsible physician-experts is
central to the identity of UpToDate (identification). The experience and status of the authors
is underlined by UpToDate: “Although these physicians serve on the faculty of prestigious
medical schools, practice medicine, and in some cases conduct groundbreaking research, they
repeatedly carve time from their demanding schedules to contribute to UpToDate”
(UpToDate, “Physician Authors and Editors,” 2017). For UpToDate, the authors’ identity as
trusted and prestigious experts is key to bringing together evidence and practice for
practicing physicians.
Summary of Results
Evidence Selection
In the absence of transparent, clear, and systematic guidelines for the production of
content for UpToDate, the selection of evidence is loosely aligned with the commonly
accepted guidelines of evidence-based medicine. For example, systematic reviews and
clinical trials highly valued within evidence hierarchies were commonly privileged for
selection by UpToDate authors. In contrast, evidence sources often overlooked in evidence
hierarchies (such as qualitative research) were very rarely included.
Authors selected evidence for their entries from a large corpus of research. In order to
better understand what is overlooked or omitted as evidence for UpToDate, searches aimed at
understanding the body of literature from which evidence was selected were completed. For
each topic two targeted searches were performed: one to identify systematic reviews
addressing clinical questions similar or the same as those addressed in the entry, and one to
identify qualitative research on the topics of the cases. The availability of systematic reviews
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and qualitative research varied across the topics. For example, the UpToDate entry for
fibromyalgia cited the most systematic reviews, yet the targeted search still identified the
highest number of potentially relevant systematic reviews that had not been cited. In contrast,
while the fewest systematic reviews and the greatest number of clinical trials were cited in
the entry for androgenetic alopecia, no additional systematic reviews were identified in the
targeted search. Despite a robust body of clinical trials there appeared to be a dearth of
systematic reviews available on the topic. For androgenetic alopecia, this lack of systematic
reviews may reflect the commercial investment in trials of treatment, but not the synthesis of
the trials. This analysis demonstrated that additional systematic reviews addressing clinical
questions similar to those addressed in the entry were available. However, in the absence of
clear guidelines by UpToDate, the reasons reviews were or were not cited are not known.
The targeted searches indicated that availability of qualitative research varied for each
topic. Not surprisingly, searches identified the largest bodies of qualitative research for the
topics of grief and bereavement and intimate partner violence, both of which have prominent
social, emotional, and psychological features. Qualitative meta-analyses, which aims to
synthesize a large body of qualitative studies, were also identified for the topics of
fibromyalgia, chronic fatigue syndrome, grief and bereavement, and intimate partner
violence. Although qualitative research was often available, across the eight topics, only two
qualitative studies were cited (neither of which were syntheses). Qualitative research helps to
provide increased understanding of the patient experience of illness from the patient
perspective, and this knowledge is largely absent from the content of UpToDate.
In addition to methodological approaches to research, other commonalities also
existed across the evidence selected for inclusion. For example, although the authorship of
the evidence cited was made of up many professional backgrounds, the voice of the
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physician was dominant. . Only in the cases of Grief and Bereavement and Intimate Partner
Violence did non-physician authors equal or slightly exceed the numbers of physicianauthors. The journals that UpToDate identified as key journals for evidence selection (core
journals) were heavily called upon and also further favoured the physician voice. Not
surprisingly, the physician-authors favoured the expert voice of fellow physicians. The
favouring of like-voices also transferred to the location of the studies cited. The content of all
eight entries was written by physicians situated within the United States. Similarly, research
that was located with the context of the United States was more commonly cited than
research undertaken in other countries. While research is often transferrable across sites, it is
reasonable to expect that the availability of drug and treatment options and coverage may
vary across nations. This is noteworthy because UpToDate is widely marketed for use around
the world. UpToDate is used by physicians in more than 187 countries across the globe
(UpToDate, “Around the Globe”, 2017). While the content of UpToDate is only available in
English, the search is available in nine languages. The emphasis on American authorship and
research seems a divergence from the international marketing focus.
Situating the author, the evidence, and the patient-physician relationship
Authors situated themselves as experts sharing their knowledge and guidance within
the entries. Suggestions and professional guidance, made explicitly or implicitly, by the
authors often focused on operationalizing treatment regimes in practice to meet the needs of
individual patients. Author recommendations for treatment were also provided when the
literature base lacked strong evidence to address a clinical question. How the authors position
themselves in the content varied across the eight cases. For example, much of the content of
the entry for Acute Otitis Media was situated as emerging from the authors’ expertise. In
contrast, the authors of the entry for Intimate Partner Violence referred explicitly to
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themselves as a source of expertise only once. While some authors appear to be cautious
about positioning themselves explicitly, their experiences, expertise, and tacit knowledge are
present within all eight entries.
The evidence selected by the authors for inclusion in the entries was generally
situated within the entry as support for the authors’ implicit and explicit recommendations.
For selected evidence, the authors’ provided detailed descriptions of the study design, patient
population, and outcomes of the research. Robust descriptions often were included for
clinical trials and systematic reviews which clearly supported authors’ recommendations.
Authors sometimes provided commentary on the quality and quantity of evidence available
on the topics. In the absence of a clear and consistent framework for the topics, the authors
selected, presented, and used the evidence in ways that supported their approach and their
recommendations.
The patient-physician relationship was not situated prominently across the entries.
The patient’s role in decision-making was nearly absent across the entries, with the exception
of the entries for Intimate Partner Violence and Irritable Bowel Syndrome. The importance
of the physicians’ role in validating the condition as ‘real’ was a key element for entries for
the more contested conditions: Irritable Bowel Syndrome, Fibromyalgia, Chronic Fatigue
Syndrome, and Complicated Grief. Where included, the patient information provided
additional insight as to how the patient is situated in UpToDate, but key elements of the
patient-physician relationship, such as decision-making responsibilities, sometimes appeared
to contradict content in the expert entry.
The Circuit of Culture and the Emergence of Expertise
Applying the Circuit of Culture provides additional understanding of the position and
meaning of UpToDate within the health and information environments. UpToDate is
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represented and consumed as an evidence-based clinical tool; however, concurrently,
expertise emerges prominently across the five elements of the Circuit of Culture:
representation, production, consumption, identity, and regulation. UpToDate is produced for
physicians, by physicians and the analysis using Circuit of Culture suggests that expertise is
an important facet in securing the meaning and position of UpToDate in the health
information environment. The content producers of UpToDate do not follow a rigid
framework as often associated with evidence based medicine resources. Instead, they
interpose their experience and expertise with the evidence in order to increase the
applicability of evidence to clinical practice. The emergence of expertise across the five
elements of the Circuit of Culture points to ways in which UpToDate may bridge evidence
with the realities of clinical practice.
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Chapter 4: Discussion and Conclusion
Discussion
Findings from this study illustrate what evidence and whose voices are privileged in
the process of creating clinical guidance for the widely used information tool, UpToDate.
The analysis of the seven cases reveals that physician-authors are situated not only as writers
and creators, but also as sources of expertise. While the ways in which the authors enact or
position their expertise varies, the authors incorporated their own recommendations,
suggestions, and clinical experiences, as well as their tacit knowledge into each of the entries
studied. In the absence of explicit guidelines, the authors chose evidence to support their
recommendation, loosely adhering to the principles of evidence-based medicine. The
permeation of expertise across the five components of Hall’s Circuit of Culture reinforces the
importance of expertise in UpToDate. From the overall analysis, UpToDate emerges as a
potential surrogate for consultation and knowledge-sharing between physicians, traditionally
performed through face-to-face interactions. Specifically, those engaged in the production of
UpToDate are not simply intermediaries who replicate information, but rather are mediaries
who transform, translate, and modify information for consumption (Latour, 2005). Through
the mediary functions of the producers, UpToDate becomes a technological surrogate and
performs the roles of ‘Curbside Consultant’ and ‘Mentor’.
UpToDate within the EBM Landscape
Although evidence-based medicine was conceived by David Sackett as an approach
to practice that promoted the application of evidence within the context of clinical judgement
and patient needs and preferences, it quickly evolved into a structured set of rules and
guidelines that privileged and excluded certain types of information and knowledge. While
the focus on evidence was intended to move clinical practices away from anecdotes, habits,
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and traditions, the first decade of the evidence based medicine movement created an
overabundance of evidence that had limited application to clinical settings. Clinical trials,
synthesized bodies of trials, algorithms, and rules have not been able to adequately address
the complex realities facing individual patients. As such, in recent years, the value of
applying a broader range of knowledge to clinical questions, beyond the data provided by
studies, is increasingly being integrated into the practices of evidence-based medicine.
Likewise, there is an increased recognition of the uncertainty inherent in evidence, as well as
appreciation of the importance of psychosocial elements of care, patient experiences, and the
physicians’ expertise. In the last decade, new models are evolving in order to integrate
expertise and uncertainty into evidence tools in a systematic way. One such example is
GRADE, the Grading of Recommendations Assessment, Development and Evaluation
approach, which produces a rating of the quality of a recommendation based on transparent
criteria of the evidence including study design, risk of bias, imprecision, inconsistency,
inconsistency, indirectness, and magnitude of effort (Guyatt, Oxman, Vist, Kunz, FalckYtter, Alonso-Coello, et al., 2008), while also considering issues such as acceptability (to
providers and patients), feasibility and equity. The systematic and transparent process leads
to the classification of recommendations along a continuum, from conditional to strong,
which also leaves room for the emergence of new, potentially different, evidence and
knowledge.
In seven of the eight entries analysed in this study, the UpToDate authors applied a
final assessment of the evidence with a GRADE ranking, but the structured process was not
applied or shared. Similar to the ways that evidence is selected following overarching EBM
principles in the absence of an explicit and systematic process, the comprehensive and
transparent steps of the GRADE process were not followed. Instead, the authors loosely
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applied these principles, choosing to address and expand the evidence through their own
narratives, tacit knowledge and expertise. This expertise appears to emerge as a critical
component of UpToDate’s capacity to bridge evidence and practice.
The Emergence of Mediary Roles
Examining how physician expertise permeates the five components of the Circuit of
Culture is useful for understanding the techno-social aspects of clinical practice tools, such as
UpToDate, which can act as surrogates for traditional physician interactions and knowledge
sharing in face-to-face contexts. As Champ and Brooks (2010) explain:
those promoting the circuit of culture argue that, even more than recognizing
these separate locations of meaning-making activity, we must attempt to
account for the interrelation of the five processes of representation, identity,
production, consumption, and regulation… It is the researcher’s task to
identify and describe how particular meanings result from the overlap of these
processes. (pp. 576-577)
A key role of UpToDate authors, the content producers, is to provide expertise to the
consumers of the UpToDate product. Expertise, in turn, becomes an important element of the
representation, identity, and regulation of the tool. Through the provision of expertise, the
authors of UpToDate are not simply intermediaries who reproduce information without
modification, but rather, are mediators who transform, distort, translate and modify the
meaning of the information they convey (Latour, 2005). Content producers are mediators
positioned “between the information sources [the evidence] and the information seekers
[physicians]” (Wyatt, Harris & Wathen, 2008). In 2008, Wyatt, Harris, and Wathen used this
framework to construct the concept of info(r)mediation wherein health information (or in this
case, evidence) is translated and transformed to effect changes in thinking, behaviour, or
attitude. In this case, the physician-authors of UpToDate attempt to effect change in, or at
least guide, others’ clinical practice.
The overt recognition of the mediator function of the content producers is critical
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because the hierarchies, rules, and guidelines of EBM can “become a form of collective
forgetting, or naturalization, of the contingent, messy work that they replace” (Bowker &
Star, p. 299). Providing evidence to guide physicians in answering multifaceted clinical
question is “messy work” and can often be concealed by the presentation of EBM’s
somewhat facile rules and frameworks (Wieringa, Engebretsen, Heggen & Greenhalgh,
2017). To recognize content producers and the subsequent technologies/tools that collect and
share medical evidence not as intermediaries, but as mediators, ensures that the social
elements and the complexity of the process of creating ‘practice-ready’ advice are
acknowledged.
Through their sharing of clinical experiences, expertise, and judgement, UpToDate’s
authors are key mediators who exist between the evidence and the information users and are
integral to creating a technological surrogate for key physician interactions, specifically, as a
Curbside Consultant (Findling, Shaker, Brickner, Riordan & Aron, 1996; Kuo, Gifford &
Stein, 1998) and as a Mentor (Balmer, D’Alessandro, Risko, Gusic, 2011; Taylor, Taylor &
Stoller, 2009).
UpToDate as Curbside Consultant
In much of the content analyzed in the cases included in this study, authors are
prominent not only as the selectors and interpreters of evidence and content, but as sources of
clinical expertise. The UpToDate Editorial Policy highlights that evidence is not enough to
make decisions, but rather clinical expertise “is required to move from evidence to
recommendations” (UpToDate, “Editorial Policy,” 2017). Further, the Editorial Policy
defines expertise as the ability to address what evidence cannot. Specifically, the Policy
points to Guyatt and colleagues’ observation that evidence cannot address “the benefits and
risks, inconvenience, and costs associated with alternative management strategies, and … the
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patient's values” (Guyatt, Rennie, Meade & Cook, 2002). This type of knowledge is often
attained through experience, a key contributor to the attainment of expertise (Haynes, 2002).
The sharing of clinical expertise is reflected in the authors’ provision of recommendations,
suggestions, and experiences, and is a key component of building a resource “which
clinicians trust to make the right point-of-care decisions” (UpToDate, “About Us,” 2017). As
reflected in this statement, UpToDate is situated as a trusted colleague upon whom
physicians would call for advice. Positioning UpToDate as a trusted colleague aligns with
longstanding research recognizing the value of colleagues in physician information seeking
and decision-making (Dawes & Sampson, 2003; Leckie, 1996; Verhoeven et al., 1995).
Toward this end, the content producers provide recommendations for treatment, made
explicitly or implicitly, across all cases examined. While, “[i]t is the policy of UpToDate to
make specific recommendations for patient care whenever possible” (UpToDate, “Editorial
Policy,” 2017), explicit recommendations were most prevalent in the entries for Acute Otitis
Media, Fibromyalgia, and Irritable Bowel Syndrome. Further, in alignment with the
UpToDate Editorial Policy, recommendations were often denoted with the phrase ‘we
recommend’ or ‘we suggest’. The use of the collective first person pronoun implicitly
denotes that the recommendation is emerging from the individual (albeit collective)
experience and expertise, rather than directly from the evidence. Explicit recommendations
most often provided details about how to implement or tailor treatments to best meet the
needs of specific patients.
Because there are recognized challenges in effectively applying the results of
structured research studies to the complexities of practice (Greenhalgh, 2002; Greenhalgh &
Weiringa, 2011; May et al., 2006; Tonelli, 1998), recommendations are rarely a reiteration or
intermediation of research conclusions. EBM requires clinicians to translate the results of
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RCTs or systematic reviews into a treatment plan for an individual (May et al., 2006). For
example, unavoidably, the patients who comprise the subject base of a given study, often
those most likely to be responsive, do not necessarily or precisely reflect the population seen
by physicians in their clinics (Daly, 2005). The authors of UpToDate attempt to address this
limitation of evidence by sharing their expertise and experience as a means to provide
recommendations for tailoring treatment for an array of patients. Such recommendations,
shared by the expert authors in UpToDate, reflect the “experiential know-how” of tacit
knowledge (Abidi, Cheah & Curran, 2005, p. 193). Abidi et al. provide a simple
differentiation between explicit and tacit knowledge in health care: Explicit knowledge is
documented and articulated knowledge presented in the published medical literature and
presents “how things should work”; while tacit knowledge focuses on “what really works and
how to make it work” and embodies experiential know-how, personal skills, and intuitive
judgment (p. 194). At times, the tacit knowledge shared by the authors in the analysed entries
seems to be in conflict with the explicit knowledge presented in the published literature. For
example, the authors of the entry for Fibromyalgia are very direct about their perception of
the lack of effectiveness of a single medication in the “real-world”, despite promising study
outcomes:
Despite the clinical trial efficacy, in “realworld experience” the majority
of fibromyalgia patients do not achieve great benefit from any single
medication. (FIB)
Because tacit knowledge relies heavily on personal experiences (anecdotes), individuals with
familiarity and expertise often share their tacit knowledge through personal exchanges
(Panahi, Watson & Partridge, 2015). In health care, informal interactions during which
physicians share their expertise and guidance as it relates to patient care are referred to as
curbside (or hallway) consultations. Curbside consultations are informal physician-to-
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physician information exchanges regarding the management of a particular patient, without
the consultant seeing the patient or keeping any written record (Findling, Shaker, Brickner,
Riordan & Aron, 1996; Kuo, Gifford & Stein, 1998). Information studies scholars have long
recognized interpersonal resources as a key information source of physicians (Dawes &
Sampson, 2003; Elayyan, 1988; Haug, 1997; Leckie, 1996; Verhoeven et al., 1995), and such
interpersonal sources continue to be central avenues—primarily due to ease of accessibility
and time efficiency—through which physicians seek answers to clinical questions (Andrews,
Pearce, Ireson & Love, 2005; Clarke et al., 2013; Gonzalez-Gonzalez et al., 2007). Increasing
workloads and pressure to see more patients may “squeeze out the time that previously
allowed them to provide curbside consultations” (Cook, Sorensen, & Wilkinson, 2014, p.
606). Clinicians may feel uncomfortable imposing on the busy schedules of their colleagues
to ask for guidance and advice. Additional challenges in curbside consultations identified by
Cook et al. include incomplete or misinformation, trouble accessing an expert, and
communication barriers. It may be challenging in the context of a fragmented and busy
health care system to conduct meaningful curbside consultations and so the popularity of
UpToDate may indicate a shift from interpersonal to new digital resources as a source of tacit
knowledge.
UpToDate as Mentor
In addition to providing tacit knowledge about how to implement treatment regimes
in ‘the real world’, UpToDate authors also share their tacit knowledge in relation to what to
expect from the patient encounter. Specifically, most of the entries analyzed for this study
include authors’ perceptions of the patient experience, advice on how to navigate the patientphysician relationship, and descriptions of the challenges in providing care, especially to
those with contested and uncertain diagnoses, treatment and outcomes. The sharing of this
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type of tacit knowledge aligns with the mentorship that occurs in the clinical setting. The role
of senior physicians in providing socialization, guidance, and modeling for younger
colleagues is a long-standing and important tradition in medicine (Boudreau, Macdonald &
Steinert, 2014; Cruess, Cruess, Boudreau, Snell & Steinert, 2015; Kenny, Mann & McLeod,
2002). The information shared about the patient-physician encounter is akin to the tacit
knowledge shared from mentor to mentee.
The authors provide detailed guidance to the reader about how to navigate the patientphysician encounter. For example, they suggest that those experiencing normal grief and
bereavement will appreciate “condolence letters, telephone calls, attending the funeral or
memorial service, and home visits” (NGB). In the entries for Intimate Partner Violence and
Grief & Bereavement, the authors provide talking points and scripts to help physicians speak
with patients. The authors also detail what information physicians should provide to patients
to ensure proper follow-up and self-care.
In addition to providing guidance about navigating the patient-physician relationship,
UpToDate also brings readers’ attention to features of certain conditions that physicians may
find challenging. For example, authors warn readers that doctors “will not be able to satisfy
all patients with [chronic fatigue syndrome]” (CFS), patients will “take up a great deal of
time” (CFS), and doctors “may be surprised or frustrated” (IPV). The authors emphasize that
these conditions are not simple or easy to treat. While the evidence establishes that no
treatment can cure these conditions, the authors’ sharing of professional challenges helps
prepare the reader for interactions with patients. The authors’ experiences and tacit
knowledge of the difficulties faced in practice is also validating to the reader—and is a form
of emotional and psychological support—one of the key components of the mentorship
relationship (Balmer, D’Alessandro, Risko, Gusic, 2011; Taylor, Taylor & Stoller, 2009).
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While UpToDate entries may help to prepare physicians for patient encounters,
especially potentially difficult ones, the authors in these cases place little emphasis on the
role and experience of the patient. For example, the patient’s role in decision-making was
largely ignored in most of the entries directed at clinicians. In the majority of cases
examined, authors position the physician as the primary decision-maker, either by explicitly
stating so or by not mentioning the patient when discussing treatment options in the
professional entries. The physician is, explicitly or implicitly, the individual given primary
responsibility for decision-making in all professional entries except Intimate Partner
Violence. The focus on the physician in decision-making can be contrasted against the patient
information entries which were more likely to suggest a greater decision-making role for the
patient. By placing the responsibility for decisions solely with the physician in the
professional entries, UpToDate may in fact reinforce the patriarchal doctor-centred model of
medicine and, simultaneously, through the patient education material that appears to
contradict this message, set up potential conflicts as a result of competing expectations in the
physician-patient encounter.
The emphasis on physicians’ roles in decision-making found in these case entries
aligns with the literature addressing the socialization of medical students. Specifically, the
teachings of patient-centred care and the role of patients in their own care, which are often
provided early in the medical curriculum and often delivered in the preclinical classroom
sessions with medical students, may be overshadowed by the informal “hidden curriculum”
represented in the experiences and socialization to which students are exposed during their
clinical education (Hafferty, 1998; Haidet et al., 2002). Medical students have demonstrated
an increase in doctor-centred attitudes and a decrease in patient-centredness as they moved
from their pre-clerkship (classroom) training to clinical training (Haidet et al., 2002; Hur,
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Kim, Park, Cho & Choi, 2014). This may be a result of the students’ observations of the
“dissonance between didactic concepts from the curriculum and observed medical practices”
(Gallentine, Salinas-Miranda, Bradley-Klug, Shaffer-Hudkins, Hinojosa & Monroe, 2014, p.
95). Because UpToDate is used heavily by medical students, medical residents and new
medical professionals, the mentorship role of UpToDate has the potential to reinforce the
hidden curriculum of medicine by de-emphasizing the patient in clinical decision-making.
Additionally, the authors’ description of the patient experience via imparting their personal
perceptions, rather than calling upon research, may further reinforce the potential for doctorcentred approaches over patient-centred approaches, as well as re-affirm the position of
UpToDate as mentor.
As noted above, qualitative research was almost entirely absent in the content
analysed. Despite the availability of qualitative research for all but one topic, only two
qualitative studies were cited across all eight entries. As such, patient experience was
presented through the eyes and experiences of the physician, not of the patient. For example,
the authors of the Chronic Fatigue Syndrome entry explain that “[b]ecause of the lack of
laboratory abnormalities, most patients struggle with the validity of their disease (as do many
of their clinicians) and may experience feelings of guilt” (CFS). While the authors describe
what they commonly see in their practice, this information is not situated in the documented
lived experiences that would evolve from a qualitative study. For example, participants in
Winger et al.’s (2014) phenomenological study describe adolescents with CFS observing
their teachers’ doubt and skepticism of their condition through body language and
disbelieving glances. The study emphasized the participants’ feelings of disrespect and
isolation (Winger, Elstedt, Wyller & Helseth, 2014). Qualitative research attempts to capture
patients’ complex and multifaceted lived reality. The lack of inclusion of qualitative evidence
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that captures the illness experience through the lens of the patient may re-enforce the
dominance of the physician perspective.
The authors of UpToDate entries attempt to assist physicians through the patient
encounter, providing guidance and advice, disclosing their practices, and sharing
experiences. This type of information sharing is an essential element of the apprenticeship
model of medical education. In the cases examined in this study, the authors seem
(consciously or unconsciously) to replicate these practices and roles that they have
experienced as trainees and enacted as mentors.
Summary
This analysis, which situates authors, evidence and the patient-physician relationship
within UpToDate, reveals how the function of UpToDate extends beyond that of merely
providing a quick summary of evidence. Through the lens of the Circuit of Culture, expertise
emerges as an important element in the role and meaning of UpToDate in the information
landscape. UpToDate represents an attempt to address documented gaps between evidence
and practice. In particular, the evidence contained within hierarchies such as 6S that are
called upon to inform summary resources appear to be a poor fit when it comes to addressing
the complex needs of individual patients, the need for tailored care, and the challenges of the
patient-physician interaction. Within this research, UpToDate is revealed to be a mediator,
rather than an intermediary, between evidence and clinicians. Specifically, the function of
UpToDate extends to include the roles of mentor and curbside consultant. In these roles,
UpToDate emerges as not only a supplement to, but a technological surrogate for human
interaction and expert consultation. The challenges embedded within these surrogate roles
also mirror those of the human interaction. This dominance of the author in describing the
patient experience, alongside the tendency to place decision-making responsibility with the
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physician, may lead UpToDate to reinforce doctor-centered care, as well as perpetuate the
much criticized ‘art of medicine.’
Limitations and Future Research
Two potential limitations of the current study that may limit the applications of the
findings are: 1) the selection of entries to represent specific phenomena, rather than, for
example, a random selection; and 2) the selection of a single summary resource. While the
selection of eight entries, representing seven topic cases, aligned with the principles of
qualitative research and case study methodology (Cresswell, 2007; Stake, 2006; Yin, 2009),
the extent to which these findings are generalizable across all entries is unknown. These eight
entries were chosen from more than 9,500 topics across 24 specialties. Case study research
allows the researcher to purposefully select cases that represent different contexts for
phenomenon of interest to exist (Stake, 2006). The criteria used to select the eight entries
were to represent varying levels of medicalization, certainty, and contestation within the
cases. These eight entries are not, and are not intended to be, representative of all 9,500
topics. Many of the topics addressed in UpToDate are conditions with recognized organic
causes and have a widely accepted level of certainty in their aetiology, treatment and
outcomes. Additional research is required to evaluate the generalizability of the themes and
analyses from in this study across the numerous topics of UpToDate. For example, future
research may explore how the authors, evidence, and patient-physician relationship is
situated in acute conditions, rare diseases, or conditions that are not considered to be
contested or medicalized.
UpToDate is one example of point of care resources occupying the Summary level
from the 6S Model. Across the literature, UpToDate is consistently reported to be the most
useful product for answering clinical questions (Ahmadi et al., 2011; Campbell & Ash, 2006;
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Thiele, 2010) and is cited to change the way physicians manage patients (Isaac, Xheng &
Jha, 2012). Other resources situated on the Summary level of evidence include DynaMed,
FirstConsult, BMJ’s Best Practice and, generally, clinical practice guidelines from a wide
range of authors (Ahmadi et al., 2011; Campbell & Ash, 2006). Each point of care resource
will apply a different set of editorial policies and make use of different authors. As evident in
this study, editorial policies and author approaches are likely to influence greatly the final
product, especially if standardized criteria are lacking. In order to gain an understanding of
how the findings from this analysis of UpToDate compares to other Summary resources,
repeating such analysis in comparable products would be beneficial. Using the same methods
to analyze the same cases would not only advance understanding of how the author,
evidence, and patient-physician relationship are situated, but should also reveal the overlap
and divergences of what evidence is included and excluded and, in turn, inform a greater
understanding of resource creation and utility. Comparing the same topics in another
summary evidence resource (e.g. DynaMed) would not only expose differences in processes
between two summary resources but would also reveal whether it is possible that two sets of
authors, using the same evidence, arrive at similar or different recommendations and
guidance. Further, exploring differences in the knowledge contained across the resources
(e.g., presence or absence of tacit knowledge) may be useful in understanding the reported
application, utility, and influence of UpToDate (Ahmadi et al., 2011; Campbell & Ash, 2006;
Thiele, 2011; Isaac, Xheng & Jha, 2012).
This study points to additional opportunities for future research for library and
information studies scholars. For example, while research-derived evidence is one part of
evidence-based practice, this analysis accentuates the key roles of expertise and tacit
knowledge in the information practices of physicians (Dawes & Sampson, 2003; Elayyan,
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1988; Haug, 1997; Leckie, 1996; Nasir, Nicholson, Vandermeer, Kumar& Robinson, 2014;
Verhoeven et al., 1995). Building on the results of the current study, future research should
address the consequences of documented shortcomings of evidence-based practice through
the sharing of observations, experiences and acquired expertise. In a resource like UpToDate,
such tacit information guides readers through the clinical encounter, possibly at the cost of
returning to a model of care that is more doctor-centered and that relies on the ‘art of
medicine.’ Further investigation into this dynamic would be valuable.
Future research should also focus on the information seeking behaviours within
UpToDate. This research has identified potential new functions for UpToDate as a
technological surrogate for mentors and curbside consultants. The importance and influence
of the tacit knowledge that contributes to these functions is not known. Are these surrogate
roles a driver for UpToDate’s popularity? If so, what conditions lead to the need for
physicians to seek out this information through technology? Further, what information is
most memorable and most used in UpToDate? How does the importance and application of
the tacit knowledge presented in UpToDate compare to the application of evidence from
clinical studies? Further investigation is needed to understand how the need for UpToDate to
fulfill the role of mentor and consultant developed and to understand the importance and
influence of sharing tacit information alongside clinical evidence.
Conclusion
Prior to the evidence-based medicine movement, clinicians relied heavily on a
knowledge base made up their own experience and the collective experiences of the
profession learned through apprenticeship and modeling (the so-called ‘art’ of medicine) to
navigate decision-making. While evidence based medicine is a widely accepted feature of
contemporary medical practice, the applicability of clinical trials to clinical practice is often
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questioned. Within this context, UpToDate emerges as one of the most popular and heavily
used Summary level, point-of-care evidence resources. While studies have been done
previously to evaluate the utility and features of UpToDate, no critical analysis of the content
has yet been undertaken. This study is an attempt to understand the context, process, and
underlying meaning of how lower order evidence (i.e., studies and synthesis) evolves into
highly applicable evidence in Summary resources.
While it was expected that patterns would emerge based on the level of certainty and
medicalization of the topic, the results of the study indicate that the variability across the
cases did not appear to follow a systematic pattern based on attributes of the cases. In
contrast to the loose adherence to principles of EBM found in UpToDate, structure and
hierarchy are a fundamental features of evidence-based medicine. UpToDate’s lack of
explicit structure calls into question the truth of its primary claim that it is “an evidencebased, physician-authored clinical decision support resource which clinicians trust to make
the right point-of-care decisions” (UpToDate, “About Us,” 2017).
By applying the lens of Science and Technology Studies in this research, the value of
investigating the development of evidence (and evidence tools) as ‘social’ rather than merely
‘technological’ acts has been underlined. Library and information practitioners and scholars
often view the production as an act of intermediation, whereby information is transported
without transformation (Latour, 2005). The present results support Latour’s observation that
individuals who create, develop and package evidence for clinical care “translate, transform,
and modify” research in order to create meaning and initiate change in practitioners (Latour,
p. 39). Authors who contribute to UpToDate not only provide and translate evidence, but also
interpose their own expertise and tacit knowledge. Analysing the results through the lens of
Hall’s Circuit of Culture suggests that expertise is an integral element of the role and
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meaning of UpToDate within the health information environment.
This research broadens what is known about the content and functions of UpToDate
and offers insights that may help to explain the immense popularity of this clinical tool.
UpToDate attempts to address a very real gap between evidence and practice, but this
research sheds light on a ‘hidden curriculum’ that is embedded in the tool. UpToDate
attempts to bridge evidence with practice by incorporating clinical judgment, clinical
expertise, and the incorporation of ways to tailor care for patients with selected evidence;
however, the results of this study raise important questions about the nature of this content
and the potential risk in entrenching physician-centred care and the ‘art of medicine’ —the
very things that evidence-based medicine was intended to attenuate - within a tool marketed
as ‘evidence-based’.
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Selected Conference Presentations 2013-17
Berg, S. A., Hoffmann, K. M., & Koufogiannakis, D. A. (2017). Understanding Research
Productivity: Fresh New Evidence for Librarians. Evidence-Based Library and
Information Practice 9. Philadelphia, Pennsylvania.
Berg, S. A., Hoffmann, K. M., & Koufogiannakis, D. A. (2017). Understanding Ourselves as

Researchers; Critical Reflections on National Survey. Canadian Association of
Professional Academic Librarians. Toronto, Ontario.

Berg, S. A., Hoffmann, K. M., & Koufogiannakis, D. A. (2017). Focus on what matters: Factors that
improve the research productivity of academic librarians. Ontario Library Association,
Toronto, Ontario.
“Success in research: Factors that contribute to research productivity in LIS” May 2014.
Canadian Association of Information Science. St. Catharines, Ontario. (Peer reviewed)
Invited Keynote: Making it our own: Research culture in Canadian academic libraries. April
2014. Concordia Libraries’ 12th Annual Research Forum. Montreal, Quebec. (Closing
Plenary)
“‘I felt like a real librarian’: Field experiences as an opportunity for professional identity
development” January 2013. Association of Library and Information Sciences Education.
Seattle, Washington. with Kristin Hoffmann (Peer reviewed)
"Perceptions of current and ideal research environments: Feedback from the inaugural
Librarians' Research Institute in Canada" July 2013. Evidence Based Library and
Information Practice. Saskatoon, Saskatchewan. With Cathy Maskell (Peer reviewed)
Research Grants and Awards

Canadian Association of Research Libraries Research Grant: Co-Principal-Investigator
Co-op Placements in Academic Libraries: Their Role in the Formation of Professional Identity
- Award Date: November 2009

Research Grant for Women (University of Windsor): Principal Investigator
Early Medical Students Perceptions of Information Application & Exchange in Clinical Settings
- Award Date: April 2009
Courses Taught

W2014 & W2015
2009- 2015
2010- 2015

LIS 9320: Consumer Health
Faculty of Information and Media Studies, Western University
Patient Centered Context: Integration & Application Year 1
Schulich School of Medicine, Windsor Program
Patient Centered Context: Integration & Application Year 2
Schulich School of Medicine, Windsor Program
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Related Teaching Experiences
Research Workshops
May 2016
October 2015
March 2015
Nov 2014
May 2014

Delving Deeper: Building a Meaningful Program of Research
CAPAL 2016 Pre-conference Workshop (workshop design only)
Transforming Ideas into Well-Designed Research Questions
C-EBLIP 2015 Pre-symposium Workshop

Questions, Methods, and Habits: Preconference Workshop
Association of College and Research Libraries Conference, Seattle
Presented with Heidi LM Jacobs and Kristin Hoffmann

Librarians as Researchers
Grant McEwan Library, Edmonton
Workshop presented with Heidi LM Jacobs and Denise Koufogiannakis
Questions, Methods, & Habits: A Research Workshop
University of Toronto Libraries
Workshop presented with Heidi LM Jacobs and Kristin Hoffmann

Selected Service to Library and Academic Community
2015- present
2014- present
2012- present
2015- 2016
2013 and 2014
2010 – 2012

Reviewer: Canadian Journal of Academic Librarianship
Canadian Association of Professional Academic Librarians

Reviewer: Partnership Journal
Partnership: The Provincial and Territorial Library Assocs of Canada

Reviewer: Journal of Academic Librarianship
Elsevier

Researcher-in-Residence
Centre for Evidence-Based Library and Information Practice

University of Saskatchewan
Librarians’ Research Institute, Program Chair
Canadian Association of Research Libraries

2012 Librarians’ Research Institute, Creator, and Program Chair
Canadian Association of Research Libraries

